Medications for human use with a single active ingredient starting with the letter A-C.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre A-C.

Update: 2021-06-04
Product Name;
DIN;
Active ingredient(s) and concentration;
Original market date;
Route(s) of administration;
Dosage form(s);
AHFS;
Schedule;
Company
Monograph
ZIAGEN;
02240358;
abacavir (abacavir sulfate) 20 mg / ml;
1999-06-15;
Oral;
Solution;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63900
ZIAGEN;
02240357;
abacavir (abacavir sulfate) 300 mg;
1999-06-09;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63899
APO-ABACAVIR;
02396769;
abacavir (abacavir sulfate) 300 mg;
2016-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88178
MINT-ABACAVIR;
02480956;
abacavir (abacavir sulfate) 300 mg;
2019-03-25;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97160
ORENCIA;
02402475;
abatacept 125 mg / ml;
2013-05-09;
Subcutaneous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88731
ORENCIA;
02282097;
abatacept 250 mg / vial;
2006-08-08;
Intravenous;
Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76776
VERZENIO;
02487101;
abemaciclib 100 mg;
2019-07-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97724
VERZENIO;
02487128;
abemaciclib 150 mg;
2019-07-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97725
VERZENIO;
02487136;
abemaciclib 200 mg;
2019-07-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97726
VERZENIO;
02487098;
abemaciclib 50 mg;
2019-07-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97723
ZYTIGA;
02371065;
abiraterone acetate 250 mg;
2011-07-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85626
REDDY-ABIRATERONE;
02477114;
abiraterone acetate 250 mg;
2021-03-26;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96788
SANDOZ ABIRATERONE;
02486393;
abiraterone acetate 250 mg;
2021-01-18;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97660
APO-ABIRATERONE FILM COATED TABLETS;
02491397;
abiraterone acetate 250 mg;
2021-01-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98140
PMS-ABIRATERONE;
02492601;
abiraterone acetate 250 mg;
2021-01-11;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98260
NAT-ABIRATERONE;
02494132;
abiraterone acetate 250 mg;
2021-01-18;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98417
JAMP ABIRATERONE;
02502305;
abiraterone acetate 250 mg;
2021-02-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99188
MAR-ABIRATERONE;
02503980;
abiraterone acetate 250 mg;
2021-02-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99344
ZYTIGA;
02457113;
abiraterone acetate 500 mg;
2016-09-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94420
APO-ABIRATERONE FILM COATED TABLETS;
02491400;
abiraterone acetate 500 mg;
2021-01-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98141
PMS-ABIRATERONE;
02501503;
abiraterone acetate 500 mg;
2021-01-11;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99112
MAR-ABIRATERONE;
02503999;
abiraterone acetate 500 mg;
2021-02-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99345
DYSPORT AESTHETIC;
02387735;
abobotulinumtoxina 300 unit / vial;
2013-02-19;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
IPSEN BIOPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87332
DYSPORT THERAPEUTIC;
02460203;
abobotulinumtoxina 300 unit / vial;
2017-02-27;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
IPSEN BIOPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94749
DYSPORT THERAPEUTIC;
02456117;
abobotulinumtoxina 500 unit / vial;
2017-02-27;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
IPSEN BIOPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94296
CALQUENCE;
02491788;
acalabrutinib 100 mg;
2019-10-02;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98179
CAMPRAL;
02293269;
acamprosate calcium 333 mg;
2007-07-30;
Oral;
Tablet (Delayed-Release);
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77863
GLUCOBAY;
02190893;
acarbose 100 mg;
1996-02-02;
Oral;
Tablet;
68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19655
ACARBOSE TABLETS;
02493799;
acarbose 100 mg;
2020-05-28;
Oral;
Tablet;
68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98379
MAR-ACARBOSE;
02494086;
acarbose 100 mg;
2020-02-05;
Oral;
Tablet;
68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98411
GLUCOBAY;
02190885;
acarbose 50 mg;
1996-02-02;
Oral;
Tablet;
68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19648
ACARBOSE TABLETS;
02493780;
acarbose 50 mg;
2020-05-28;
Oral;
Tablet;
68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98378
MAR-ACARBOSE;
02494078;
acarbose 50 mg;
2020-02-05;
Oral;
Tablet;
68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98410
APO-ACEBUTOLOL;
02147602;
acebutolol (acebutolol hydrochloride) 100 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17826
ACEBUTOLOL-100;
02164396;
acebutolol (acebutolol hydrochloride) 100 mg;
1996-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19939
TEVA-ACEBUTOLOL;
02204517;
acebutolol (acebutolol hydrochloride) 100 mg;
1996-08-16;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42996
APO-ACEBUTOLOL;
02147610;
acebutolol (acebutolol hydrochloride) 200 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17827
ACEBUTOLOL-200;
02164418;
acebutolol (acebutolol hydrochloride) 200 mg;
1996-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19940
TEVA-ACEBUTOLOL;
02204525;
acebutolol (acebutolol hydrochloride) 200 mg;
1996-08-16;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42997
APO-ACEBUTOLOL;
02147629;
acebutolol (acebutolol hydrochloride) 400 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17828
ACEBUTOLOL – 400;
02164426;
acebutolol (acebutolol hydrochloride) 400 mg;
1996-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19941
TEVA-ACEBUTOLOL;
02204533;
acebutolol (acebutolol hydrochloride) 400 mg;
1996-08-16;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42998
ACETAMINOPHEN INJECTION;
02483343;
acetaminophen 10 mg / ml;
2019-09-13;
Intravenous;
Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
AVIR PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97378
ACET 120;
02230434;
acetaminophen 120 mg;
1998-01-05;
Rectal;
Suppository;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49357
ACETAMINOPHEN CHEWABLE TABLETS 160 MG;
01996169;
acetaminophen 160 mg;
1993-12-31;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14449
ACETAMINOPHEN CHEWABLE TABLETS 160 MG FOR CHILDREN;
02017431;
acetaminophen 160 mg;
1993-12-31;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14450
ACET 160;
02230435;
acetaminophen 160 mg;
1998-01-05;
Rectal;
Suppository;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49359
ACETAMINOPHEN 160 MG CHEWABLE TABLETS;
02237562;
acetaminophen 160 mg;
1998-08-27;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60900
CHILDREN’S TYLENOL CHEWABLES;
02241361;
acetaminophen 160 mg;
2000-08-22;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64993
CHILDREN’S TYLENOL FEVER & SORE THROAT PAIN;
02435144;
acetaminophen 160 mg;
2015-07-06;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91942
JUNIOR STRENGTH CHILDREN’S ACETAMINOPHEN TABLETS;
02447819;
acetaminophen 160 mg;
2018-03-07;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93341
PDP-ACETAMINOPHEN SOLUTION 160MG/5ML;
00792691;
acetaminophen 160 mg / 5 ml;
1990-12-31;
Oral;
Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10450
ACETAMINOPHEN ORAL SOL FOR CHILDREN USP;
01958836;
acetaminophen 160 mg / 5 ml;
1992-12-31;
Oral;
Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12412
ACETAMINOPHENE – LIQ 160 MG/5 ML;
02226871;
acetaminophen 160 mg / 5 ml;
1997-01-31;
Oral;
Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33482
TEMPRA DOUBLE STRENGTH CHILDREN’S SYRUP;
00875996;
acetaminophen 160 mg / 5 ml;
1985-12-31;
Oral;
Syrup;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42066
PEDIATRIX;
02027798;
acetaminophen 160 mg / 5 ml;
1993-12-31;
Oral;
Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42135
CHILDREN’S TYLENOL;
02046040;
acetaminophen 160 mg / 5 ml;
1992-12-31;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42388
CHILDREN’S ACETAMINOPHEN SUSPENSION;
02236728;
acetaminophen 160 mg / 5 ml;
1998-10-31;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60014
CHILDREN’S FEVER FROM COLDS OR FLU;
02371138;
acetaminophen 160 mg / 5 ml;
2013-02-28;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85631
CHILDREN’S TYLENOL FEVER & SORE THROAT PAIN;
02389924;
acetaminophen 160 mg / 5 ml;
2018-05-28;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87539
CHILDREN’S ACETAMINOPHEN DYE-FREE;
02468417;
acetaminophen 160 mg / 5 ml;
2018-08-02;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95684
APO-ACETAMINOPHEN;
00544981;
acetaminophen 325 mg;
1982-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4733
NOVO-GESIC;
00389218;
acetaminophen 325 mg;
1982-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5035
TYLENOL REGULAR STRENGTH;
00559393;
acetaminophen 325 mg;
1961-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5254
ACETAMINOPHEN TABLETS 325 MG;
00605751;
acetaminophen 325 mg;
1983-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5570
TYLENOL REGULAR STRENGTH CAPLETS;
00723894;
acetaminophen 325 mg;
1985-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8597
ACETAMINOPHEN TAB 325MG USP;
00789801;
acetaminophen 325 mg;
1989-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9628
ACÉTAMINOPHÈNE COMPRIMÉ TABLET 325;
02022214;
acetaminophen 325 mg;
1993-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14130
ACETAMINOPHEN 325 MG USP REGULAR STRENGTH;
00743542;
acetaminophen 325 mg;
1993-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14475
ACETAMINOPHEN CAPLET 325MG USP;
01977415;
acetaminophen 325 mg;
1995-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19418
JAMP ACETAMINOPHEN 325;
01938088;
acetaminophen 325 mg;
2003-07-02;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22086
APO-ACETAMINOPHEN CAPLETS;
02229873;
acetaminophen 325 mg;
1998-10-14;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48231
ACET 325;
02230436;
acetaminophen 325 mg;
1998-01-05;
Rectal;
Suppository;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49360
ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH;
02252805;
acetaminophen 325 mg;
2004-12-20;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73774
REGULAR STRENGTH ACETAMINOPHEN;
02332647;
acetaminophen 325 mg;
2014-02-04;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81831
ACÉTAMINOPHÈNE CAPLET 325;
02362198;
acetaminophen 325 mg;
2014-12-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84722
ACETAMINOPHEN CAPLETS 325 MG;
02362341;
acetaminophen 325 mg;
2011-06-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84736
ACETAMINOPHEN TABLETS USP 325 MG;
02362422;
acetaminophen 325 mg;
2011-05-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84743
TYLENOL LIQUID GELS;
02407612;
acetaminophen 325 mg;
2016-06-08;
Oral;
Capsule;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89234
APO-ACETAMINOPHEN EXTRA STRENGTH;
00545007;
acetaminophen 500 mg;
1982-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4734
NOVO-GESIC FORTE;
00482323;
acetaminophen 500 mg;
1983-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5184
TYLENOL EXTRA STRENGTH;
00559407;
acetaminophen 500 mg;
1975-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5255
ACETAMINOPHEN 500 MG TABLETS USP EXTRA STRENGTH;
00549703;
acetaminophen 500 mg;
1983-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5476
EXTRA STRENGTH ACETAMINOPHEN TABLETS 500 MG;
00605778;
acetaminophen 500 mg;
1983-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5571
TYLENOL EXTRA STRENGTH CAPLETS;
00723908;
acetaminophen 500 mg;
1985-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8387
ACETAMINOPHEN TAB 500MG USP;
00789798;
acetaminophen 500 mg;
1989-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9627
TYLENOL RAPID RELEASE;
00863270;
acetaminophen 500 mg;
1989-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13865
ACÉTAMINOPHÈNE COMPRIMÉ TABLET 500;
02022222;
acetaminophen 500 mg;
1993-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14131
PAINAID FREE ACETAMINOPHEN TABLETS – 500MG;
02144514;
acetaminophen 500 mg;
1995-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
ZEE MEDICAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19084
ACETAMINOPHEN CAPLET 500MG;
01977474;
acetaminophen 500 mg;
1995-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19419
JAMP ACETAMINOPHEN 500;
01939122;
acetaminophen 500 mg;
2003-07-02;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22143
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH;
02229977;
acetaminophen 500 mg;
1998-10-14;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48431
TAMINOL CAPLETS;
02244331;
acetaminophen 500 mg;
2006-12-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VIVA PHARMACEUTICAL INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68299
ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH;
02252813;
acetaminophen 500 mg;
2004-09-17;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73775
ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW;
02255251;
acetaminophen 500 mg;
2005-01-20;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74040
EXTRA STRENGTH ACETAMINOPHEN;
02285797;
acetaminophen 500 mg;
2006-10-10;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77128
RAPID ACTION;
02319942;
acetaminophen 500 mg;
2009-09-24;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80540
EXTRA STRENGTH ACETAMINOPHEN CAPLETS;
02326698;
acetaminophen 500 mg;
2014-02-03;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81204
JAMP ACETAMINOPHEN BLAZON 500;
02355299;
acetaminophen 500 mg;
2011-11-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84054
ACÉTAMINOPHÈNE BLASON SHIELD 500;
02362201;
acetaminophen 500 mg;
2014-12-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84723
ACÉTAMINOPHÈNE CAPLET 500;
02362228;
acetaminophen 500 mg;
2014-12-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84724
ACETAMINOPHEN TABLETS USP 500 MG;
02362244;
acetaminophen 500 mg;
2011-09-26;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84726
ACETAMINOPHEN CAPLETS 500 MG;
02362368;
acetaminophen 500 mg;
2011-05-26;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84737
ACETAMINOPHEN EXTRA STRENGTH LIQUID GELS;
02469928;
acetaminophen 500 mg;
2019-03-14;
Oral;
Capsule;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95882
ACET 650;
02230437;
acetaminophen 650 mg;
1998-01-05;
Rectal;
Suppository;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49361
TYLENOL ARTHRITIS PAIN 8H;
02238885;
acetaminophen 650 mg;
1999-11-10;
Oral;
Tablet (Extended-Release);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62325
TYLENOL MUSCLE & BODY;
02246060;
acetaminophen 650 mg;
2002-11-01;
Oral;
Tablet (Extended-Release);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70191
ACETAMINOPHEN ARTHRITIS PAIN;
02272482;
acetaminophen 650 mg;
2006-08-28;
Oral;
Tablet (Extended-Release);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75800
MUSCLE ACHES AND BODY PAIN RELIEF;
02455560;
acetaminophen 650 mg;
2016-08-15;
Oral;
Tablet (Extended-Release);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94236
ARTHRITIS PAIN RELIEF;
02371146;
acetaminophen 650.0 mg;
2012-04-16;
Oral;
Tablet (Extended-Release);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85632
ACETAMINOPHEN CHEWABLE TABLETS 80 MG;
01905856;
acetaminophen 80 mg;
1991-12-31;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11794
ACETAMINOPHEN CHEWABLE TABLETS 80 MG FOR CHILDREN;
02017458;
acetaminophen 80 mg;
1993-12-31;
Oral;
Tablet (Chewable);
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14206
TEMPRA INFANT DROPS;
00875988;
acetaminophen 80 mg / ml;
1991-12-31;
Oral;
Drops;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41869
PEDIATRIX DROPS;
02027801;
acetaminophen 80 mg / ml;
1993-12-31;
Oral;
Drops;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42136
INFANTS’ TYLENOL;
02046059;
acetaminophen 80 mg / ml;
1992-12-31;
Oral;
Drops;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42341
INFANTS’ TYLENOL FEVER & SORE THROAT PAIN;
02389908;
acetaminophen 80 mg / ml;
2018-08-03;
Oral;
Drops;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87537
TEMPRA CHILDREN’S SYRUP;
00884553;
acetaminophen 80 mg / 5 ml;
1991-12-31;
Oral;
Syrup;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41867
ACETAZOLAMIDE FOR INJECTION, USP;
02358328;
acetazolamide (acetazolamide sodium) 500 mg / vial;
2010-12-03;
Intravenous;
Powder For Solution;
52:40.00 – ANTIGLAUCOMA AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84336
ACETAZOLAMIDE;
00545015;
acetazolamide 250 mg;
1982-12-31;
Oral;
Tablet;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4899
MIOCHOL E;
02133326;
acetylcholine chloride 20 mg / vial;
1996-08-14;
Ophthalmic;
Powder For Solution;
52:40.20 – MIOTICS;
Prescription;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31096
ACETYLCYSTEINE SOLUTION USP;
02459906;
acetylcysteine 200 mg / ml;
2018-01-26;
Inhalation , Intravenous , Oral;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94721
NOVASEN;
00216666;
acetylsalicylic acid 325 mg;
1976-12-31;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3369
ASA 325MG;
00530336;
acetylsalicylic acid 325 mg;
1981-12-31;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4272
ASPIRIN REGULAR STRENGTH;
02150328;
acetylsalicylic acid 325 mg;
1970-12-31;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19474
ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH;
02150417;
acetylsalicylic acid 325 mg;
1995-12-31;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19489
ACETYLSALICYLIC ACID 325MG TABLETS USP;
02252856;
acetylsalicylic acid 325 mg;
2004-11-12;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73778
ASPIRIN EXTRA STRENGTH;
02150336;
acetylsalicylic acid 500 mg;
1995-12-31;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19475
ACETYLSALICYLIC ACID EXTRA STRENGTH 500MG TABLETS USP;
02252864;
acetylsalicylic acid 500 mg;
2004-11-19;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73779
ASA 500 MG TABLETS EXTRA STRENGTH;
02270323;
acetylsalicylic acid 500 mg;
2013-05-02;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75571
NOVASEN;
00229296;
acetylsalicylic acid 650 mg;
1976-12-31;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2410
ASAPHEN;
02009013;
acetylsalicylic acid 80 mg;
1995-12-31;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18349
RIVASA 80MG CROQUABLE – TAB;
02202352;
acetylsalicylic acid 80 mg;
1999-12-01;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36346
RIVASA FC;
02202360;
acetylsalicylic acid 80 mg;
2004-01-01;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36347
ASAPHEN E.C. 80 MG;
02238545;
acetylsalicylic acid 80 mg;
1998-12-03;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61971
JAMP-ASA CHEW;
02269139;
acetylsalicylic acid 80 mg;
2006-10-26;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75453
ASATAB 80 MG CHEWABLE TABLETS;
02280167;
acetylsalicylic acid 80 mg;
2006-05-23;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76584
JAMP-ASA EC;
02283905;
acetylsalicylic acid 80 mg;
2006-09-28;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76948
PRO-AAS EC – 80;
02311496;
acetylsalicylic acid 80 mg;
2008-07-03;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79706
PRO-AAS – 80 (CROQUABLE);
02311518;
acetylsalicylic acid 80 mg;
2008-07-03;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79707
SNS-ASA EC;
02427176;
acetylsalicylic acid 80 mg;
2014-07-16;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91170
M-ASA 80 MG CROQUABLE;
02429950;
acetylsalicylic acid 80 mg;
2015-02-11;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91435
RIVASA 80 MG EC;
02485222;
acetylsalicylic acid 80 mg;
2019-02-01;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97547
ASA 80MG;
02497115;
acetylsalicylic acid 80 mg;
2020-11-27;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98698
BIO-ASA;
02515687;
acetylsalicylic acid 80 mg;
2021-05-25;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100507
ASPIRIN 81MG;
02237726;
acetylsalicylic acid 81 mg;
1998-09-02;
Oral;
Tablet (Enteric-Coated);
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61080
ENTROPHEN;
02242281;
acetylsalicylic acid 81 mg;
2000-06-20;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65982
ENTROPHEN CHEWABLE;
02243974;
acetylsalicylic acid 81 mg;
2001-11-01;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67917
ASA 81 MG;
02244993;
acetylsalicylic acid 81 mg;
2001-11-30;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68992
PRAXIS ASA EC 81 MG DAILY LOW DOSE;
02283700;
acetylsalicylic acid 81 mg;
2006-08-15;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76929
ASPIRIN 81MG QUICK CHEWS;
02289970;
acetylsalicylic acid 81 mg;
2007-05-22;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77528
ENTERIC COATED DAILY LOW DOSE ASA 81MG;
02363127;
acetylsalicylic acid 81 mg;
2011-06-27;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84814
ASA 81 MG;
02372177;
acetylsalicylic acid 81 mg;
2012-01-12;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85732
ASA DAILY LOW DOSE;
02394790;
acetylsalicylic acid 81 mg;
2013-05-01;
Oral;
Tablet (Chewable);
28:08.04.24 – SALICYLATES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87994
RIVASA 81 MG EC;
02420279;
acetylsalicylic acid 81 mg;
2014-03-20;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90486
ASA EC;
02426811;
acetylsalicylic acid 81 mg;
2014-07-25;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91137
JAMP-ASA 81MG EC;
02427206;
acetylsalicylic acid 81 mg;
2015-01-13;
Oral;
Tablet (Enteric-Coated);
28:08.04.24 – SALICYLATES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91173
ASA;
02433044;
acetylsalicylic acid 81 mg;
2015-05-06;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91745
ASA 81 MG;
02449277;
acetylsalicylic acid 81 mg;
2016-04-20;
Oral;
Tablet (Delayed-Release);
28:08.04.24 – SALICYLATES;
Otc;
LABORATOIRES TRIANON INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93510
SORIATANE;
02070847;
acitretin 10 mg;
1994-12-31;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16168
TARO-ACITRETIN;
02466074;
acitretin 10 mg;
2018-02-06;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95437
MINT-ACITRETIN;
02468840;
acitretin 10 mg;
2018-01-24;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95745
SORIATANE;
02070863;
acitretin 25 mg;
1994-12-31;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16167
TARO-ACITRETIN;
02466082;
acitretin 25 mg;
2018-03-26;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95438
MINT-ACITRETIN;
02468859;
acitretin 25 mg;
2018-01-24;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95746
TUDORZA GENUAIR;
02409720;
aclidinium bromide 400 mcg / act;
2013-09-13;
Inhalation;
Powder (Metered Dose);
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89440
ACYCLOVIR SODIUM INJECTION;
02236916;
acyclovir (acyclovir sodium) 25 mg / ml;
1998-03-18;
Intravenous;
Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60208
ACYCLOVIR SODIUM INJECTION;
02236926;
acyclovir (acyclovir sodium) 50 mg / ml;
1998-05-08;
Intravenous;
Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60218
ACYCLOVIR SODIUM INJECTION;
02456524;
acyclovir (acyclovir sodium) 50 mg / ml;
2018-09-24;
Intravenous;
Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94341
ACYCLOVIR SODIUM INJECTION;
02494558;
acyclovir (acyclovir sodium) 50 mg / ml;
2020-10-21;
Intravenous;
Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98455
APO-ACYCLOVIR – TAB 200MG;
02207621;
acyclovir 200 mg;
1997-08-22;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43018
MYLAN-ACYCLOVIR;
02242784;
acyclovir 200 mg;
2000-09-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66607
TEVA-ACYCLOVIR;
02285959;
acyclovir 200 mg;
2006-10-23;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77144
ZOVIRAX;
00886157;
acyclovir 200 mg / 5 ml;
1991-12-31;
Oral;
Suspension;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11416
APO-ACYCLOVIR – TAB 400MG;
02207648;
acyclovir 400 mg;
1997-08-22;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43019
MYLAN-ACYCLOVIR;
02242463;
acyclovir 400 mg;
2000-06-30;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66188
TEVA-ACYCLOVIR;
02285967;
acyclovir 400 mg;
2006-10-23;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77145
ZOVIRAX;
00569771;
acyclovir 5 % / w/w;
1982-12-31;
Topical;
Ointment;
84:04.06 – ANTIVIRALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4959
ZOVIRAX;
02039524;
acyclovir 5 % / w/w;
1993-12-31;
Topical;
Cream;
84:04.06 – ANTIVIRALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15525
APO-ACYCLOVIR OINTMENT;
02477130;
acyclovir 5 % / w/w;
2019-03-14;
Topical;
Ointment;
84:04.06 – ANTIVIRALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96789
APO-ACYCLOVIR;
02207656;
acyclovir 800 mg;
1997-08-22;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43020
MYLAN-ACYCLOVIR;
02242464;
acyclovir 800 mg;
2000-06-30;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66189
TEVA-ACYCLOVIR;
02285975;
acyclovir 800 mg;
2006-10-23;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77146
HUMIRA;
02474263;
adalimumab 20 mg / 0.2 ml;
2020-08-18;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96431
HYRIMOZ;
02505258;
adalimumab 20 mg / 0.4 ml;
2021-02-15;
Subcutaneous;
Solution;
#N/A;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99460
HUMIRA;
02258595;
adalimumab 40 mg / 0.8 ml;
2004-09-24;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74379
HADLIMA;
02473097;
adalimumab 40 mg / 0.8 ml;
2021-02-19;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS , 92:20.00 – Immunomodulatory Agents , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SAMSUNG BIOEPIS CO., LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96243
HADLIMA PUSHTOUCH;
02473100;
adalimumab 40 mg / 0.8 ml;
2021-02-19;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS , 92:20.00 – Immunomodulatory Agents , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SAMSUNG BIOEPIS CO., LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96244
HYRIMOZ;
02492156;
adalimumab 40 mg / 0.8 ml;
2021-02-15;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98214
HYRIMOZ;
02492164;
adalimumab 40 mg / 0.8 ml;
2021-02-15;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98215
HULIO;
02502399;
adalimumab 40 mg / 0.8 ml;
2021-02-16;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99197
HULIO;
02502402;
adalimumab 40 mg / 0.8 ml;
2021-02-16;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99198
IDACIO;
02502674;
adalimumab 40 mg / 0.8 ml;
2021-02-16;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99222
AMGEVITA;
02459299;
adalimumab 50 mg / ml;
2021-02-19;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94649
AMGEVITA;
02459302;
adalimumab 50 mg / ml;
2021-02-19;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94650
AMGEVITA;
02459310;
adalimumab 50 mg / ml;
2021-02-19;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94651
DIFFERIN;
02148749;
adapalene 0.1 %;
1996-12-31;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20107
DIFFERIN;
02231592;
adapalene 0.1 %;
1998-01-08;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50959
DIFFERIN XP;
02274000;
adapalene 0.3 %;
2007-07-19;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75946
HEPSERA;
02247823;
adefovir dipivoxil 10 mg;
2006-04-18;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72117
AA-ADEFOVIR;
02420333;
adefovir dipivoxil 10 mg;
2014-08-07;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90493
ADENOCARD INJECTION -PRE-FILLED SYRINGE;
02145820;
adenosine 3 mg / ml;
1994-12-31;
Intravenous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19437
ADENOSINE INJECTION;
02267659;
adenosine 3 mg / ml;
2007-03-27;
Intravenous;
Solution;
24:04.04.24 – CLASS IV ANTIARRYTHMICS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75307
ADENOSINE INJECTION;
02457474;
adenosine 3 mg / ml;
2017-08-17;
Intravenous;
Solution;
24:04.04.24 – CLASS IV ANTIARRYTHMICS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94452
ADENOSINE INJECTION;
02457482;
adenosine 3 mg / ml;
2017-08-17;
Intravenous;
Solution;
24:04.04.24 – CLASS IV ANTIARRYTHMICS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94453
GIOTRIF;
02415666;
afatinib (afatinib dimaleate) 20 mg;
2014-01-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90026
GIOTRIF;
02415674;
afatinib (afatinib dimaleate) 30 mg;
2014-01-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90027
GIOTRIF;
02415682;
afatinib (afatinib dimaleate) 40 mg;
2014-01-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90028
EYLEA;
02415992;
aflibercept 40 mg / ml;
2013-12-23;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription , Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90055
EYLEA;
02505355;
aflibercept 40 mg / ml;
2020-11-17;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription , Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99471
REPLAGAL;
02249057;
agalsidase alfa 1 mg / ml;
2004-03-18;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73392
FABRAZYME;
02248966;
agalsidase beta 35 mg / vial;
2004-04-08;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73341
FABRAZYME;
02248965;
agalsidase beta 5 mg / vial;
2004-09-17;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73340
MEDICAL AIR 100%;
00572837;
air 100 %;
1911-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5684
DILUENT FOR ALLERGENIC EXTRACT STERILE ALBUMIN SALINE WITH PHENOL;
02223732;
albumin (human) 0.03 %;
1996-12-16;
Intradermal , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43388
STERILE DILUENT FOR ALLERGENIC EXTRACT – ALBUMIN SALINE WITH PHENOL;
02283735;
albumin (human) 0.03 %;
2007-03-02;
Intravenous;
Solution;
40:50.00* – DILUENTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76932
STERILE DILUENT FOR ALLERGENIC EXTRACTS NORMAL SALINE WITH HSA;
02375141;
albumin (human) 0.03 %;
2014-02-19;
Intradermal , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86055
ALBUMIN (HUMAN) 25% SOLUTION USP;
02223708;
albumin (human) 25 %;
1997-02-10;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
GRIFOLS THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43385
OCTALBIN 25%;
02267357;
albumin (human) 25 %;
2015-01-06;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75278
ALBUREX – 25;
02274663;
albumin (human) 25 %;
2007-10-16;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76014
ALBUMIN (HUMAN) 5% SOLUTION, USP;
02223694;
albumin (human) 5 %;
1997-05-06;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
GRIFOLS THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43384
ALBUREX – 5;
02274655;
albumin (human) 5 %;
2008-01-15;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76013
OCTALBIN 5%;
02302705;
albumin (human) 5 %;
2015-01-06;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78800
PLASBUMIN-5;
02189100;
albumin (human) 50 mg / ml;
1997-01-17;
Intravenous;
Solution;
16:00.00 – BLOOD DERIVATIVES;
Schedule D;
GRIFOLS THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42926
PROLEUKIN;
02130181;
aldesleukin 22000000 unit / vial;
1995-12-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18314
ALECENSARO;
02458136;
alectinib (alectinib hydrochloride) 150 mg;
2016-10-14;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94518
LEMTRADA;
02418320;
alemtuzumab 12 mg / 1.2 ml;
2014-01-29;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90290
MABCAMPATH;
02290960;
alemtuzumab 30 mg / ml;
2007-09-07;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77636
TEVA-ALENDRONATE;
02247373;
alendronic acid (alendronate sodium) 10 mg;
2003-05-12;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71618
SANDOZ ALENDRONATE;
02288087;
alendronic acid (alendronate sodium) 10 mg;
2007-01-11;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77347
ACH-ALENDRONATE;
02381486;
alendronic acid (alendronate sodium) 10 mg;
2012-03-20;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86733
AURO-ALENDRONATE;
02388545;
alendronic acid (alendronate sodium) 10 mg;
2012-07-26;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87407
TEVA-ALENDRONATE;
02248251;
alendronic acid (alendronate sodium) 5 mg;
2003-12-23;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72588
APO-ALENDRONATE;
02248727;
alendronic acid (alendronate sodium) 5 mg;
2004-05-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73095
ACH-ALENDRONATE;
02381478;
alendronic acid (alendronate sodium) 5 mg;
2012-03-20;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86732
FOSAMAX;
02245329;
alendronic acid (alendronate sodium) 70 mg;
2002-02-14;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69356
APO-ALENDRONATE;
02248730;
alendronic acid (alendronate sodium) 70 mg;
2005-05-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73098
TEVA-ALENDRONATE;
02261715;
alendronic acid (alendronate sodium) 70 mg;
2005-05-31;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74709
RIVA-ALENDRONATE;
02270889;
alendronic acid (alendronate sodium) 70 mg;
2005-09-12;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75626
PMS-ALENDRONATE-FC;
02284006;
alendronic acid (alendronate sodium) 70 mg;
2006-08-15;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76957
SANDOZ ALENDRONATE;
02288109;
alendronic acid (alendronate sodium) 70 mg;
2007-01-11;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77349
ALENDRONATE;
02299712;
alendronic acid (alendronate sodium) 70 mg;
2008-03-13;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78508
ALENDRONATE-70;
02303078;
alendronic acid (alendronate sodium) 70 mg;
2008-07-11;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78840
ALENDRONATE;
02352966;
alendronic acid (alendronate sodium) 70 mg;
2010-07-30;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83819
ACH-ALENDRONATE;
02381494;
alendronic acid (alendronate sodium) 70 mg;
2012-03-20;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86734
JAMP-ALENDRONATE;
02385031;
alendronic acid (alendronate sodium) 70 mg;
2012-06-18;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87070
AURO-ALENDRONATE;
02388553;
alendronic acid (alendronate sodium) 70 mg;
2012-07-26;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87408
AG-ALENDRONATE;
02485184;
alendronic acid (alendronate sodium) 70 mg;
2021-02-05;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97543
MINT-ALENDRONATE;
02394871;
alendronic acid (alendronate sodium) 70.0 mg;
2012-11-21;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88003
PROLASTIN-C;
02204606;
alfa 1-proteinase inhibitor (human) 1000 mg / vial;
1996-11-11;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Schedule D;
GRIFOLS THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43004
ONE-ALPHA;
00474517;
alfacalcidol 0.25 mcg;
1980-12-31;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7292
ONE-ALPHA;
00474525;
alfacalcidol 1 mcg;
1980-12-31;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7293
ONE-ALPHA;
02240329;
alfacalcidol 2 mcg / ml;
2000-12-04;
Oral;
Drops;
88:16.00 – VITAMIN D;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63869
ONE-ALPHA;
02242502;
alfacalcidol 2 mcg / ml;
2001-02-20;
Intravenous;
Liquid;
88:16.00 – VITAMIN D;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66245
XATRAL;
02245565;
alfuzosin hydrochloride 10 mg;
2002-02-21;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69657
SANDOZ ALFUZOSIN;
02304678;
alfuzosin hydrochloride 10 mg;
2008-08-28;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78993
APO-ALFUZOSIN;
02315866;
alfuzosin hydrochloride 10 mg;
2008-08-20;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80137
AURO-ALFUZOSIN;
02443201;
alfuzosin hydrochloride 10 mg;
2015-09-02;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92777
ALFUZOSIN;
02447576;
alfuzosin hydrochloride 10 mg;
2015-11-25;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93315
MYOZYME;
02284863;
alglucosidase alfa 50 mg / vial;
2006-12-06;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77041
PRALUENT;
02453835;
alirocumab 150 mg / ml;
2016-04-29;
Subcutaneous;
Solution;
24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94037
PRALUENT;
02453819;
alirocumab 75 mg / ml;
2016-05-18;
Subcutaneous;
Solution;
24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94035
RASILEZ;
02302063;
aliskiren (aliskiren fumarate) 150 mg;
2007-11-26;
Oral;
Tablet;
24:32.40 – RENIN INHIBITORS;
Prescription;
NODEN PHARMA DAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78739
RASILEZ;
02302071;
aliskiren (aliskiren fumarate) 300 mg;
2007-11-29;
Oral;
Tablet;
24:32.40 – RENIN INHIBITORS;
Prescription;
NODEN PHARMA DAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78740
TOCTINO;
02337630;
alitretinoin 10 mg;
2011-01-11;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82321
TOCTINO;
02337649;
alitretinoin 30 mg;
2010-11-19;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82322
ALLERGY CANADA ALLERGEN EXTRACT – ALUM PRECIPITATED;
02242713;
allergen extract – alum precipitated 10000 unit / ml;
2001-04-01;
Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALLERGY CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66518
OMEGA ALLERGENIC EXTRACTS – NON-POLLENS (AQUEOUS);
02247756;
allergenic extract non-pollen 40000 unit / ml;
2003-06-30;
Intradermal , Subcutaneous;
Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72048
OMEGA ALLERGENIC EXTRACTS – NON-POLLENS (GLYCERINATED);
02247757;
allergenic extract non-pollen 40000 unit / ml;
2003-07-02;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72049
OMEGA ALLERGENIC EXTRACTS – NON-POLLENS (SUSPAL);
02247758;
allergenic extract non-pollen 40000 unit / ml;
2003-07-02;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72050
OMEGA ALLERGENIC EXTRACTS – POLLENS (AQUEOUS);
02247753;
allergenic extracts pollens 40000 unit / ml;
2003-06-30;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72045
OMEGA ALLERGENIC EXTRACTS – POLLENS (GLYCERINATED);
02247754;
allergenic extracts pollens 40000 unit / ml;
2003-07-02;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72046
OMEGA ALLERGENIC EXTRACTS – POLLENS (SUSPAL);
02247755;
allergenic extracts pollens 40000 unit / ml;
2003-07-02;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72047
ZYLOPRIM;
00402818;
allopurinol 100 mg;
1981-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4276
ALLOPURINOL-100;
00555681;
allopurinol 100 mg;
1982-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4724
MAR-ALLOPURINOL;
02396327;
allopurinol 100 mg;
2013-04-17;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88136
APO-ALLOPURINOL;
02402769;
allopurinol 100 mg;
2013-04-23;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88760
JAMP-ALLOPURINOL;
02421593;
allopurinol 100 mg;
2014-03-10;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90624
AG-ALLOPURINOL;
02481863;
allopurinol 100 mg;
2019-10-27;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97234
ZYLOPRIM;
00479799;
allopurinol 200 mg;
1981-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4303
ALLOPURINOL-200;
02130157;
allopurinol 200 mg;
1995-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19183
MAR-ALLOPURINOL;
02396335;
allopurinol 200 mg;
2013-04-17;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88137
APO-ALLOPURINOL;
02402777;
allopurinol 200 mg;
2013-04-23;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88761
JAMP-ALLOPURINOL;
02421607;
allopurinol 200 mg;
2014-03-10;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90625
AG-ALLOPURINOL;
02481871;
allopurinol 200 mg;
2019-09-20;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97235
ZYLOPRIM;
00402796;
allopurinol 300 mg;
1981-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4302
ALLOPURINOL-300;
00555703;
allopurinol 300 mg;
1982-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4725
MAR-ALLOPURINOL;
02396343;
allopurinol 300 mg;
2013-04-17;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88138
APO-ALLOPURINOL;
02402785;
allopurinol 300 mg;
2013-04-23;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88762
JAMP-ALLOPURINOL;
02421615;
allopurinol 300 mg;
2014-03-10;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90626
AG-ALLOPURINOL;
02481898;
allopurinol 300 mg;
2019-09-20;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97236
MYLAN-ALMOTRIPTAN;
02398443;
almotriptan (almotriptan malate) 12.5 mg;
2013-07-22;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88340
SANDOZ ALMOTRIPTAN;
02405334;
almotriptan (almotriptan malate) 12.5 mg;
2013-07-22;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89013
ALMOTRIPTAN;
02424029;
almotriptan (almotriptan malate) 12.5 mg;
2014-06-10;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90875
TEVA-ALMOTRIPTAN;
02434849;
almotriptan (almotriptan malate) 12.5 mg;
2014-12-12;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91914
ALMOTRIPTAN;
02466821;
almotriptan (almotriptan malate) 12.5 mg;
2018-03-06;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95519
MYLAN-ALMOTRIPTAN;
02398435;
almotriptan (almotriptan malate) 6.25 mg;
2013-07-22;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88339
NESINA;
02417197;
alogliptin (alogliptin benzoate) 12.5 mg;
2014-04-30;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90183
NESINA;
02417200;
alogliptin (alogliptin benzoate) 25 mg;
2014-05-13;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90184
NESINA;
02417189;
alogliptin (alogliptin benzoate) 6.25 mg;
2014-04-30;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90182
PIQRAY;
02497069;
alpelisib 150 mg;
2020-06-29;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98692
PIQRAY;
02497077;
alpelisib 200 mg;
2020-06-29;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98693
ALPRAZOLAM-0.5;
01908170;
alprazolam .5 mg;
1991-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11485
XANAX;
00548359;
alprazolam 0.25 mg;
1981-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4471
APO-ALPRAZ;
00865397;
alprazolam 0.25 mg;
1990-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10904
ALPRAZOLAM-0.25;
01908189;
alprazolam 0.25 mg;
1991-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11484
TEVA-ALPRAZOLAM;
01913484;
alprazolam 0.25 mg;
1991-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11803
ALPRAZOLAM;
02349191;
alprazolam 0.25 mg;
2010-04-30;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83451
XANAX;
00548367;
alprazolam 0.5 mg;
1981-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4472
APO-ALPRAZ;
00865400;
alprazolam 0.5 mg;
1990-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10905
TEVA-ALPRAZOLAM;
01913492;
alprazolam 0.5 mg;
1993-09-23;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11804
ALPRAZOLAM;
02349205;
alprazolam 0.50 mg;
2010-04-30;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83452
XANAX;
00723770;
alprazolam 1 mg;
1993-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13685
APO-ALPRAZ;
02243611;
alprazolam 1 mg;
2001-04-16;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67530
ALPRAZOLAM;
02248706;
alprazolam 1 mg;
2004-04-01;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73070
XANAX TS;
00813958;
alprazolam 2 mg;
1993-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13686
APO-ALPRAZ TS;
02243612;
alprazolam 2 mg;
2001-04-16;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67531
MUSE;
02238595;
alprostadil 1000 mcg;
1998-09-24;
Urethral;
Suppository;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62023
CAVERJECT STERILE POWDER;
02215756;
alprostadil 20 mcg / vial;
1996-07-30;
Intracavernosal;
Kit , Liquid , Powder For Solution;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20353
CAVERJECT STERILE POWDER – PWS 23.2MCG/VIAL;
02215187;
alprostadil 20 mcg / vial;
1997-09-24;
Intracavernosal;
Powder For Solution;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43155
MUSE;
02238593;
alprostadil 250 mcg;
1998-09-24;
Urethral;
Suppository;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62021
MUSE;
02238594;
alprostadil 500 mcg;
1998-09-24;
Urethral;
Suppository;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62022
PROSTIN VR STERILE SOLUTION;
00559253;
alprostadil 500 mcg / ml;
1982-12-31;
Intra-Arterial , Intravenous;
Solution;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4802
CATHFLO;
02245859;
alteplase 2 mg / vial;
2002-09-26;
Instillation;
Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69976
PDP-AMANTADINE HYDROCHLORIDE CAPSULES;
01990403;
amantadine hydrochloride 100 mg;
1992-12-31;
Oral;
Capsule;
08:18.04 – ADAMANTANES , 28:36.04 – ADAMANTANES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13464
PDP-AMANTADINE HYDROCHLORIDE SYRUP;
02022826;
amantadine hydrochloride 50 mg / 5 ml;
1993-12-31;
Oral;
Syrup;
08:18.04 – ADAMANTANES , 28:36.04 – ADAMANTANES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14393
VOLIBRIS;
02307073;
ambrisentan 10 mg;
2008-06-24;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79275
APO-AMBRISENTAN;
02475383;
ambrisentan 10 mg;
2018-11-26;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96576
VOLIBRIS;
02307065;
ambrisentan 5 mg;
2008-06-24;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79274
APO-AMBRISENTAN;
02475375;
ambrisentan 5 mg;
2018-11-26;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96575
TARO-AMCINONIDE;
02246714;
amcinonide 0.1 %;
2003-02-13;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70909
RATIO-AMCINONIDE;
02247096;
amcinonide 0.1 %;
2004-05-05;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71333
RATIO-AMCINONIDE;
02247097;
amcinonide 0.1 %;
2004-05-06;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71334
RATIO-AMCINONIDE;
02247098;
amcinonide 0.1 %;
2003-09-18;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71335
FIRDAPSE;
02502984;
amifampridine (amifampridine phosphate) 10 mg;
2020-10-23;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
KYE PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99250
RUZURGI;
02503034;
amifampridine 10 mg;
2020-09-24;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
MEDUNIK CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99254
AMIKACIN SULFATE INJECTION USP;
02242971;
amikacin (amikacin sulfate) 250 mg / ml;
2001-01-29;
Intramuscular , Intravenous;
Liquid;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66810
AMIKACIN SULFATE INJECTION;
02486717;
amikacin (amikacin sulfate) 250 mg / ml;
2019-07-31;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97689
ERFA-AMIKACIN;
02489147;
amikacin (amikacin sulfate) 250 mg / ml;
2019-11-29;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97920
AMIKACIN SULFATE INJECTION USP;
02481073;
amikacin (amikacin sulfate) 500 mg / 2 ml;
2019-03-01;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97163
VPI-AMIKACIN;
02506599;
amikacin (amikacin sulfate) 500 mg / 2 ml;
2021-01-25;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
VPI PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99595
MIDAMOR;
02249510;
amiloride hydrochloride 5.0 mg;
2004-06-18;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73433
GLEOLAN;
02504928;
aminolevulinic acid hydrochloride 1.5 g / vial;
2021-02-22;
Oral;
Powder For Solution;
36:68.00 – ROENTGENOGRAPHY;
Prescription;
MEDEXUS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99429
LEVULAN KERASTICK;
02243933;
aminolevulinic acid hydrochloride 20 %;
2004-06-03;
Topical;
Powder For Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
DUSA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67875
AMINOPHYLLINE INJECTION USP;
00497193;
aminophylline 25 mg / ml;
1981-12-31;
Intravenous;
Solution;
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4226
AMINOPHYLLINE INJ 25MG/ML;
00582662;
aminophylline 25 mg / ml;
1984-12-31;
Intravenous;
Solution;
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5705
PMS-AMIODARONE;
02292173;
amiodarone hydrochloride 100 mg;
2007-04-03;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77754
TEVA-AMIODARONE;
02239835;
amiodarone hydrochloride 200 mg;
1999-03-29;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63322
PMS-AMIODARONE;
02242472;
amiodarone hydrochloride 200 mg;
2000-07-28;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66199
SANDOZ AMIODARONE;
02243836;
amiodarone hydrochloride 200 mg;
2001-08-21;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67777
APO-AMIODARONE TABLETS;
02246194;
amiodarone hydrochloride 200 mg;
2003-09-05;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70344
RIVA-AMIODARONE;
02247217;
amiodarone hydrochloride 200 mg;
2003-03-05;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71459
PRO-AMIODARONE – 200;
02309661;
amiodarone hydrochloride 200 mg;
2008-07-04;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79532
AMIODARONE;
02364336;
amiodarone hydrochloride 200 mg;
2011-06-10;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84924
AMIODARONE;
02385465;
amiodarone hydrochloride 200 mg;
2012-06-10;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87109
AMIODARONE HYDROCHLORIDE FOR INJECTION;
02242325;
amiodarone hydrochloride 50 mg / ml;
2000-06-14;
Intravenous;
Liquid;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66036
AMIODARONE HYDROCHLORIDE INJECTION;
02245248;
amiodarone hydrochloride 50 mg / ml;
2002-04-23;
Intravenous;
Solution;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69271
ELAVIL;
00335053;
amitriptyline hydrochloride 10 mg;
1975-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2213
AMITRIPTYLINE-10;
00370991;
amitriptyline hydrochloride 10 mg;
1976-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2426
PMS-AMITRIPTYLINE;
00654523;
amitriptyline hydrochloride 10 mg;
1988-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9417
TEVA-AMITRIPTYLINE;
02326043;
amitriptyline hydrochloride 10 mg;
2014-12-03;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81139
APO-AMITRIPTYLINE;
02403137;
amitriptyline hydrochloride 10 mg;
2013-06-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88796
MAR-AMITRIPTYLINE;
02429861;
amitriptyline hydrochloride 10 mg;
2015-04-24;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91430
JAMP-AMITRIPTYLINE TABLETS;
02435527;
amitriptyline hydrochloride 10 mg;
2015-01-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91987
AG-AMITRIPTYLINE;
02477963;
amitriptyline hydrochloride 10 mg;
2018-12-24;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96850
PRIVA-AMITRIPTYLINE;
02490110;
amitriptyline hydrochloride 10 mg;
2020-02-25;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98018
PMS-AMITRIPTYLINE;
02468409;
amitriptyline hydrochloride 100 mg;
2017-10-18;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95683
ELAVIL;
00335061;
amitriptyline hydrochloride 25 mg;
1975-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2214
AMITRIPTYLINE-25;
00371009;
amitriptyline hydrochloride 25 mg;
1976-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2427
PMS-AMITRIPTYLINE;
00654515;
amitriptyline hydrochloride 25 mg;
1988-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9346
TEVA-AMITRIPTYLINE;
02326051;
amitriptyline hydrochloride 25 mg;
2014-12-03;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81140
APO-AMITRIPTYLINE;
02403145;
amitriptyline hydrochloride 25 mg;
2013-06-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88797
MAR-AMITRIPTYLINE;
02429888;
amitriptyline hydrochloride 25 mg;
2015-04-24;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91431
JAMP-AMITRIPTYLINE TABLETS;
02435535;
amitriptyline hydrochloride 25 mg;
2015-01-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91988
AG-AMITRIPTYLINE;
02477971;
amitriptyline hydrochloride 25 mg;
2018-12-24;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96851
PRIVA-AMITRIPTYLINE;
02490129;
amitriptyline hydrochloride 25 mg;
2020-02-25;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98019
ELAVIL;
00335088;
amitriptyline hydrochloride 50 mg;
1975-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2215
AMITRIPTYLINE-50;
00456349;
amitriptyline hydrochloride 50 mg;
1978-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3141
PMS-AMITRIPTYLINE;
00654507;
amitriptyline hydrochloride 50 mg;
1988-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9418
TEVA-AMITRIPTYLINE;
02326078;
amitriptyline hydrochloride 50 mg;
2014-12-03;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81141
APO-AMITRIPTYLINE;
02403153;
amitriptyline hydrochloride 50 mg;
2013-06-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88798
MAR-AMITRIPTYLINE;
02429896;
amitriptyline hydrochloride 50 mg;
2015-04-24;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91432
JAMP-AMITRIPTYLINE TABLETS;
02435543;
amitriptyline hydrochloride 50 mg;
2015-01-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91989
AG-AMITRIPTYLINE;
02477998;
amitriptyline hydrochloride 50 mg;
2018-12-24;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96852
PRIVA-AMITRIPTYLINE;
02490137;
amitriptyline hydrochloride 50 mg;
2020-02-25;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98020
ELAVIL;
00754129;
amitriptyline hydrochloride 75 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8199
APO-AMITRIPTYLINE;
02403161;
amitriptyline hydrochloride 75 mg;
2013-06-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88799
MAR-AMITRIPTYLINE;
02429918;
amitriptyline hydrochloride 75 mg;
2015-04-27;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91433
JAMP-AMITRIPTYLINE TABLETS;
02435551;
amitriptyline hydrochloride 75 mg;
2015-01-12;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91990
PRIVA-AMITRIPTYLINE;
02490145;
amitriptyline hydrochloride 75 mg;
2020-02-25;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98021
PDP-AMLODIPINE;
02484706;
amlodipine (amlodipine besylate) 1 mg / ml;
2019-08-28;
Oral;
Solution;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97499
NORVASC;
00878936;
amlodipine (amlodipine besylate) 10 mg;
1992-12-31;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12939
TEVA-AMLODIPINE;
02250500;
amlodipine (amlodipine besylate) 10 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73530
SANDOZ AMLODIPINE;
02284391;
amlodipine (amlodipine besylate) 10 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76998
ACT AMLODIPINE;
02297493;
amlodipine (amlodipine besylate) 10 mg;
2009-07-10;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78284
TARO-AMLODIPINE;
02321866;
amlodipine (amlodipine besylate) 10 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80727
AMLODIPINE;
02326817;
amlodipine (amlodipine besylate) 10 mg;
2009-07-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81215
AMLODIPINE;
02331292;
amlodipine (amlodipine besylate) 10 mg;
2009-10-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81700
RIVA-AMLODIPINE;
02331500;
amlodipine (amlodipine besylate) 10 mg;
2009-10-06;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81719
JAMP-AMLODIPINE;
02357208;
amlodipine (amlodipine besylate) 10 mg;
2011-01-27;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84233
SEPTA-AMLODIPINE;
02357720;
amlodipine (amlodipine besylate) 10 mg;
2010-11-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SEPTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84282
MINT-AMLODIPINE;
02362678;
amlodipine (amlodipine besylate) 10 mg;
2011-02-16;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84767
AG-AMLODIPINE;
02369249;
amlodipine (amlodipine besylate) 10 mg;
2014-09-25;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85418
MAR-AMLODIPINE TABLETS;
02371723;
amlodipine (amlodipine besylate) 10 mg;
2012-10-24;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85686
AMLODIPINE;
02385805;
amlodipine (amlodipine besylate) 10 mg;
2012-06-11;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87142
AURO-AMLODIPINE;
02397080;
amlodipine (amlodipine besylate) 10 mg;
2013-02-12;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88207
ACH-AMLODIPINE;
02419572;
amlodipine (amlodipine besylate) 10 mg;
2018-11-05;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90419
AMLODIPINE;
02429225;
amlodipine (amlodipine besylate) 10 mg;
2014-09-04;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91366
PRIVA-AMLODIPINE;
02444461;
amlodipine (amlodipine besylate) 10 mg;
2017-10-25;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92952
M-AMLODIPINE;
02468034;
amlodipine (amlodipine besylate) 10 mg;
2018-04-03;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95639
PHARMA-AMLODIPINE;
02469049;
amlodipine (amlodipine besylate) 10 mg;
2018-05-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95769
NRA-AMLODIPINE;
02476479;
amlodipine (amlodipine besylate) 10 mg;
2018-11-27;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96696
AMLODIPINE;
02490811;
amlodipine (amlodipine besylate) 10 mg;
2019-12-30;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98086
MYLAN-AMLODIPINE;
02272121;
amlodipine (amlodipine besylate) 10.0 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75766
APO-AMLODIPINE;
02273381;
amlodipine (amlodipine besylate) 10.0 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75887
PMS-AMLODIPINE;
02284073;
amlodipine (amlodipine besylate) 10.0 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76964
BIO-AMLODIPINE;
02392143;
amlodipine (amlodipine besylate) 10.00 mg;
2013-01-15;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87743
PMS-AMLODIPINE;
02295148;
amlodipine (amlodipine besylate) 2.5 mg;
2009-07-15;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78046
ACT AMLODIPINE;
02297477;
amlodipine (amlodipine besylate) 2.5 mg;
2010-03-02;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78282
AMLODIPINE;
02326795;
amlodipine (amlodipine besylate) 2.5 mg;
2009-07-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81213
SANDOZ AMLODIPINE;
02330474;
amlodipine (amlodipine besylate) 2.5 mg;
2009-08-05;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81620
RIVA-AMLODIPINE;
02331489;
amlodipine (amlodipine besylate) 2.5 mg;
2009-10-13;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81717
JAMP-AMLODIPINE;
02357186;
amlodipine (amlodipine besylate) 2.5 mg;
2011-01-27;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84231
AG-AMLODIPINE;
02369222;
amlodipine (amlodipine besylate) 2.5 mg;
2018-06-06;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85416
MAR-AMLODIPINE TABLETS;
02371707;
amlodipine (amlodipine besylate) 2.5 mg;
2012-10-24;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85684
AMLODIPINE;
02385783;
amlodipine (amlodipine besylate) 2.5 mg;
2012-06-11;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87140
BIO-AMLODIPINE;
02392127;
amlodipine (amlodipine besylate) 2.5 mg;
2013-01-15;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87741
ACH-AMLODIPINE;
02419556;
amlodipine (amlodipine besylate) 2.5 mg;
2018-11-05;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90417
PRIVA-AMLODIPINE;
02444445;
amlodipine (amlodipine besylate) 2.5 mg;
2017-11-13;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92950
M-AMLODIPINE;
02468018;
amlodipine (amlodipine besylate) 2.5 mg;
2018-03-07;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95637
PHARMA-AMLODIPINE;
02469022;
amlodipine (amlodipine besylate) 2.5 mg;
2018-05-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95767
NRA-AMLODIPINE;
02476452;
amlodipine (amlodipine besylate) 2.5 mg;
2018-11-27;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96694
AMLODIPINE;
02490781;
amlodipine (amlodipine besylate) 2.5 mg;
2019-12-30;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98084
AMLODIPINE;
02492199;
amlodipine (amlodipine besylate) 2.5 mg;
2020-08-24;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98218
NORVASC;
00878928;
amlodipine (amlodipine besylate) 5 mg;
1992-12-31;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12938
TEVA-AMLODIPINE;
02250497;
amlodipine (amlodipine besylate) 5 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73529
SANDOZ AMLODIPINE;
02284383;
amlodipine (amlodipine besylate) 5 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76997
ACT AMLODIPINE;
02297485;
amlodipine (amlodipine besylate) 5 mg;
2009-07-10;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78283
TARO-AMLODIPINE;
02321858;
amlodipine (amlodipine besylate) 5 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80726
AMLODIPINE;
02326809;
amlodipine (amlodipine besylate) 5 mg;
2009-07-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81214
AMLODIPINE;
02331284;
amlodipine (amlodipine besylate) 5 mg;
2009-10-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81699
RIVA-AMLODIPINE;
02331497;
amlodipine (amlodipine besylate) 5 mg;
2009-10-07;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81718
JAMP-AMLODIPINE;
02357194;
amlodipine (amlodipine besylate) 5 mg;
2011-01-27;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84232
SEPTA-AMLODIPINE;
02357712;
amlodipine (amlodipine besylate) 5 mg;
2010-11-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SEPTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84281
MINT-AMLODIPINE;
02362651;
amlodipine (amlodipine besylate) 5 mg;
2011-02-16;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84766
AG-AMLODIPINE;
02369230;
amlodipine (amlodipine besylate) 5 mg;
2014-09-25;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85417
MAR-AMLODIPINE TABLETS;
02371715;
amlodipine (amlodipine besylate) 5 mg;
2012-10-24;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85685
AMLODIPINE;
02385791;
amlodipine (amlodipine besylate) 5 mg;
2012-06-12;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87141
AURO-AMLODIPINE;
02397072;
amlodipine (amlodipine besylate) 5 mg;
2013-02-12;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88206
ACH-AMLODIPINE;
02419564;
amlodipine (amlodipine besylate) 5 mg;
2018-11-05;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90418
AMLODIPINE;
02429217;
amlodipine (amlodipine besylate) 5 mg;
2014-09-04;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91365
PRIVA-AMLODIPINE;
02444453;
amlodipine (amlodipine besylate) 5 mg;
2017-10-11;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92951
M-AMLODIPINE;
02468026;
amlodipine (amlodipine besylate) 5 mg;
2017-12-14;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95638
PHARMA-AMLODIPINE;
02469030;
amlodipine (amlodipine besylate) 5 mg;
2018-05-22;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95768
NRA-AMLODIPINE;
02476460;
amlodipine (amlodipine besylate) 5 mg;
2018-11-27;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96695
AMLODIPINE;
02490803;
amlodipine (amlodipine besylate) 5 mg;
2019-12-30;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98085
MYLAN-AMLODIPINE;
02272113;
amlodipine (amlodipine besylate) 5.0 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75765
APO-AMLODIPINE;
02273373;
amlodipine (amlodipine besylate) 5.0 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75886
PMS-AMLODIPINE;
02284065;
amlodipine (amlodipine besylate) 5.0 mg;
2009-07-09;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76963
BIO-AMLODIPINE;
02392135;
amlodipine (amlodipine besylate) 5.00 mg;
2013-01-15;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87742
NOVAMOXIN;
02036347;
amoxicillin (amoxicillin trihydrate) 125 mg;
1994-12-31;
Oral;
Tablet (Chewable);
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15559
NOVAMOXIN;
00452149;
amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml;
1979-12-31;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3345
APO-AMOXI;
00628131;
amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml;
1984-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5824
NOVAMOXIN;
01934171;
amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml;
1994-12-31;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16955
NOVAMOXIN;
00406724;
amoxicillin (amoxicillin trihydrate) 250 mg;
1979-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3264
APO-AMOXI;
00628115;
amoxicillin (amoxicillin trihydrate) 250 mg;
1984-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5822
NOVAMOXIN;
02036355;
amoxicillin (amoxicillin trihydrate) 250 mg;
1993-12-31;
Oral;
Tablet (Chewable);
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14506
AMOXICILLIN;
02352710;
amoxicillin (amoxicillin trihydrate) 250 mg;
2010-08-28;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83797
AURO-AMOXICILLIN;
02388073;
amoxicillin (amoxicillin trihydrate) 250 mg;
2012-07-26;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87364
JAMP-AMOXICILLIN;
02433060;
amoxicillin (amoxicillin trihydrate) 250 mg;
2015-12-07;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91747
AG-AMOXICILLIN;
02477718;
amoxicillin (amoxicillin trihydrate) 250 mg;
2018-09-06;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96864
NOVAMOXIN;
00452130;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
1979-12-31;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3344
APO-AMOXI;
00628158;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
1984-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5825
PRO-AMOX-250;
00644331;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
1985-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6511
NOVAMOXIN;
01934163;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
1994-12-31;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16954
AMOXICILLIN;
02352753;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
2010-11-02;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83801
AMOXICILLIN;
02352788;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
2010-09-27;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83803
AMOXICILLIN;
02401541;
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
2013-02-14;
Oral;
Granules For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88644
NOVAMOXIN;
00406716;
amoxicillin (amoxicillin trihydrate) 500 mg;
1979-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3263
APO-AMOXI;
00628123;
amoxicillin (amoxicillin trihydrate) 500 mg;
1984-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5823
PRO-AMOX-500;
00644315;
amoxicillin (amoxicillin trihydrate) 500 mg;
1985-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6510
PMS-AMOXICILLIN;
02230244;
amoxicillin (amoxicillin trihydrate) 500 mg;
2002-10-04;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48976
AMOXICILLIN;
02352729;
amoxicillin (amoxicillin trihydrate) 500 mg;
2010-07-28;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83798
AURO-AMOXICILLIN;
02388081;
amoxicillin (amoxicillin trihydrate) 500 mg;
2012-07-26;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87365
AMOXICILLIN;
02401509;
amoxicillin (amoxicillin trihydrate) 500 mg;
2013-02-14;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88640
JAMP-AMOXICILLIN;
02433079;
amoxicillin (amoxicillin trihydrate) 500 mg;
2015-12-07;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91748
AG-AMOXICILLIN;
02477726;
amoxicillin (amoxicillin trihydrate) 500 mg;
2018-09-06;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96865
ABELCET;
02231590;
amphotericin b 5 mg / ml;
1997-09-25;
Intravenous;
Suspension;
08:14.28 – POLYENES;
Prescription;
LEADIANT BIOSCIENCES, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50926
FUNGIZONE;
00029149;
amphotericin b 50 mg / vial;
1958-12-31;
Intravenous;
Powder For Solution;
08:14.28 – POLYENES;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=933
AMBISOME;
02241630;
amphotericin b 50 mg / vial;
2000-05-29;
Intravenous;
Powder For Solution;
08:14.28 – POLYENES;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65288
AMPICILLIN SODIUM FOR INJECTION, USP;
01933345;
ampicillin (ampicillin sodium) 1 g / vial;
1992-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12267
AMPICILLIN FOR INJECTION, USP;
02227002;
ampicillin (ampicillin sodium) 1 g / vial;
1998-08-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37492
AMPICILLIN SODIUM FOR INJECTION BP;
02462338;
ampicillin (ampicillin sodium) 1 g / vial;
2017-10-20;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95006
AMPICILLIN SODIUM FOR INJECTION, USP;
01933353;
ampicillin (ampicillin sodium) 2 g / vial;
1992-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12268
AMPICILLIN FOR INJECTION, USP;
02226995;
ampicillin (ampicillin sodium) 2 g / vial;
1998-07-27;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37491
AMPICILLIN SODIUM FOR INJECTION BP;
02462346;
ampicillin (ampicillin sodium) 2 g / vial;
2017-10-20;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95007
AMPICILLIN SODIUM FOR INJECTION, USP;
00872644;
ampicillin (ampicillin sodium) 250 mg / vial;
1992-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12261
AMPICILLIN FOR INJECTION, USP;
02227029;
ampicillin (ampicillin sodium) 250 mg / vial;
1998-08-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37494
AMPICILLIN SODIUM FOR INJECTION BP;
02462303;
ampicillin (ampicillin sodium) 250 mg / vial;
2017-10-20;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95004
AMPICILLIN SODIUM FOR INJECTION, USP;
00872652;
ampicillin (ampicillin sodium) 500 mg / vial;
1992-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12262
AMPICILLIN FOR INJECTION, USP;
02227010;
ampicillin (ampicillin sodium) 500 mg / vial;
1998-08-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37493
AMPICILLIN SODIUM FOR INJECTION BP;
02462311;
ampicillin (ampicillin sodium) 500 mg / vial;
2017-10-20;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95005
TEVA-AMPICILLIN;
00020877;
ampicillin (ampicillin trihydrate) 250 mg;
1971-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1125
TEVA-AMPICILLIN;
00020885;
ampicillin (ampicillin trihydrate) 500 mg;
1971-12-31;
Oral;
Capsule;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1124
SANDOZ ANAGRELIDE;
02260107;
anagrelide (anagrelide hydrochloride monohydrate) 0.5 mg;
2004-11-05;
Oral;
Capsule;
20:12.14 – PLATELET-REDUCING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74534
PMS-ANAGRELIDE;
02274949;
anagrelide (anagrelide hydrochloride monohydrate) 0.5 mg;
2006-01-06;
Oral;
Capsule;
20:12.14 – PLATELET-REDUCING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76047
AGRYLIN;
02236859;
anagrelide (anagrelide hydrochloride) 0.5 mg;
1998-01-06;
Oral;
Capsule;
20:12.14 – PLATELET-REDUCING AGENTS;
Prescription;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60149
KINERET;
02245913;
anakinra 150 mg / ml;
2002-05-29;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70033
ARIMIDEX TAB 1MG;
02224135;
anastrozole 1 mg;
1996-08-30;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43395
PMS-ANASTROZOLE;
02320738;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80614
SANDOZ ANASTROZOLE;
02338467;
anastrozole 1 mg;
2012-07-26;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82412
JAMP-ANASTROZOLE;
02339080;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82471
ACH-ANASTROZOLE;
02351218;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83640
TARO-ANASTROZOLE;
02365650;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85053
APO-ANASTROZOLE;
02374420;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85968
MAR-ANASTROZOLE;
02379562;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86544
RIVA-ANASTROZOLE;
02392259;
anastrozole 1 mg;
2012-10-26;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87753
BIO-ANASTROZOLE;
02392488;
anastrozole 1 mg;
2013-01-15;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87775
MINT-ANASTROZOLE;
02393573;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87879
TEVA-ANASTROZOLE;
02394898;
anastrozole 1 mg;
2012-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88004
ANASTROZOLE;
02395649;
anastrozole 1 mg;
2012-11-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88072
NAT-ANASTROZOLE;
02417855;
anastrozole 1 mg;
2015-02-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90247
ANASTROZOLE;
02442736;
anastrozole 1 mg;
2015-07-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92706
CCP-ANASTROZOLE;
02458799;
anastrozole 1 mg;
2017-07-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94594
SIALOR;
02240344;
anethole trithione 25.0 mg;
2000-08-02;
Oral;
Tablet;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Ethical;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63884
ERAXIS;
02330695;
anidulafungin 100 mg / vial;
2010-01-25;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81644
WINRHO SDF;
02302578;
anti-d (rh) immunoglobulin (human) 1500 unit / vial;
2008-06-16;
Intramuscular , Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78788
WINRHO SDF;
02302594;
anti-d (rh) immunoglobulin (human) 5000 unit / vial;
2008-06-16;
Intramuscular , Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78786
WINRHO SDF;
02302551;
anti-d (rh) immunoglobulin (human) 600 unit / vial;
2008-06-16;
Intramuscular , Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78787
FEIBA NF;
02202581;
anti-inhibitor coagulant complex 1300 unit / vial;
1997-10-27;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42981
FEIBA NF;
02353903;
anti-inhibitor coagulant complex 3250 unit / vial;
2011-04-04;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83912
THYMOGLOBULIN;
02246805;
anti-thymocyte globulin (rabbit) 25 mg / vial;
2003-05-06;
Intravenous;
Powder For Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71005
JIVI;
02481774;
antihemophilic factor (recombinant – b-domain deleted – pegylated) 1000 unit / vial;
2020-03-11;
Intravenous;
Powder For Solution;
20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97225
JIVI;
02481782;
antihemophilic factor (recombinant – b-domain deleted – pegylated) 2000 unit / vial;
2020-03-11;
Intravenous;
Powder For Solution;
20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97226
JIVI;
02481790;
antihemophilic factor (recombinant – b-domain deleted – pegylated) 3000 unit / vial;
2020-01-27;
Intravenous;
Powder For Solution;
20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97227
JIVI;
02481766;
antihemophilic factor (recombinant – b-domain deleted – pegylated) 500 unit / vial;
2020-04-08;
Intravenous;
Powder For Solution;
20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97224
ELOCTATE;
02430320;
antihemophilic factor (recombinant bdd) – fc fusion protein 1000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91481
ELOCTATE;
02430339;
antihemophilic factor (recombinant bdd) – fc fusion protein 1500 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91482
ELOCTATE;
02430347;
antihemophilic factor (recombinant bdd) – fc fusion protein 2000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91483
ELOCTATE;
02430290;
antihemophilic factor (recombinant bdd) – fc fusion protein 250 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91477
ELOCTATE;
02430355;
antihemophilic factor (recombinant bdd) – fc fusion protein 3000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91484
ELOCTATE;
02430304;
antihemophilic factor (recombinant bdd) – fc fusion protein 500 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91479
ELOCTATE;
02430312;
antihemophilic factor (recombinant bdd) – fc fusion protein 750 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91480
ADYNOVATE;
02459051;
antihemophilic factor (recombinant) – pegylated 1000 unit / vial;
2018-03-06;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94621
ADYNOVATE;
02459078;
antihemophilic factor (recombinant) – pegylated 2000 unit / vial;
2018-03-06;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94622
ADYNOVATE;
02459035;
antihemophilic factor (recombinant) – pegylated 250 unit / vial;
2018-03-06;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94619
ADYNOVATE;
02498626;
antihemophilic factor (recombinant) – pegylated 3000 unit / vial;
2020-09-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98837
ADYNOVATE;
02459043;
antihemophilic factor (recombinant) – pegylated 500 unit / vial;
2018-03-06;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94620
ADVATE;
02284154;
antihemophilic factor (recombinant) 1000 unit / vial;
2006-10-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76970
KOVALTRY;
02451476;
antihemophilic factor (recombinant) 1000 unit / vial;
2016-07-06;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93775
ADVATE;
02284162;
antihemophilic factor (recombinant) 1500 unit / vial;
2006-10-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76971
ADVATE;
02313111;
antihemophilic factor (recombinant) 2000 unit / vial;
2008-09-04;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79865
KOVALTRY;
02451484;
antihemophilic factor (recombinant) 2000 unit / vial;
2016-07-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93776
ADVATE;
02365944;
antihemophilic factor (recombinant) 250 unit / vial;
2012-01-16;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85081
KOVALTRY;
02451441;
antihemophilic factor (recombinant) 250 unit / vial;
2016-07-20;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93773
ADVATE;
02337193;
antihemophilic factor (recombinant) 3000 unit / vial;
2010-01-05;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82280
KOVALTRY;
02451492;
antihemophilic factor (recombinant) 3000 unit / vial;
2016-08-18;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93777
ADVATE;
02365952;
antihemophilic factor (recombinant) 500 unit / vial;
2012-03-05;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SHIRE PHARMA CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85082
KOVALTRY;
02451468;
antihemophilic factor (recombinant) 500 unit / vial;
2016-07-06;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93774
OBIZUR;
02447401;
antihemophilic factor (recombinant) porcine sequence 500 unit / ml;
2016-11-30;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93300
ANTITHROMBIN III NF;
02237810;
antithrombin iii (human) 1100 unit / vial;
1999-07-05;
Intravenous;
Kit , Powder For Solution;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61169
ANTITHROMBIN III NF;
02237811;
antithrombin iii (human) 550 unit / vial;
1999-07-05;
Intravenous;
Kit , Powder For Solution;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61170
ERLEADA;
02478374;
apalutamide 60 mg;
2018-07-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96913
PHARMALGEN HONEY BEE VENOM;
01948911;
apis mellifera venom protein extract 120 mcg / vial;
1993-12-31;
Intradermal , Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14601
ELIQUIS;
02377233;
apixaban 2.5 mg;
2012-02-01;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86287
ELIQUIS;
02397714;
apixaban 5 mg;
2012-12-21;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88264
KYNMOBI;
02500264;
apomorphine hydrochloride 10 mg / film;
2020-11-17;
Sublingual;
Film, Soluble;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98995
MOVAPO;
02459132;
apomorphine hydrochloride 10 mg / ml;
2017-09-07;
Subcutaneous;
Solution;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94632
KYNMOBI;
02500272;
apomorphine hydrochloride 15 mg / film;
2020-11-17;
Sublingual;
Film, Soluble;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98997
KYNMOBI;
02500280;
apomorphine hydrochloride 20 mg / film;
2020-11-17;
Sublingual;
Film, Soluble;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98998
KYNMOBI;
02500299;
apomorphine hydrochloride 25 mg / film;
2020-11-17;
Sublingual;
Film, Soluble;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98999
KYNMOBI;
02500302;
apomorphine hydrochloride 30 mg / film;
2020-11-17;
Sublingual;
Film, Soluble;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99000
IOPIDINE;
02076306;
apraclonidine (apraclonidine hydrochloride) 0.5 %;
1995-12-31;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18228
IOPIDINE;
00888354;
apraclonidine (apraclonidine hydrochloride) 1 %;
1992-12-31;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12993
OTEZLA;
02434334;
apremilast 30 mg;
2014-12-01;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91866
EMEND;
02298805;
aprepitant 125 mg;
2007-09-24;
Oral;
Capsule;
56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78411
EMEND;
02298791;
aprepitant 80 mg;
2007-09-24;
Oral;
Capsule;
56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78410
ARGATROBAN;
02243835;
argatroban 100 mg / ml;
2002-06-13;
Intravenous;
Solution;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67776
L-ARGININE HYDROCHLORIDE INJECTION;
00399736;
arginine hydrochloride 250 mg / ml;
1973-12-31;
Intravenous;
Liquid;
36:66.00 – PITUITARY FUNCTION;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3378
ABILIFY;
02322390;
aripiprazole 10 mg;
2009-09-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80784
AURO-ARIPIPRAZOLE;
02460041;
aripiprazole 10 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94734
TEVA-ARIPIPRAZOLE;
02464160;
aripiprazole 10 mg;
2018-07-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95232
PMS-ARIPIPRAZOLE;
02466651;
aripiprazole 10 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95500
APO-ARIPIPRAZOLE;
02471108;
aripiprazole 10 mg;
2018-04-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96021
SANDOZ ARIPIPRAZOLE;
02473674;
aripiprazole 10 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96306
RIVA-ARIPIPRAZOLE;
02479362;
aripiprazole 10 mg;
2018-08-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96996
MINT-ARIPIPRAZOLE;
02483572;
aripiprazole 10 mg;
2020-04-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97394
ARIPIPRAZOLE;
02488027;
aripiprazole 10 mg;
2019-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97813
ARIPIPRAZOLE;
02506726;
aripiprazole 10 mg;
2021-04-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99607
ABILIFY;
02322404;
aripiprazole 15 mg;
2009-09-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80785
AURO-ARIPIPRAZOLE;
02460068;
aripiprazole 15 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94735
TEVA-ARIPIPRAZOLE;
02464179;
aripiprazole 15 mg;
2018-07-11;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95233
PMS-ARIPIPRAZOLE;
02466678;
aripiprazole 15 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95501
APO-ARIPIPRAZOLE;
02471116;
aripiprazole 15 mg;
2018-04-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96022
SANDOZ ARIPIPRAZOLE;
02473682;
aripiprazole 15 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96307
RIVA-ARIPIPRAZOLE;
02479370;
aripiprazole 15 mg;
2018-08-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96997
MINT-ARIPIPRAZOLE;
02483580;
aripiprazole 15 mg;
2020-04-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97395
ARIPIPRAZOLE;
02488035;
aripiprazole 15 mg;
2019-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97814
ARIPIPRAZOLE;
02506734;
aripiprazole 15 mg;
2021-04-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99609
ABILIFY;
02322374;
aripiprazole 2 mg;
2009-09-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80782
AURO-ARIPIPRAZOLE;
02460025;
aripiprazole 2 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94732
TEVA-ARIPIPRAZOLE;
02464144;
aripiprazole 2 mg;
2018-07-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95230
PMS-ARIPIPRAZOLE;
02466635;
aripiprazole 2 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95498
APO-ARIPIPRAZOLE;
02471086;
aripiprazole 2 mg;
2018-04-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96019
SANDOZ ARIPIPRAZOLE;
02473658;
aripiprazole 2 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96304
RIVA-ARIPIPRAZOLE;
02479346;
aripiprazole 2 mg;
2018-08-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96994
MINT-ARIPIPRAZOLE;
02483556;
aripiprazole 2 mg;
2020-05-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97392
ARIPIPRAZOLE;
02488000;
aripiprazole 2 mg;
2019-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97811
ARIPIPRAZOLE;
02506688;
aripiprazole 2 mg;
2021-04-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99604
ABILIFY;
02322412;
aripiprazole 20 mg;
2009-09-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80786
AURO-ARIPIPRAZOLE;
02460076;
aripiprazole 20 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94736
TEVA-ARIPIPRAZOLE;
02464187;
aripiprazole 20 mg;
2018-07-11;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95234
PMS-ARIPIPRAZOLE;
02466686;
aripiprazole 20 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95503
APO-ARIPIPRAZOLE;
02471124;
aripiprazole 20 mg;
2018-04-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96023
SANDOZ ARIPIPRAZOLE;
02473690;
aripiprazole 20 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96308
RIVA-ARIPIPRAZOLE;
02479389;
aripiprazole 20 mg;
2018-08-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96998
MINT-ARIPIPRAZOLE;
02483599;
aripiprazole 20 mg;
2020-04-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97396
ARIPIPRAZOLE;
02488043;
aripiprazole 20 mg;
2019-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97815
ARIPIPRAZOLE;
02506750;
aripiprazole 20 mg;
2021-04-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99611
ABILIFY;
02322455;
aripiprazole 30 mg;
2009-09-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80790
AURO-ARIPIPRAZOLE;
02460084;
aripiprazole 30 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94737
TEVA-ARIPIPRAZOLE;
02464195;
aripiprazole 30 mg;
2018-07-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95235
PMS-ARIPIPRAZOLE;
02466694;
aripiprazole 30 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95504
APO-ARIPIPRAZOLE;
02471132;
aripiprazole 30 mg;
2018-04-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96024
SANDOZ ARIPIPRAZOLE;
02473704;
aripiprazole 30 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96309
RIVA-ARIPIPRAZOLE;
02479397;
aripiprazole 30 mg;
2018-08-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96999
MINT-ARIPIPRAZOLE;
02483602;
aripiprazole 30 mg;
2020-04-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97397
ARIPIPRAZOLE;
02488051;
aripiprazole 30 mg;
2019-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97816
ARIPIPRAZOLE;
02506785;
aripiprazole 30 mg;
2021-04-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99613
ABILIFY MAINTENA;
02420864;
aripiprazole 300 mg / vial;
2014-03-27;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90545
ABILIFY MAINTENA;
02420872;
aripiprazole 400 mg / vial;
2014-03-27;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90546
ABILIFY;
02322382;
aripiprazole 5 mg;
2009-09-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80783
AURO-ARIPIPRAZOLE;
02460033;
aripiprazole 5 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94733
TEVA-ARIPIPRAZOLE;
02464152;
aripiprazole 5 mg;
2018-07-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95231
PMS-ARIPIPRAZOLE;
02466643;
aripiprazole 5 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95499
APO-ARIPIPRAZOLE;
02471094;
aripiprazole 5 mg;
2018-04-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96020
SANDOZ ARIPIPRAZOLE;
02473666;
aripiprazole 5 mg;
2018-07-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96305
RIVA-ARIPIPRAZOLE;
02479354;
aripiprazole 5 mg;
2018-08-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96995
MINT-ARIPIPRAZOLE;
02483564;
aripiprazole 5 mg;
2020-04-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97393
ARIPIPRAZOLE;
02488019;
aripiprazole 5 mg;
2019-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97812
ARIPIPRAZOLE;
02506718;
aripiprazole 5 mg;
2021-04-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99606
ARSENIC TRIOXIDE FOR INJECTION;
02492768;
arsenic trioxide 1 mg / ml;
2019-12-20;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98274
TRISENOX;
02407833;
arsenic trioxide 10 mg / 10 ml;
2013-09-09;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89255
ARSENIC TRIOXIDE SOLUTION FOR INJECTION;
02487357;
arsenic trioxide 10 mg / 10 ml;
2020-01-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHEBRA PTY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97753
TRISENOX;
02480387;
arsenic trioxide 12 mg / 6 ml;
2020-04-16;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97091
VITAMIN C;
02245214;
ascorbic acid (ascorbic acid) 500 mg / ml;
2002-05-29;
Intramuscular , Intravenous , Subcutaneous;
Solution;
88:12.00 – VITAMIN C;
Ethical;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69229
VITAMIN C;
00780634;
ascorbic acid (sodium ascorbate) 250 mg / ml;
1989-12-31;
Intramuscular , Intravenous;
Liquid;
88:12.00 – VITAMIN C;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9992
ASCOR L 500;
02355981;
ascorbic acid 500 mg / ml;
2014-09-11;
Intramuscular , Intravenous , Subcutaneous;
Solution;
88:12.00 – VITAMIN C;
Ethical;
MCGUFF PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84117
SAPHRIS;
02374811;
asenapine (asenapine maleate) 10 mg;
2011-12-19;
Sublingual;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86018
SAPHRIS;
02374803;
asenapine (asenapine maleate) 5 mg;
2011-12-19;
Sublingual;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86017
STRENSIQ;
02444658;
asfotase alfa 100 mg / ml;
2016-02-17;
Subcutaneous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
ALEXION PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92972
STRENSIQ;
02444615;
asfotase alfa 40 mg / ml;
2015-10-20;
Subcutaneous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
ALEXION PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92969
STRENSIQ;
02444623;
asfotase alfa 40 mg / ml;
2016-06-07;
Subcutaneous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
ALEXION PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92970
STRENSIQ;
02444631;
asfotase alfa 40 mg / ml;
2016-06-01;
Subcutaneous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
ALEXION PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92971
KIDROLASE;
01926438;
asparaginase 10000 unit / vial;
1974-12-31;
Intramuscular , Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
JAZZ PHARMACEUTICALS FRANCE SAS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12995
REYATAZ;
02248610;
atazanavir (atazanavir sulfate) 150 mg;
2004-01-09;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72966
TEVA-ATAZANAVIR;
02443791;
atazanavir (atazanavir sulfate) 150 mg;
2017-04-18;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92854
MYLAN-ATAZANAVIR;
02456877;
atazanavir (atazanavir sulfate) 150 mg;
2017-05-03;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94389
REYATAZ;
02248611;
atazanavir (atazanavir sulfate) 200 mg;
2004-01-09;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72967
TEVA-ATAZANAVIR;
02443813;
atazanavir (atazanavir sulfate) 200 mg;
2017-04-18;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92856
MYLAN-ATAZANAVIR;
02456885;
atazanavir (atazanavir sulfate) 200 mg;
2017-05-03;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94390
REYATAZ;
02294176;
atazanavir (atazanavir sulfate) 300 mg;
2007-05-31;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77952
TEVA-ATAZANAVIR;
02443821;
atazanavir (atazanavir sulfate) 300 mg;
2017-04-18;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92857
MYLAN-ATAZANAVIR;
02456893;
atazanavir (atazanavir sulfate) 300 mg;
2017-05-02;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94391
APO-ATENOL TAB 100MG;
00773697;
atenolol 100 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9175
ATENOLOL;
00828793;
atenolol 100 mg;
1989-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9904
TENORMIN 100MG;
02039540;
atenolol 100 mg;
1994-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17906
TEVA-ATENOLOL;
02171805;
atenolol 100 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19692
PMS-ATENOLOL;
02237601;
atenolol 100 mg;
1998-03-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60940
ATENOLOL;
02238318;
atenolol 100 mg;
1999-03-09;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61719
RIVA-ATENOLOL 100 MG;
02242093;
atenolol 100 mg;
2000-05-23;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65768
TARO-ATENOLOL;
02267993;
atenolol 100 mg;
2005-07-05;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75338
JAMP-ATENOLOL;
02367572;
atenolol 100 mg;
2011-06-09;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85241
MINT-ATENOL;
02368048;
atenolol 100 mg;
2011-06-13;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85285
AG-ATENOLOL;
02369192;
atenolol 100 mg;
2018-07-18;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85413
MAR-ATENOLOL;
02371995;
atenolol 100 mg;
2012-10-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85712
ATENOLOL;
02466473;
atenolol 100 mg;
2017-10-20;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95483
PMS-ATENOLOL;
02246581;
atenolol 25 mg;
2002-11-28;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70768
TEVA-ATENOLOL;
02266660;
atenolol 25 mg;
2005-11-17;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75207
RIVA-ATENOLOL;
02277379;
atenolol 25 mg;
2006-07-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76301
ATENOLOL;
02326701;
atenolol 25 mg;
2009-06-15;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81205
JAMP-ATENOLOL;
02367556;
atenolol 25 mg;
2011-06-09;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85239
MINT-ATENOL;
02368013;
atenolol 25 mg;
2011-06-13;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85283
AG-ATENOLOL;
02369176;
atenolol 25 mg;
2018-07-18;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85411
MAR-ATENOLOL;
02371979;
atenolol 25 mg;
2012-10-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85710
TARO-ATENOLOL;
02373963;
atenolol 25 mg;
2012-01-18;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85918
APO-ATENOL TAB 50MG;
00773689;
atenolol 50 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9174
ATENOLOL;
00828807;
atenolol 50 mg;
1989-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9905
TENORMIN 50MG;
02039532;
atenolol 50 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17905
TEVA-ATENOLOL;
02171791;
atenolol 50 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19691
PMS-ATENOLOL;
02237600;
atenolol 50 mg;
1998-03-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60939
ATENOLOL;
02238316;
atenolol 50 mg;
1999-09-03;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61718
RIVA-ATENOLOL 50 MG;
02242094;
atenolol 50 mg;
2000-05-23;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65769
TARO-ATENOLOL;
02267985;
atenolol 50 mg;
2005-07-05;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75337
JAMP-ATENOLOL;
02367564;
atenolol 50 mg;
2011-06-09;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85240
MINT-ATENOL;
02368021;
atenolol 50 mg;
2011-06-13;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85284
AG-ATENOLOL;
02369184;
atenolol 50 mg;
2018-07-18;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85412
MAR-ATENOLOL;
02371987;
atenolol 50 mg;
2012-10-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85711
ATENOLOL;
02466465;
atenolol 50 mg;
2017-10-20;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95482
TECENTRIQ;
02462990;
atezolizumab 1200 mg / 20 ml;
2017-05-02;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95089
TECENTRIQ;
02492393;
atezolizumab 840 mg / 14 ml;
2019-10-16;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98241
STRATTERA;
02262800;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2005-02-24;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74816
TEVA-ATOMOXETINE;
02314541;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2010-09-16;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80008
APO-ATOMOXETINE;
02318024;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2011-03-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80353
PMS-ATOMOXETINE;
02381028;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2012-06-13;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86676
SANDOZ ATOMOXETINE;
02386410;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87200
ATOMOXETINE;
02396904;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2012-11-29;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88191
RIVA-ATOMOXETINE;
02405962;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2013-07-18;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89071
ATOMOXETINE;
02445883;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2015-10-07;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93116
ATOMOXETINE;
02467747;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95610
AURO-ATOMOXETINE;
02471485;
atomoxetine (atomoxetine hydrochloride) 10 mg;
2019-02-04;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96064
STRATTERA;
02279355;
atomoxetine (atomoxetine hydrochloride) 100 mg;
2010-01-08;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76496
APO-ATOMOXETINE;
02318083;
atomoxetine (atomoxetine hydrochloride) 100 mg;
2011-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80359
TEVA-ATOMOXETINE;
02362538;
atomoxetine (atomoxetine hydrochloride) 100 mg;
2013-10-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84753
SANDOZ ATOMOXETINE;
02386488;
atomoxetine (atomoxetine hydrochloride) 100 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87206
ATOMOXETINE;
02467828;
atomoxetine (atomoxetine hydrochloride) 100 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95616
AURO-ATOMOXETINE;
02471558;
atomoxetine (atomoxetine hydrochloride) 100 mg;
2019-02-04;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96070
STRATTERA;
02262819;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2005-02-24;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74817
TEVA-ATOMOXETINE;
02314568;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2010-09-16;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80009
APO-ATOMOXETINE;
02318032;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2011-03-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80354
PMS-ATOMOXETINE;
02381036;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2012-06-13;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86677
SANDOZ ATOMOXETINE;
02386429;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87201
ATOMOXETINE;
02396912;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2012-11-29;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88192
RIVA-ATOMOXETINE;
02405970;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2013-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89072
ATOMOXETINE;
02445905;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2015-10-07;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93118
ATOMOXETINE;
02467755;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95611
AURO-ATOMOXETINE;
02471493;
atomoxetine (atomoxetine hydrochloride) 18 mg;
2019-02-04;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96065
STRATTERA;
02262827;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2005-03-03;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74820
TEVA-ATOMOXETINE;
02314576;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2010-09-16;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80010
APO-ATOMOXETINE;
02318040;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2011-03-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80355
PMS-ATOMOXETINE;
02381044;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2012-06-13;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86678
SANDOZ ATOMOXETINE;
02386437;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87202
ATOMOXETINE;
02396920;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2012-11-29;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88193
RIVA-ATOMOXETINE;
02405989;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2013-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89073
ATOMOXETINE;
02445913;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2015-10-07;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93120
ATOMOXETINE;
02467763;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95612
AURO-ATOMOXETINE;
02471507;
atomoxetine (atomoxetine hydrochloride) 25 mg;
2019-02-04;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96066
STRATTERA;
02262835;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2005-03-03;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74822
TEVA-ATOMOXETINE;
02314584;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2010-09-16;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80011
APO-ATOMOXETINE;
02318059;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2011-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80356
PMS-ATOMOXETINE;
02381052;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2012-06-13;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86679
SANDOZ ATOMOXETINE;
02386445;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87203
ATOMOXETINE;
02396939;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2012-11-29;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88194
RIVA-ATOMOXETINE;
02405997;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2013-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89074
ATOMOXETINE;
02445948;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2015-10-07;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93121
ATOMOXETINE;
02467771;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95613
AURO-ATOMOXETINE;
02471515;
atomoxetine (atomoxetine hydrochloride) 40 mg;
2019-02-04;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96067
STRATTERA;
02262843;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2005-03-03;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74823
TEVA-ATOMOXETINE;
02314592;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2010-09-16;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80012
APO-ATOMOXETINE;
02318067;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2011-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80357
PMS-ATOMOXETINE;
02381060;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2012-06-13;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86680
SANDOZ ATOMOXETINE;
02386453;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87204
ATOMOXETINE;
02396947;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2012-11-29;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88195
RIVA-ATOMOXETINE;
02406004;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2013-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89075
ATOMOXETINE;
02445956;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2015-10-07;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93122
ATOMOXETINE;
02467798;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95614
AURO-ATOMOXETINE;
02471523;
atomoxetine (atomoxetine hydrochloride) 60 mg;
2019-02-02;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96068
STRATTERA;
02279347;
atomoxetine (atomoxetine hydrochloride) 80 mg;
2009-12-16;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76495
APO-ATOMOXETINE;
02318075;
atomoxetine (atomoxetine hydrochloride) 80 mg;
2011-07-19;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80358
TEVA-ATOMOXETINE;
02362511;
atomoxetine (atomoxetine hydrochloride) 80 mg;
2014-02-28;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84752
SANDOZ ATOMOXETINE;
02386461;
atomoxetine (atomoxetine hydrochloride) 80 mg;
2012-05-30;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87205
ATOMOXETINE;
02467801;
atomoxetine (atomoxetine hydrochloride) 80 mg;
2018-01-15;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95615
AURO-ATOMOXETINE;
02471531;
atomoxetine (atomoxetine hydrochloride) 80 mg;
2019-02-04;
Oral;
Capsule;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96069
APO-ATORVASTATIN;
02295261;
atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78058
ATORVASTATIN;
02346486;
atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
2010-05-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83185
ATORVASTATIN;
02348705;
atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
2010-05-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83405
ATORVASTATIN-10;
02411350;
atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89596
APO-ATORVASTATIN;
02295288;
atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78059
ATORVASTATIN;
02346494;
atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
2010-05-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83192
ATORVASTATIN;
02348713;
atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
2010-05-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83406
ATORVASTATIN-20;
02411369;
atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89597
APO-ATORVASTATIN;
02295296;
atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78060
ATORVASTATIN;
02346508;
atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
2010-05-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83193
ATORVASTATIN;
02348721;
atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
2010-05-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83407
ATORVASTATIN-40;
02411377;
atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89598
APO-ATORVASTATIN;
02295318;
atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78061
ATORVASTATIN;
02346516;
atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
2010-05-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83194
ATORVASTATIN;
02348748;
atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
2010-05-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83408
ATORVASTATIN-80;
02411385;
atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89599
LIPITOR;
02230711;
atorvastatin (atorvastatin calcium) 10 mg;
1997-03-05;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49973
TEVA-ATORVASTATIN;
02310899;
atorvastatin (atorvastatin calcium) 10 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79651
TARO-ATORVASTATIN;
02313707;
atorvastatin (atorvastatin calcium) 10 mg;
2010-05-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79921
SANDOZ ATORVASTATIN;
02324946;
atorvastatin (atorvastatin calcium) 10 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81036
JAMP-ATORVASTATIN;
02391058;
atorvastatin (atorvastatin calcium) 10 mg;
2012-09-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87642
MYLAN-ATORVASTATIN;
02392933;
atorvastatin (atorvastatin calcium) 10 mg;
2014-06-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87820
ATORVASTATIN;
02399377;
atorvastatin (atorvastatin calcium) 10 mg;
2013-03-26;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88426
AURO-ATORVASTATIN;
02407256;
atorvastatin (atorvastatin calcium) 10 mg;
2013-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89196
REDDY-ATORVASTATIN;
02417936;
atorvastatin (atorvastatin calcium) 10 mg;
2015-06-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90253
RIVA-ATORVASTATIN;
02422751;
atorvastatin (atorvastatin calcium) 10 mg;
2014-03-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90742
MAR-ATORVASTATIN;
02454017;
atorvastatin (atorvastatin calcium) 10 mg;
2017-05-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94054
ACH-ATORVASTATIN CALCIUM;
02457741;
atorvastatin (atorvastatin calcium) 10 mg;
2019-10-18;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94478
M-ATORVASTATIN;
02471167;
atorvastatin (atorvastatin calcium) 10 mg;
2018-03-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96027
ATORVASTATIN;
02475022;
atorvastatin (atorvastatin calcium) 10 mg;
2018-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96530
NRA-ATORVASTATIN;
02476517;
atorvastatin (atorvastatin calcium) 10 mg;
2019-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96687
ATORVASTATIN;
02476940;
atorvastatin (atorvastatin calcium) 10 mg;
2019-02-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96737
PMS-ATORVASTATIN;
02477149;
atorvastatin (atorvastatin calcium) 10 mg;
2020-04-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96790
AG-ATORVASTATIN;
02478145;
atorvastatin (atorvastatin calcium) 10 mg;
2018-09-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96887
MINT-ATORVASTATIN;
02479508;
atorvastatin (atorvastatin calcium) 10 mg;
2020-01-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97017
BIO-ATORVASTATIN;
02481189;
atorvastatin (atorvastatin calcium) 10 mg;
2019-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97130
PRIVA-ATORVASTATIN;
02482886;
atorvastatin (atorvastatin calcium) 10 mg;
2019-10-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97328
LIPITOR;
02230713;
atorvastatin (atorvastatin calcium) 20 mg;
1997-03-05;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49974
TEVA-ATORVASTATIN;
02310902;
atorvastatin (atorvastatin calcium) 20 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79652
TARO-ATORVASTATIN;
02313715;
atorvastatin (atorvastatin calcium) 20 mg;
2010-05-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79922
SANDOZ ATORVASTATIN;
02324954;
atorvastatin (atorvastatin calcium) 20 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81037
JAMP-ATORVASTATIN;
02391066;
atorvastatin (atorvastatin calcium) 20 mg;
2012-09-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87643
MYLAN-ATORVASTATIN;
02392941;
atorvastatin (atorvastatin calcium) 20 mg;
2014-06-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87821
ATORVASTATIN;
02399385;
atorvastatin (atorvastatin calcium) 20 mg;
2013-03-26;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88427
AURO-ATORVASTATIN;
02407264;
atorvastatin (atorvastatin calcium) 20 mg;
2013-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89197
REDDY-ATORVASTATIN;
02417944;
atorvastatin (atorvastatin calcium) 20 mg;
2015-06-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90254
RIVA-ATORVASTATIN;
02422778;
atorvastatin (atorvastatin calcium) 20 mg;
2014-03-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90743
MAR-ATORVASTATIN;
02454025;
atorvastatin (atorvastatin calcium) 20 mg;
2017-05-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94055
ACH-ATORVASTATIN CALCIUM;
02457768;
atorvastatin (atorvastatin calcium) 20 mg;
2019-10-18;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94479
M-ATORVASTATIN;
02471175;
atorvastatin (atorvastatin calcium) 20 mg;
2018-03-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96028
ATORVASTATIN;
02475030;
atorvastatin (atorvastatin calcium) 20 mg;
2018-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96531
NRA-ATORVASTATIN;
02476525;
atorvastatin (atorvastatin calcium) 20 mg;
2019-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96688
ATORVASTATIN;
02476959;
atorvastatin (atorvastatin calcium) 20 mg;
2019-02-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96738
PMS-ATORVASTATIN;
02477157;
atorvastatin (atorvastatin calcium) 20 mg;
2020-04-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96791
AG-ATORVASTATIN;
02478153;
atorvastatin (atorvastatin calcium) 20 mg;
2018-09-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96888
MINT-ATORVASTATIN;
02479516;
atorvastatin (atorvastatin calcium) 20 mg;
2020-01-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97018
BIO-ATORVASTATIN;
02481197;
atorvastatin (atorvastatin calcium) 20 mg;
2019-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97131
PRIVA-ATORVASTATIN;
02482894;
atorvastatin (atorvastatin calcium) 20 mg;
2019-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97329
LIPITOR;
02230714;
atorvastatin (atorvastatin calcium) 40 mg;
1997-03-05;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49975
TEVA-ATORVASTATIN;
02310910;
atorvastatin (atorvastatin calcium) 40 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79653
TARO-ATORVASTATIN;
02313723;
atorvastatin (atorvastatin calcium) 40 mg;
2010-05-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79923
SANDOZ ATORVASTATIN;
02324962;
atorvastatin (atorvastatin calcium) 40 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81038
JAMP-ATORVASTATIN;
02391074;
atorvastatin (atorvastatin calcium) 40 mg;
2012-09-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87644
MYLAN-ATORVASTATIN;
02392968;
atorvastatin (atorvastatin calcium) 40 mg;
2014-06-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87822
ATORVASTATIN;
02399393;
atorvastatin (atorvastatin calcium) 40 mg;
2013-03-26;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88428
AURO-ATORVASTATIN;
02407272;
atorvastatin (atorvastatin calcium) 40 mg;
2013-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89198
REDDY-ATORVASTATIN;
02417952;
atorvastatin (atorvastatin calcium) 40 mg;
2015-06-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90255
RIVA-ATORVASTATIN;
02422786;
atorvastatin (atorvastatin calcium) 40 mg;
2014-03-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90744
MAR-ATORVASTATIN;
02454033;
atorvastatin (atorvastatin calcium) 40 mg;
2018-10-05;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94056
ACH-ATORVASTATIN CALCIUM;
02457776;
atorvastatin (atorvastatin calcium) 40 mg;
2019-10-18;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94480
M-ATORVASTATIN;
02471183;
atorvastatin (atorvastatin calcium) 40 mg;
2018-03-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96029
ATORVASTATIN;
02475049;
atorvastatin (atorvastatin calcium) 40 mg;
2018-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96532
NRA-ATORVASTATIN;
02476533;
atorvastatin (atorvastatin calcium) 40 mg;
2019-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96689
ATORVASTATIN;
02476967;
atorvastatin (atorvastatin calcium) 40 mg;
2019-02-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96739
PMS-ATORVASTATIN;
02477165;
atorvastatin (atorvastatin calcium) 40 mg;
2020-04-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96792
AG-ATORVASTATIN;
02478161;
atorvastatin (atorvastatin calcium) 40 mg;
2018-09-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96889
MINT-ATORVASTATIN;
02479524;
atorvastatin (atorvastatin calcium) 40 mg;
2020-01-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97019
BIO-ATORVASTATIN;
02481200;
atorvastatin (atorvastatin calcium) 40 mg;
2019-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97132
PRIVA-ATORVASTATIN;
02482908;
atorvastatin (atorvastatin calcium) 40 mg;
2019-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97330
LIPITOR;
02243097;
atorvastatin (atorvastatin calcium) 80 mg;
2001-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66964
TEVA-ATORVASTATIN;
02310929;
atorvastatin (atorvastatin calcium) 80 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79654
TARO-ATORVASTATIN;
02313758;
atorvastatin (atorvastatin calcium) 80 mg;
2010-05-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79925
SANDOZ ATORVASTATIN;
02324970;
atorvastatin (atorvastatin calcium) 80 mg;
2010-05-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81039
JAMP-ATORVASTATIN;
02391082;
atorvastatin (atorvastatin calcium) 80 mg;
2012-09-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87645
MYLAN-ATORVASTATIN;
02392976;
atorvastatin (atorvastatin calcium) 80 mg;
2014-06-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87823
ATORVASTATIN;
02399407;
atorvastatin (atorvastatin calcium) 80 mg;
2013-03-26;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88429
AURO-ATORVASTATIN;
02407280;
atorvastatin (atorvastatin calcium) 80 mg;
2013-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89199
REDDY-ATORVASTATIN;
02417960;
atorvastatin (atorvastatin calcium) 80 mg;
2015-06-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90256
RIVA-ATORVASTATIN;
02422794;
atorvastatin (atorvastatin calcium) 80 mg;
2014-03-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90745
MAR-ATORVASTATIN;
02454041;
atorvastatin (atorvastatin calcium) 80 mg;
2018-10-05;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94057
ACH-ATORVASTATIN CALCIUM;
02457784;
atorvastatin (atorvastatin calcium) 80 mg;
2019-10-18;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94481
M-ATORVASTATIN;
02471191;
atorvastatin (atorvastatin calcium) 80 mg;
2018-03-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96030
ATORVASTATIN;
02475057;
atorvastatin (atorvastatin calcium) 80 mg;
2018-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96533
NRA-ATORVASTATIN;
02476541;
atorvastatin (atorvastatin calcium) 80 mg;
2019-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96690
PMS-ATORVASTATIN;
02477173;
atorvastatin (atorvastatin calcium) 80 mg;
2020-04-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96793
AG-ATORVASTATIN;
02478188;
atorvastatin (atorvastatin calcium) 80 mg;
2018-09-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96890
BIO-ATORVASTATIN;
02481219;
atorvastatin (atorvastatin calcium) 80 mg;
2019-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97133
PRIVA-ATORVASTATIN;
02482916;
atorvastatin (atorvastatin calcium) 80 mg;
2019-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97331
MEPRON;
02217422;
atovaquone 750 mg / 5 ml;
1996-09-10;
Oral;
Suspension;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43212
ATROPINE SULFATE INJECTION USP;
00392693;
atropine sulfate .6 mg / ml;
1979-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3553
ATROPINE SULFATE INJECTION USP;
00392782;
atropine sulfate 0.4 mg / ml;
1979-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3554
ATROPINE INJECTION BP;
02432188;
atropine sulfate 0.4 mg / ml;
2015-12-04;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
TELIGENT PHARMA, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91662
ATROPINE SULFATE INJECTION;
02426269;
atropine sulfate 0.5 mg / 5 ml;
2015-01-20;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BIOSYENT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91086
ATROPINE SULFATE INJECTION USP;
02472171;
atropine sulfate 0.5 mg / 5 ml;
2020-03-25;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96149
ATROPINE INJECTION BP;
02432196;
atropine sulfate 0.6 mg / ml;
2016-01-28;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
TELIGENT PHARMA, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91663
ATROPINE;
02023695;
atropine sulfate 1 %;
1994-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
PHARMA STULLN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16476
ISOPTO ATROPINE;
00035017;
atropine sulfate 1 % / w/v;
1964-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=254
MINIMS ATROPINE SULPHATE;
02148358;
atropine sulfate 1 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18862
ATROPINE SULFATE INJECTION USP;
00328154;
atropine sulfate 1 mg / 10 ml;
1975-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2390
ATROPINE SULFATE INJECTION;
02426277;
atropine sulfate 1 mg / 5 ml;
2015-01-20;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BIOSYENT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91087
RIDAURA;
01916823;
auranofin 3 mg;
1993-12-31;
Oral;
Capsule;
60:00.00 – GOLD COMPOUNDS;
Prescription;
XEDITON PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15902
BAVENCIO;
02469723;
avelumab 20 mg / ml;
2017-12-18;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95856
YESCARTA;
02485648;
axicabtagene ciloleucel 200000000 cells / bag;
2019-11-27;
Intravenous;
Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97587
INLYTA;
02389630;
axitinib 1 mg;
2012-08-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87513
INLYTA;
02389649;
axitinib 5 mg;
2012-08-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87514
VIDAZA;
02336707;
azacitidine 100 mg / vial;
2010-01-04;
Subcutaneous;
Powder For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82233
AZACITIDINE FOR INJECTION;
02462826;
azacitidine 100 mg / vial;
2017-10-25;
Subcutaneous;
Powder For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95068
ONUREG;
02510197;
azacitidine 200 mg;
2021-03-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99943
ONUREG;
02510200;
azacitidine 300 mg;
2021-03-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99944
IMURAN;
02244895;
azathioprine (azathioprine sodium) 50 mg / vial;
2001-12-20;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68893
IMURAN;
00004596;
azathioprine 50 mg;
1966-12-31;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1192
TEVA-AZATHIOPRINE;
02236819;
azathioprine 50 mg;
1998-02-02;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60109
APO-AZATHIOPRINE;
02242907;
azathioprine 50 mg;
2000-10-17;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66740
AZATHIOPRINE-50;
02243371;
azathioprine 50 mg;
2009-06-10;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67279
FINACEA;
02270811;
azelaic acid 15 % / w/w;
2010-06-15;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75617
EDARBI;
02381389;
azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg;
2012-11-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86721
EDARBI;
02381397;
azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg;
2012-11-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86722
AURO-AZITHROMYCIN;
02482363;
azithromycin (azithromycin dihydrate) 100 mg / 5 ml;
2019-10-30;
Oral;
Powder For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97283
AURO-AZITHROMYCIN;
02482371;
azithromycin (azithromycin dihydrate) 200 mg / 5 ml;
2019-10-30;
Oral;
Powder For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97284
SANDOZ AZITHROMYCIN;
02265826;
azithromycin (azithromycin dihydrate) 250 mg;
2005-11-11;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75127
RIVA-AZITHROMYCIN;
02275309;
azithromycin (azithromycin dihydrate) 250 mg;
2006-03-16;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76094
AZITHROMYCIN;
02330881;
azithromycin (azithromycin dihydrate) 250 mg;
2010-02-01;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81664
APO-AZITHROMYCIN Z;
02415542;
azithromycin (azithromycin dihydrate) 250 mg;
2014-03-06;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90013
AZITHROMYCIN;
02442434;
azithromycin (azithromycin dihydrate) 250 mg;
2015-07-22;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92678
JAMP-AZITHROMYCIN;
02452308;
azithromycin (azithromycin dihydrate) 250 mg;
2016-09-29;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93868
MAR-AZITHROMYCIN;
02452324;
azithromycin (azithromycin dihydrate) 250 mg;
2016-10-12;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93870
AZITHROMYCIN;
02477610;
azithromycin (azithromycin dihydrate) 250 mg;
2019-05-07;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96816
NRA-AZITHROMYCIN;
02479680;
azithromycin (azithromycin dihydrate) 250 mg;
2019-05-07;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96991
AG-AZITHROMYCIN;
02480700;
azithromycin (azithromycin dihydrate) 250 mg;
2018-09-26;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97120
M-AZITHROMYCIN;
02502038;
azithromycin (azithromycin dihydrate) 250 mg;
2021-01-19;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99162
AZITHROMYCIN FOR INJECTION USP;
02483890;
azithromycin (azithromycin dihydrate) 500 mg / vial;
2019-04-16;
Intravenous;
Powder For Solution;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97419
AG-AZITHROMYCIN;
02480719;
azithromycin (azithromycin dihydrate) 600 mg;
2018-09-26;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97121
TEVA-AZITHROMYCIN;
02267845;
azithromycin (azithromycin monohydrate hemiethanolate) 250 mg;
2005-12-01;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75325
PRO-AZITHROMYCINE;
02310600;
azithromycin (azithromycin monohydrate hemiethanolate) 250 mg;
2008-10-27;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79623
SANDOZ AZITHROMYCIN;
02332388;
azithromycin (azithromycin monohydrate) 100 mg / 5 ml;
2009-09-08;
Oral;
Powder For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81804
SANDOZ AZITHROMYCIN;
02332396;
azithromycin (azithromycin monohydrate) 200 mg / 5 ml;
2009-09-08;
Oral;
Powder For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81805
AZITHROMYCIN FOR INJECTION, USP;
02465604;
azithromycin (azithromycin monohydrate) 500 mg / vial;
2017-10-25;
Intravenous;
Powder For Solution;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95383
ZITHROMAX – PWS ORL 100MG/5ML;
02223716;
azithromycin 100 mg / 5 ml;
1996-09-26;
Oral;
Powder For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43386
ZITHROMAX;
02223724;
azithromycin 200 mg / 5 ml;
1996-09-26;
Oral;
Powder For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43387
ZITHROMAX;
02212021;
azithromycin 250 mg;
1999-03-23;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43063
PMS-AZITHROMYCIN;
02261634;
azithromycin 250 mg;
2006-01-04;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74701
ZITHROMAX FOR INTRAVENOUS INJECTION;
02239952;
azithromycin 500 mg / vial;
1999-08-27;
Intravenous;
Powder For Solution;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63455
PMS-AZITHROMYCIN;
02261642;
azithromycin 600 mg;
2006-01-04;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74702
CAYSTON;
02329840;
aztreonam 75 mg / vial;
2009-11-11;
Inhalation;
Powder For Solution;
08:12.07.16 – MONOBACTAMS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81558
ONCOTICE;
02153513;
bacillus calmette-guerin (bcg) strain tice 800000000 unit / vial;
1995-12-31;
Intravesical;
Powder For Solution;
80:12.00 – VACCINES;
Prescription , Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19802
BACITIN;
00584908;
bacitracin 500 unit / g;
1984-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5863
BACIJECT 50,000 UNITS/VIAL;
02245571;
bacitracin 50000 unit / vial;
2003-08-28;
Intramuscular , Topical;
Powder For Solution;
84:04.04 – ANTIBIOTICS , 08:12.28.08 – BACITRACINS;
Ethical;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69667
FIRST AID ANTIBIOTIC OINTMENT;
02352079;
bacitracin zinc 500 unit / g;
2011-02-01;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
ZEE MEDICAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83729
BACITRACIN ZINC OINTMENT USP;
02374390;
bacitracin zinc 500 unit / g;
2011-11-03;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
DYNAREX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85960
BACITRACIN ZINC OINTMENT USP;
02481812;
bacitracin zinc 500 unit / g;
2020-07-30;
Topical;
Ointment;
08:12.28.08 – BACITRACINS;
Otc;
WATER-JEL TECHNOLOGIES, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97229
LIORESAL INTRATHECAL 0.05MG/ML;
02131048;
baclofen 0.05 mg / ml;
1994-12-31;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17277
BACLOFEN INJECTION;
02457059;
baclofen 0.05 mg / ml;
2017-08-25;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94414
BACLOFEN INJECTION;
02413620;
baclofen 0.05 mg / 1 ml;
2014-06-06;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89827
LIORESAL INTRATHECAL 0.5MG/ML;
02131056;
baclofen 0.5 mg / ml;
1994-12-31;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17954
BACLOFEN INJECTION;
02457067;
baclofen 0.5 mg / ml;
2017-08-25;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94415
PMS-BACLOFEN;
02063735;
baclofen 10 mg;
1994-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15547
MYLAN-BACLOFEN;
02088398;
baclofen 10 mg;
1994-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16534
APO-BACLOFEN;
02139332;
baclofen 10 mg;
1994-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17246
BACLOFEN-10;
02152584;
baclofen 10 mg;
1996-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20308
RIVA-BACLOFEN;
02242150;
baclofen 10 mg;
2003-03-03;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65828
BACLOFEN;
02287021;
baclofen 10 mg;
2010-02-25;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77246
BACLOFEN INJECTION;
02413639;
baclofen 10 mg / 20 ml;
2014-06-06;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89828
BACLOFEN INJECTION;
02413647;
baclofen 10 mg / 5 ml;
2014-06-06;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89829
LIORESAL INTRATHECAL 2MG/ML;
02131064;
baclofen 2 mg / ml;
1994-12-31;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17276
BACLOFEN INJECTION;
02457075;
baclofen 2 mg / ml;
2017-08-25;
Intrathecal;
Solution;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94416
PMS-BACLOFEN;
02063743;
baclofen 20 mg;
1994-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15548
MYLAN-BACLOFEN;
02088401;
baclofen 20 mg;
1994-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16532
APO-BACLOFEN;
02139391;
baclofen 20 mg;
1994-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17247
BACLOFEN-20;
02152592;
baclofen 20 mg;
1996-12-31;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20309
RIVA-BACLOFEN;
02242151;
baclofen 20 mg;
2003-03-03;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65829
BACLOFEN;
02287048;
baclofen 20 mg;
2010-02-25;
Oral;
Tablet;
12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77247
BAMLANIVIMAB;
02508176;
bamlanivimab 700 mg / 20 ml;
2020-12-24;
Intravenous;
Solution;
08:18.24 – MONOCLONAL ANTIBODIES;
Covid-19 – Io – Authorization , Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99754
OLUMIANT;
02480018;
baricitinib 2 mg;
2018-09-27;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97056
SIMULECT;
02242815;
basiliximab 20 mg / vial;
2000-10-23;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66643
PROPADERM;
02089602;
beclomethasone dipropionate 0.025 % / w/w;
1998-03-30;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28440
QVAR;
02242030;
beclomethasone dipropionate 100 mcg / act;
2000-05-29;
Inhalation;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65701
MYLAN-BECLO AQ;
02172712;
beclomethasone dipropionate 50 mcg / act;
1995-12-31;
Nasal;
Metered-Dose Aerosol , Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18874
APO-BECLOMETHASONE NASAL SPRAY;
02238796;
beclomethasone dipropionate 50 mcg / act;
1998-10-07;
Nasal;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62232
QVAR;
02242029;
beclomethasone dipropionate 50 mcg / act;
2000-05-29;
Inhalation;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65700
BENLYSTA;
02370050;
belimumab 120 mg / vial;
2011-08-24;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85508
BENLYSTA;
02470489;
belimumab 200 mg / 1 ml;
2018-05-14;
Subcutaneous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95946
BENLYSTA;
02370069;
belimumab 400 mg / vial;
2011-08-24;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85509
BENAZEPRIL;
02290340;
benazepril hydrochloride 10 mg;
2007-05-15;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77564
BENAZEPRIL;
02273918;
benazepril hydrochloride 20 mg;
2006-03-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75937
BENAZEPRIL;
02290332;
benazepril hydrochloride 5 mg;
2007-05-15;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77563
TREANDA;
02392569;
bendamustine hydrochloride 100 mg / vial;
2012-09-12;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87782
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02496860;
bendamustine hydrochloride 100 mg / vial;
2021-03-02;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98671
NAT-BENDAMUSTINE;
02496895;
bendamustine hydrochloride 100 mg / vial;
2021-02-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98674
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02498111;
bendamustine hydrochloride 100 mg / vial;
2021-03-12;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98790
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02509172;
bendamustine hydrochloride 100 mg / vial;
2021-05-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99848
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02509261;
bendamustine hydrochloride 100 mg / vial;
2021-03-02;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99857
TREANDA;
02392550;
bendamustine hydrochloride 25 mg / vial;
2012-09-12;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87781
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02496852;
bendamustine hydrochloride 25 mg / vial;
2021-03-02;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98670
NAT-BENDAMUSTINE;
02496887;
bendamustine hydrochloride 25 mg / vial;
2021-02-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98673
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02509164;
bendamustine hydrochloride 25 mg / vial;
2021-05-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99847
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION;
02509253;
bendamustine hydrochloride 25 mg / vial;
2021-03-02;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99856
FASENRA;
02473232;
benralizumab 30 mg / ml;
2018-03-28;
Subcutaneous;
Solution;
48:10.20 – INTERLEUKIN ANTAGONISTS;
Prescription , Schedule D;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96262
FASENRA PEN;
02496135;
benralizumab 30 mg / ml;
2021-01-13;
Subcutaneous;
Solution;
48:10.20 – INTERLEUKIN ANTAGONISTS;
Prescription , Schedule D;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98601
DIGISAN E FOAM HAND SANITIZER;
02242842;
benzalkonium chloride 0.1 %;
2001-03-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66672
KEYSTONE FOAM HAND SANITIZER;
02246427;
benzalkonium chloride 0.1 %;
2003-08-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70601
SCOTT ANTIMICROBIAL FOAM SKIN CLEANSER;
02480816;
benzalkonium chloride 0.1 %;
2019-03-27;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
KIMBERLY-CLARK GLOBAL SALES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97147
NON-ALCOHOL FOAMING HAND SANITIZER;
02498006;
benzalkonium chloride 0.1 % / v/v;
2020-06-14;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98781
SUNSHINE HAND SANITIZER;
02501341;
benzalkonium chloride 0.1 % / v/v;
2020-08-11;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
2235721 ALBERTA LTD. / SUNSHINE ENVIRONMENTAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99097
ENRICHED FOAM ALCOHOL-FREE HAND SANITIZER;
02315637;
benzalkonium chloride 0.1 % / w/w;
2010-05-04;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80116
SMART-SAN ALCOHOL-FREE HAND SANITIZER FOAM;
02349655;
benzalkonium chloride 0.1 % / w/w;
2010-06-15;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BEST SANITIZERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83493
SANI HANDS FOAM;
02513226;
benzalkonium chloride 0.1 % / w/w;
2021-03-08;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OSTREM CHEMICAL CO LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100244
HAND SANITIZING WIPES;
02399350;
benzalkonium chloride 0.12 %;
2013-09-01;
Topical;
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ATHEA LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88424
ADVANTAGE SANITIZING WIPES;
02486431;
benzalkonium chloride 0.12 % / w/v;
2019-05-19;
Topical;
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
2XL CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97664
TRIPLE RAIN HAND SANITIZER;
02502267;
benzalkonium chloride 0.125 % / v/v;
2020-09-07;
Topical (Household);
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
KIKSTICK SAFETY LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99184
AVMOR ANTIBACTERIAL FOAMING HAND SOAP/ AVMOR SAVON MOUSSANT ANTIBACTÉRIEN POUR LES MAINS;
02486288;
benzalkonium chloride 0.125 % / w/w;
2019-07-08;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
AVMOR LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97650
ECOCARE 360;
02239318;
benzalkonium chloride 0.13 %;
1999-04-20;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62787
PURELL SF607 FOAM HAND RUB;
02403463;
benzalkonium chloride 0.13 %;
2014-02-11;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88827
PURELL SANITIZING WIPES;
02403471;
benzalkonium chloride 0.13 %;
2013-07-10;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88828
DIAL COMPLETE 2 IN 1 MOISTURIZING & ANTIBACTERIAL FOAMING HAND WASH MANUKA HONEY;
02469197;
benzalkonium chloride 0.13 %;
2018-02-26;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
HENKEL CANADA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95787
DIAL COMPLETE 2 IN 1 MOISTURIZING & ANTIBACTERIAL FOAMING HAND WASH PEARL ESSENCE;
02469200;
benzalkonium chloride 0.13 %;
2018-02-26;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
HENKEL CANADA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95788
TRANQUIL MEADOWS AB;
02472198;
benzalkonium chloride 0.13 %;
2020-04-01;
Topical (Commercial);
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96148
FUZION AB FOAMING HAND SOAP;
02472236;
benzalkonium chloride 0.13 %;
2018-06-27;
Topical (Commercial);
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96151
ACCLAIM AB;
02472287;
benzalkonium chloride 0.13 %;
2019-08-19;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96159
PEAR AB HAND SOAP;
02473798;
benzalkonium chloride 0.13 %;
2019-10-30;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96343
SCOTT FOAM HAND SANITIZER;
02481456;
benzalkonium chloride 0.13 %;
2019-02-18;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
KIMBERLY-CLARK GLOBAL SALES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97189
LORIS 0.13% BZK;
02354543;
benzalkonium chloride 0.13 % / v/v;
2011-12-06;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LERNAPHARM (LORIS) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83971
ANTIBACTERIAL HAND SOAP WITH LIGHT MOISTURIZERS;
02497905;
benzalkonium chloride 0.13 % / v/v;
2020-05-16;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98770
ENEVRA NON-ALCOHOLIC HAND SANITIZER;
02498995;
benzalkonium chloride 0.13 % / v/v;
2020-07-15;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GLOBARA LABORATORIES INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98871
DYMON ANTIBACTERIAL HAND SOAP WITH MOISTURIZERS;
02499444;
benzalkonium chloride 0.13 % / v/v;
2020-06-14;
Topical (Commercial);
Solution;
-;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98916
COVALONGUARD SPRAY;
02499754;
benzalkonium chloride 0.13 % / w/v;
2020-06-26;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
COVALON TECHNOLOGIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98946
WIPE AWAY! ANTI-BACTERIAL WIPES;
02505452;
benzalkonium chloride 0.13 % / w/v;
2021-01-04;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ENCHANTE ACCESSORIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99479
X3 CLEAN GERM ATTACK HAND SANITIZER;
02290855;
benzalkonium chloride 0.13 % / w/w;
2007-09-25;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
NATURAL ESSENTIALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77627
FRAGRANCE FOAM;
02354780;
benzalkonium chloride 0.13 % / w/w;
2011-02-01;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SCENTSY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83994
BENZALKONIUM CHLORIDE ANTISEPTIC TOWELETTE;
02355736;
benzalkonium chloride 0.13 % / w/w;
2012-06-07;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84093
X3 ON-THE-GO ANTISEPTIC SPRAY;
02369575;
benzalkonium chloride 0.13 % / w/w;
2012-04-24;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
NATURAL ESSENTIALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85450
SOFTSOAP ANTIBACTERIAL;
02406802;
benzalkonium chloride 0.13 % / w/w;
2014-01-20;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
COLGATE-PALMOLIVE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89148
SANIMOR ASSAINISSEUR MOUSSANT SANS ALCOOL POUR LES MAINS | SANIMOR ALCOHOL FREE FOAMING HAND SANITIZER;
02432749;
benzalkonium chloride 0.13 % / w/w;
2015-04-10;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
AVMOR LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91715
PURELL HAND SANITIZING WIPES;
02437384;
benzalkonium chloride 0.13 % / w/w;
2016-04-01;
Topical;
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92173
ALOE-CARE ANTIBACTERIAL LOTION SOAP, BENZALKONIUM CHLORIDE LOTION 0.13% W/W;
02443163;
benzalkonium chloride 0.13 % / w/w;
2015-11-02;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92774
KLEENEX FOAM HAND SANITIZER;
02443252;
benzalkonium chloride 0.13 % / w/w;
2016-04-14;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
KIMBERLY-CLARK GLOBAL SALES LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92785
HAND SANITIZER FOAM;
02459272;
benzalkonium chloride 0.13 % / w/w;
2017-03-16;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
EMPACK SPRAYTECH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94646
DIAL COMPLETE ANTIBACTERIAL FOAMING HAND WASH;
02464802;
benzalkonium chloride 0.13 % / w/w;
2017-11-06;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
HENKEL CANADA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95295
DIAL ANTIBACTERIAL HYDRATING HAND SOAP;
02464829;
benzalkonium chloride 0.13 % / w/w;
2017-11-06;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
HENKEL CANADA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95297
ALCOHOL FREE FOAMING HAND SANITIZER;
02479729;
benzalkonium chloride 0.13 % / w/w;
2020-03-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
VI-JON, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97037
DYE FREE FRAGRANCE FREE ANTIBACTERIAL FOAMING HAND SOAP;
02480336;
benzalkonium chloride 0.13 % / w/w;
2019-11-14;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
VI-JON, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97086
CERTAINTY WIPES HAND SANITIZING WIPES;
02497522;
benzalkonium chloride 0.13 % / w/w;
2020-06-26;
Topical;
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
INNOCORE SALES & MARKETING
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98734
CERTAINTY FOAMING HAND SANITIZER;
02499037;
benzalkonium chloride 0.13 % / w/w;
2020-06-04;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
INNOCORE SALES & MARKETING
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98880
MARCELLE ULTRA GENTLE HAND SANITIZING GEL;
02499045;
benzalkonium chloride 0.13 % / w/w;
2020-06-23;
Topical (Household);
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98881
STRONGARM HAND SANITIZER;
02499150;
benzalkonium chloride 0.13 % / w/w;
2020-07-03;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ARMSTRONG MANUFACTURING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98890
FOAM-CARE ULTRA;
02500124;
benzalkonium chloride 0.13 % / w/w;
2020-06-15;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LES CHIMIQUES B.O.D. INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98983
ANTIBACTERIAL WIPES;
02500485;
benzalkonium chloride 0.13 % / w/w;
2020-09-09;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
FUSION PRODUCTS LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99016
HAMOL;
02500604;
benzalkonium chloride 0.13 % / w/w;
2020-11-27;
Topical (Household);
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
AK-PAK RICCI
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99027
ELEMENTAL HAND SANITIZER;
02502100;
benzalkonium chloride 0.13 % / w/w;
2020-07-23;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
EASY WAY CLEANING PRODUCTS LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99164
FS ANTIMICROBIAL HAND WASH;
02502852;
benzalkonium chloride 0.13 % / w/w;
2020-11-04;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99238
SPA SOAP LIQUID SOAP;
02503050;
benzalkonium chloride 0.13 % / w/w;
2020-11-18;
Topical (Household);
Solution;
-;
Otc;
SANTE MANUFACTURING INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99256
SOFTSOAP ANTIBACTERIAL WHITE TEA & BERRY;
02508168;
benzalkonium chloride 0.13 % / w/w;
2021-02-25;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
COLGATE-PALMOLIVE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99755
MEDISANI ANTI-BACTERIAL HAND SANITIZER;
02510189;
benzalkonium chloride 0.13 % / w/w;
2021-03-02;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
MEDISANI SOLUTIONS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99942
GERMS BE GONE ANTIBACTERIAL HAND SOAP;
02510650;
benzalkonium chloride 0.13 % / w/w;
2021-04-29;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BRANDS INTERNATIONAL CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99985
RITUAL;
02359715;
benzalkonium chloride 0.15 % / v/v;
2014-08-19;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ATOMS F.D. INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84471
ANTI-MICROBE M;
02502178;
benzalkonium chloride 0.15 % / v/v;
2020-07-16;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ATOMS F.D. INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99175
BIO-ODEUR;
02508370;
benzalkonium chloride 0.15 % / v/v;
2020-11-23;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PRODUITS BIO-EXPERT INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99774
SOAPOPULAR;
02270420;
benzalkonium chloride 0.15 % / w/w;
2005-11-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SOAPOPULAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75580
KLERE;
02329891;
benzalkonium chloride 0.15 % / w/w;
2010-05-03;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BIOCHEM ENVIRONMENTAL SOLUTIONS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81564
EZ PUR HAND SANITIZER;
02499274;
benzalkonium chloride 0.15 % / w/w;
2020-05-15;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PRELAM ENTERPRISES LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98901
HAND SANITIZER;
02502208;
benzalkonium chloride 0.15 % / w/w;
2020-08-28;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CONTRACT PACKAGING DISTRIBUTION INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99178
ENVIRO FRESH HAND SANITIZER;
02511436;
benzalkonium chloride 0.15 % / w/w;
2021-03-29;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ENVIRO FRESH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100063
ANTI-MICROBE;
02248351;
benzalkonium chloride 0.3 %;
2004-03-09;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ATOMS F.D. INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72696
FS ANTIMICROBIAL HAND CLEANER – 2.5% LIQ;
02119242;
benzalkonium chloride 2.5 %;
1998-09-25;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=30372
VINDA ANTIBACTERIAL WIPES;
02501074;
benzethonium chloride 0.13 % / w/w;
2020-07-20;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GRAND OCEAN INTERNATIONAL TRADING LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99072
ECOLOGICAL HAND SANITIZER WITH CONDITIONING ALOE;
02498138;
benzethonium chloride 0.15 % / v/v;
2020-05-13;
Topical (Household);
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
HUNTER AMENITIES INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98791
ZEP FOAM SAN;
02248971;
benzethonium chloride 0.2 %;
2004-02-09;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73352
WINNING HANDS ALCOHOL FREE HAND SANITIZER;
02250977;
benzethonium chloride 0.2 %;
2004-05-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BETCO CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73590
INO-F-SAN INSTANT HAND SANITIZER;
02267365;
benzethonium chloride 0.2 %;
2005-04-21;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GROUPE DISSAN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75279
GENTLE FRESH SANITIZER;
02280841;
benzethonium chloride 0.2 %;
2006-07-14;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
STATE INDUSTRIAL PRODUCTS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76652
FOAM SANITIZER;
02377896;
benzethonium chloride 0.2 % / w/w;
2012-01-23;
Topical (Commercial);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86369
FINIPIL LAIT 50;
02470837;
benzethonium chloride 0.2 % / w/w;
2018-03-29;
Topical;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
EQUIBAL LABS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95990
FINIPIL;
02470853;
benzethonium chloride 0.2 % / w/w;
2018-03-29;
Topical;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
EQUIBAL LABS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95992
FINIPIL 4 MEN ONLY;
02481480;
benzethonium chloride 0.2 % / w/w;
2019-05-31;
Topical;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
EQUIBAL LABS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97192
WET ONES;
02304112;
benzethonium chloride 0.3 % / w/w;
2008-04-22;
Topical;
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78942
BENZAC W WASH GEL 10%;
01925199;
benzoyl peroxide 10 %;
1991-12-31;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11862
RENEWAL CLEANSER;
02433486;
benzoyl peroxide 2.5 %;
2015-12-10;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91785
SPOT CLEARING LOTION;
02445247;
benzoyl peroxide 2.5 %;
2016-08-30;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
ALUMIER EUROPE LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93048
CLINIQUE ACNE SOLUTIONS ALL-OVER CLEARING TREATMENT;
02290561;
benzoyl peroxide 2.5 % / w/w;
2007-07-03;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77590
BENZAGEL SPOT-ON ACNE GEL;
02361949;
benzoyl peroxide 2.5 % / w/w;
2011-08-22;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
COLUMBIA LABORATORIES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84698
PROACTIV TREAT;
02390396;
benzoyl peroxide 2.5 % / w/w;
2013-08-08;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87583
PROACTIV CLEANSE;
02391015;
benzoyl peroxide 2.5 % / w/w;
2013-08-08;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87639
PROACTIV+ SKIN SMOOTHING EXFOLIATOR;
02394421;
benzoyl peroxide 2.5 % / w/w;
2014-06-20;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87959
PROACTIV PLUS PORE TARGETING SOLUTION;
02411245;
benzoyl peroxide 2.5 % / w/w;
2014-06-20;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89587
DUAL INTENSIVE ACNE TREATMENT;
02414309;
benzoyl peroxide 2.5 % / w/w;
2015-02-02;
Topical;
Gel , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89896
REPAIRING TREATMENT;
02433494;
benzoyl peroxide 2.5 % / w/w;
2015-12-10;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
FRUIT OF THE EARTH, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91786
STUBBORN ACNE DAILY LEAVE-ON MASK;
02440520;
benzoyl peroxide 2.5 % / w/w;
2016-01-18;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92489
ACNE CLEARING TREATMENT;
02463202;
benzoyl peroxide 2.5 % / w/w;
2019-04-09;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95111
CLEAR CELL MEDICATED ACNE FACIAL SCRUB;
02437562;
benzoyl peroxide 3 % / w/w;
2015-02-17;
Topical;
Solution;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
IMAGE INTERNATIONAL MANUFACTURING LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92189
STUBBORN ACNE CLEANSER;
02440881;
benzoyl peroxide 3.5 % / w/w;
2017-01-30;
Topical;
Paste;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92524
BENZAGEL 5 WASH;
02162121;
benzoyl peroxide 5 %;
1996-12-31;
Topical;
Solution;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
COLUMBIA LABORATORIES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20299
BENZAGEL 5 GEL;
02162113;
benzoyl peroxide 5 %;
1996-08-29;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
COLUMBIA LABORATORIES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34258
CLEAN & CLEAR PERSA-GEL 5;
02236396;
benzoyl peroxide 5 %;
2000-03-31;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59870
ADASEPT B.P.5 ACNE GEL;
02290081;
benzoyl peroxide 5 %;
2007-09-25;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77539
BENZOYL PEROXIDE ACNE TREATMENT 5%;
02412012;
benzoyl peroxide 5 %;
2014-10-24;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89660
CLEAR CELL MEDICATED ACNE LOTION;
02456656;
benzoyl peroxide 5 %;
2016-07-27;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
IMAGE INTERNATIONAL MANUFACTURING LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94364
DEEP PORE ACNE VANISHING TREATMENT;
02236796;
benzoyl peroxide 5 % / w/w;
1998-07-15;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60085
CONTINUOUS CONTROL ACNE CLEANSER;
02242134;
benzoyl peroxide 5 % / w/w;
2001-08-01;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65812
MEDICATED ACNE GEL;
02268817;
benzoyl peroxide 5 % / w/w;
2006-01-03;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
PRIME ENTERPRISES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75421
EMERGENCY ACNE VANISHING FACIAL CLEANSER;
02321874;
benzoyl peroxide 5 % / w/w;
2009-06-02;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80728
ACNE TREATMENT LOTION;
02336812;
benzoyl peroxide 5 % / w/w;
2011-06-07;
Topical;
Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
VIVIER CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82243
PROACTIV EMERGENCY BLEMISH RELIEF;
02413655;
benzoyl peroxide 5 % / w/w;
2014-10-27;
Topical;
Cream;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89830
STUBBORN ACNE SPOT GEL;
02440512;
benzoyl peroxide 5 % / w/w;
2016-01-18;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92488
DAILY ACNE WASH;
02463210;
benzoyl peroxide 5 % / w/w;
2019-04-09;
Topical;
Cream;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
RODAN & FIELDS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95112
BPO5;
02490285;
benzoyl peroxide 5 % / w/w;
2020-04-03;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
RGR PHARMA LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98034
BLEMISH GEL 5%;
02248217;
benzoyl peroxide 5.0 %;
2004-07-17;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
KAMINS DERMATOLOGICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72553
PDP-BENZTROPINE;
00706531;
benztropine mesylate 1 mg;
1987-12-31;
Oral;
Tablet;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8060
BENZTROPINE OMEGA;
02238903;
benztropine mesylate 1 mg / ml;
1999-05-28;
Intramuscular , Intravenous;
Liquid;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62344
VPI-BENZTROPINE;
02486822;
benztropine mesylate 2 mg / 2 ml;
2019-12-03;
Intramuscular , Intravenous;
Solution;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
VPI PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97699
PHARIXIA;
02229777;
benzydamine hydrochloride 0.15 % / w/v;
1996-12-02;
Buccal;
Mouthwash/Gargle;
52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48059
PMS-BENZYDAMINE;
02239537;
benzydamine hydrochloride 0.15 % / w/v;
1999-04-30;
Buccal;
Mouthwash/Gargle;
52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63013
ODAN-BENZYDAMINE;
02463105;
benzydamine hydrochloride 0.15 % / w/v;
2017-08-11;
Buccal;
Mouthwash/Gargle;
52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95103
PHARIXIA ALCOHOL FREE;
02494434;
benzydamine hydrochloride 0.15 % / w/v;
2020-07-13;
Buccal;
Mouthwash/Gargle;
52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98444
PRE-PEN;
00328693;
benzylpenicilloyl-polylysine 0.000060 m / amp;
1975-12-31;
Intradermal;
Solution;
36:30.00 – DRUG HYPERSENSITIVITY;
Prescription;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2175
BEPREVE;
02456532;
bepotastine besilate 1.5 % / w/v;
2017-03-23;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94350
SURVANTA;
02016109;
beractant 25 mg / ml;
1993-12-31;
Intratracheal;
Suspension;
48:36.00 – PULMONARY SURFACTANTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14318
BESIVANCE;
02336847;
besifloxacin (besifloxacin hydrochloride) 0.6 % / w/v;
2010-01-27;
Ophthalmic;
Suspension;
52:04.04 – ANTIBACTERIALS;
Prescription;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82246
SERC;
02243878;
betahistine hydrochloride 16 mg;
2001-08-17;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67819
TEVA-BETAHISTINE;
02280191;
betahistine hydrochloride 16 mg;
2006-08-14;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76587
PMS-BETAHISTINE;
02330210;
betahistine hydrochloride 16 mg;
2014-01-16;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81597
AURO-BETAHISTINE;
02449153;
betahistine hydrochloride 16 mg;
2015-11-30;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93497
BETAHISTINE;
02466449;
betahistine hydrochloride 16 mg;
2018-03-07;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95480
SERC;
02247998;
betahistine hydrochloride 24 mg;
2003-12-10;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72312
TEVA-BETAHISTINE;
02280205;
betahistine hydrochloride 24 mg;
2006-08-30;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76588
PMS-BETAHISTINE;
02330237;
betahistine hydrochloride 24 mg;
2014-01-16;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81599
AURO-BETAHISTINE;
02449161;
betahistine hydrochloride 24 mg;
2015-11-30;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93498
BETAHISTINE;
02466457;
betahistine hydrochloride 24 mg;
2018-03-07;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95481
TEVA-BETAHISTINE;
02280183;
betahistine hydrochloride 8 mg;
2010-12-13;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76586
AURO-BETAHISTINE;
02449145;
betahistine hydrochloride 8 mg;
2015-11-30;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93496
CYSTADANE;
02238526;
betaine 1 g / 1.7 cc;
1998-08-11;
Oral;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61949
TEVA-TOPILENE;
00849669;
betamethasone (betamethasone dipropionate) 0.05 %;
1990-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10940
TARO-SONE;
01925350;
betamethasone (betamethasone dipropionate) 0.05 %;
1992-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12272
TEVA-TOPILENE;
01927914;
betamethasone (betamethasone dipropionate) 0.05 %;
1993-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13690
TEVA-TOPILENE;
00849650;
betamethasone (betamethasone dipropionate) 0.05 %;
1990-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14445
DIPROSONE;
00323071;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1975-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2071
DIPROSONE;
00344923;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1976-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2272
DIPROSONE;
00417246;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1977-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2870
DIPROLENE;
00629367;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1985-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6529
TEVA-TOPISONE;
00809187;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1990-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10941
TEVA-TOPISONE;
00805009;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1990-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13888
TEVA-TOPISONE;
00804991;
betamethasone (betamethasone dipropionate) 0.05 % / w/w;
1993-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13889
BETNESOL RETENTION ENEMA 5MG/100ML;
02060884;
betamethasone (betamethasone sodium phosphate) 5 mg / 100 ml;
1997-04-01;
Rectal;
Enema;
68:04.00 – ADRENALS , 56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27517
TEVA-ECTOSONE;
00535427;
betamethasone (betamethasone valerate) 0.05 %;
1981-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4521
TEVA-ECTOSONE;
00653209;
betamethasone (betamethasone valerate) 0.05 %;
1986-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6822
BETADERM CRM 0.05%;
00716618;
betamethasone (betamethasone valerate) 0.05 %;
1979-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8972
BETADERM ONT 0.05%;
00716642;
betamethasone (betamethasone valerate) 0.05 %;
1979-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9270
TEVA-ECTOSONE;
00535435;
betamethasone (betamethasone valerate) 0.1 %;
1981-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4522
TEVA-ECTOSONE;
00653217;
betamethasone (betamethasone valerate) 0.1 %;
1986-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6620
BETADERM ONT 0.1%;
00716650;
betamethasone (betamethasone valerate) 0.1 %;
1988-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8973
BETADERM CRM 0.1%;
00716626;
betamethasone (betamethasone valerate) 0.1 %;
1979-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9268
BETADERM LOTION 0.1%;
00716634;
betamethasone (betamethasone valerate) 0.1 %;
1979-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9269
TEVA-ECTOSONE;
00750050;
betamethasone (betamethasone valerate) 0.1 %;
1987-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19225
BETOPTIC S;
01908448;
betaxolol (betaxolol hydrochloride) 0.25 % / w/v;
1994-12-31;
Ophthalmic;
Suspension;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15625
DUVOID TABLETS 10 MG;
01947958;
bethanechol chloride 10 mg;
1992-12-31;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12746
DUVOID TABLETS 25 MG;
01947931;
bethanechol chloride 25 mg;
1992-12-31;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12745
DUVOID TABLETS 50 MG;
01947923;
bethanechol chloride 50 mg;
1992-12-31;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12887
ZIRABEV;
02489430;
bevacizumab 100 mg / 4 ml;
2019-09-25;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97952
AVASTIN;
02270994;
bevacizumab 25 mg / ml;
2005-11-02;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75642
MVASI;
02470748;
bevacizumab 25 mg / ml;
2019-08-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95974
MVASI;
02470756;
bevacizumab 25 mg / ml;
2019-08-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95975
ZIRABEV;
02489449;
bevacizumab 400 mg / 16 ml;
2019-09-25;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97953
BEZALIP SR;
02083523;
bezafibrate 400 mg;
1994-12-21;
Oral;
Tablet (Extended-Release);
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16968
JAMP-BEZAFIBRATE SR;
02453312;
bezafibrate 400 mg;
2016-04-06;
Oral;
Tablet (Extended-Release);
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93984
CASODEX;
02184478;
bicalutamide 50 mg;
1996-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19647
TEVA-BICALUTAMIDE;
02270226;
bicalutamide 50 mg;
2006-02-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75561
PMS-BICALUTAMIDE;
02275589;
bicalutamide 50 mg;
2006-02-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76122
APO-BICALUTAMIDE;
02296063;
bicalutamide 50 mg;
2007-11-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78142
PRO-BICALUTAMIDE – 50;
02311038;
bicalutamide 50 mg;
2008-07-09;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79663
ACH-BICALUTAMIDE;
02325985;
bicalutamide 50 mg;
2010-05-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81133
JAMP-BICALUTAMIDE;
02357216;
bicalutamide 50 mg;
2010-10-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84234
BLEXTEN;
02454130;
bilastine 20 mg;
2016-12-02;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94066
LUMIGAN RC;
02324997;
bimatoprost 0.01 % / w/v;
2009-06-16;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81041
LATISSE;
02350939;
bimatoprost 0.03 % / w/v;
2010-11-01;
Topical;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83612
VISTITAN;
02429063;
bimatoprost 0.03 % / w/v;
2016-05-13;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91352
DULCOLAX;
00003875;
bisacodyl 10 mg;
1958-12-31;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1555
THE MAGIC BULLET;
02241091;
bisacodyl 10 mg;
1999-11-25;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
D & C MOBILITY SOLUTIONS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64686
SILVER BULLET SUPPOSITORY;
02280566;
bisacodyl 10 mg;
2007-12-15;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
D & C MOBILITY SOLUTIONS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76622
BISACODYL SUPPOSITORY;
02361450;
bisacodyl 10 mg;
2013-12-18;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84651
BISACODYL 10 MG;
02458853;
bisacodyl 10 mg;
2018-01-17;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94603
BISACODYL SUPPOSITORY;
02489090;
bisacodyl 10 mg;
2020-01-27;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97915
DULCOLAX;
00254142;
bisacodyl 5 mg;
1958-12-31;
Oral;
Tablet (Enteric-Coated);
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1553
CARTER’S LITTLE PILLS;
02219190;
bisacodyl 5 mg;
1998-01-07;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37161
CODULAX TABLETS;
02238155;
bisacodyl 5 mg;
1999-07-05;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61546
BISACODYL TABLETS 5MG;
02243838;
bisacodyl 5 mg;
2003-04-01;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67779
JAMP-BISACODYL;
02246039;
bisacodyl 5 mg;
2006-10-20;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70170
BISACODYL-ODAN;
02273411;
bisacodyl 5 mg;
2005-12-07;
Oral;
Tablet (Delayed-Release);
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75889
DULCOLAX FOR WOMEN;
02397854;
bisacodyl 5 mg;
2013-08-23;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88276
BISACODYL SUPPOSITORY 5 MG;
02410893;
bisacodyl 5 mg;
2014-07-22;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89553
BISACODYL TABLETS;
02417413;
bisacodyl 5 mg;
2014-04-08;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90204
LAXATIVE FOR WOMEN;
02450232;
bisacodyl 5 mg;
2016-03-03;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93629
BISACODYL 5 MG;
02458845;
bisacodyl 5 mg;
2018-01-17;
Rectal;
Suppository;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94602
NEO-LARYNGOBIS;
00065927;
bismuth dipropylacetate 135 mg;
1950-12-31;
Rectal;
Suppository;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1090
DEVROM CHEW TAB 200MG;
00452696;
bismuth subgallate 200 mg;
1978-12-31;
Oral;
Tablet (Chewable);
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
THE PARTHENON COMPANY INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3166
BISMUTH SUBSALICYLATE LIQUID;
02313162;
bismuth subsalicylate 17.5 mg / ml;
2008-12-12;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
GUARDIAN DRUG COMPANY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79869
REGULAR STRENGTH BISMUTH;
02468646;
bismuth subsalicylate 17.5 mg / ml;
2018-07-17;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95706
PEPTO-BISMOL;
02097079;
bismuth subsalicylate 17.6 mg / ml;
1987-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42395
PEPTO BISMOL CAPLET – 262MG/CAPLET;
02177994;
bismuth subsalicylate 262 mg;
1996-12-31;
Oral;
Tablet;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42736
PEPTO-BISMOL WITH INSTACOOL;
02325896;
bismuth subsalicylate 262 mg;
2010-01-21;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81124
BISMUTH SUBSALICYLATE CAPLETS;
02326582;
bismuth subsalicylate 262 mg;
2010-02-01;
Oral;
Tablet;
56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
GUARDIAN DRUG COMPANY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81194
BISMUTH CAPLETS;
02457121;
bismuth subsalicylate 262 mg;
2018-09-28;
Oral;
Tablet;
56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94421
PEPTO BISMOL LIQUICAPS;
02499991;
bismuth subsalicylate 262 mg;
2021-03-15;
Oral;
Capsule;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98971
EXTRA STRENGTH BISMUTH SUBSALICYLATE LIQUID;
02328453;
bismuth subsalicylate 35 mg / ml;
2010-07-01;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
GUARDIAN DRUG COMPANY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81398
PEPTO-BISMOL EXTRA;
02229668;
bismuth subsalicylate 35.2 mg / ml;
2000-02-01;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47656
EXTRA STRENGTH BISMUTH;
02475855;
bismuth subsalicylate 35.2 mg / ml;
2020-09-11;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96658
SANDOZ BISOPROLOL;
02247440;
bisoprolol fumarate 10 mg;
2003-04-24;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71686
APO-BISOPROLOL;
02256177;
bisoprolol fumarate 10 mg;
2004-08-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74140
TEVA-BISOPROLOL;
02267489;
bisoprolol fumarate 10 mg;
2005-10-07;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75289
PRO-BISOPROLOL – 10;
02307006;
bisoprolol fumarate 10 mg;
2008-07-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79268
BISOPROLOL;
02383063;
bisoprolol fumarate 10 mg;
2012-06-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86885
BISOPROLOL;
02391597;
bisoprolol fumarate 10 mg;
2012-10-01;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87692
MINT-BISOPROLOL;
02465620;
bisoprolol fumarate 10 mg;
2019-02-05;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95385
RIVA-BISOPROLOL;
02471272;
bisoprolol fumarate 10 mg;
2018-01-19;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96038
SANDOZ BISOPROLOL TABLETS;
02494043;
bisoprolol fumarate 10 mg;
2019-11-27;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98406
BISOPROLOL TABLETS;
02495570;
bisoprolol fumarate 10 mg;
2020-05-26;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98547
SANDOZ BISOPROLOL;
02247439;
bisoprolol fumarate 5 mg;
2003-04-24;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71685
APO-BISOPROLOL;
02256134;
bisoprolol fumarate 5 mg;
2004-08-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74136
TEVA-BISOPROLOL;
02267470;
bisoprolol fumarate 5 mg;
2005-10-07;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75288
PRO-BISOPROLOL – 5;
02306999;
bisoprolol fumarate 5 mg;
2008-07-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79267
BISOPROLOL;
02383055;
bisoprolol fumarate 5 mg;
2012-06-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86884
BISOPROLOL;
02391589;
bisoprolol fumarate 5 mg;
2012-10-01;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87691
MINT-BISOPROLOL;
02465612;
bisoprolol fumarate 5 mg;
2019-02-05;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95384
RIVA-BISOPROLOL;
02471264;
bisoprolol fumarate 5 mg;
2018-01-19;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96037
SANDOZ BISOPROLOL TABLETS;
02494035;
bisoprolol fumarate 5 mg;
2019-11-27;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98405
BISOPROLOL TABLETS;
02495562;
bisoprolol fumarate 5 mg;
2020-05-26;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98546
ANGIOMAX;
02246533;
bivalirudin 250 mg / vial;
2003-05-08;
Intravenous;
Powder For Solution;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70715
BIVALIRUDIN FOR INJECTION;
02435268;
bivalirudin 250 mg / vial;
2019-04-23;
Intravenous;
Powder For Solution;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91953
BIVALIRUDIN INJECTION;
02505517;
bivalirudin 5 mg / ml;
2021-03-05;
Intravenous;
Solution;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
AVIR PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99489
BLEOMYCIN FOR INJECTION USP;
02131692;
bleomycin (bleomycin sulfate) 15 unit / vial;
1998-03-12;
Intra-Arterial , Intracavitary , Intramuscular , Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43892
BLEOMYCIN FOR INJECTION;
02265982;
bleomycin (bleomycin sulfate) 15 unit / vial;
2009-03-20;
Intramuscular , Intrapleural , Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75142
BLINCYTO;
02450283;
blinatumomab 38.5 mcg / vial;
2016-03-17;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93642
BORTEZOMIB FOR INJECTION;
02467003;
bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial;
2020-06-23;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95541
BORTEZOMIB FOR INJECTION;
02494930;
bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial;
2020-10-05;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98491
VELCADE;
02262452;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2005-02-01;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74782
BORTEZOMIB FOR INJECTION;
02423405;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2015-01-06;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90813
ACT BORTEZOMIB;
02438399;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2015-11-17;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92278
BORTEZOMIB FOR INJECTION;
02452456;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2017-03-21;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93883
BORTEZOMIB;
02456176;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2019-03-25;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94301
PMS-BORTEZOMIB;
02466708;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2018-06-05;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95502
BORTEZOMIB FOR INJECTION;
02493306;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2020-05-19;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98328
TARO-BORTEZOMIB;
02499061;
bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
2021-04-12;
Intravenous , Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98883
TRACLEER;
02244982;
bosentan (bosentan monohydrate) 125 mg;
2001-12-14;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68980
PMS-BOSENTAN;
02383020;
bosentan (bosentan monohydrate) 125 mg;
2012-06-12;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86881
SANDOZ BOSENTAN;
02386283;
bosentan (bosentan monohydrate) 125 mg;
2012-06-13;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87186
NAT-BOSENTAN;
02467992;
bosentan (bosentan monohydrate) 125 mg;
2020-04-30;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95636
TRACLEER;
02244981;
bosentan (bosentan monohydrate) 62.5 mg;
2001-12-14;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68979
PMS-BOSENTAN;
02383012;
bosentan (bosentan monohydrate) 62.5 mg;
2012-06-12;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86880
SANDOZ BOSENTAN;
02386275;
bosentan (bosentan monohydrate) 62.5 mg;
2012-06-13;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87185
NAT-BOSENTAN;
02467984;
bosentan (bosentan monohydrate) 62.5 mg;
2020-04-30;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95635
TARO-BOSENTAN;
02483130;
bosentan (bosentan monohydrate) 62.5 mg;
2020-05-07;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97359
BOSULIF;
02419149;
bosutinib (bosutinib monohydrate) 100 mg;
2014-04-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90368
BOSULIF;
02419157;
bosutinib (bosutinib monohydrate) 500 mg;
2014-03-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90369
ADCETRIS;
02401347;
brentuximab vedotin 50 mg / vial;
2013-02-19;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SEATTLE GENETICS, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88626
REXULTI;
02461749;
brexpiprazole 0.25 mg;
2017-04-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94950
REXULTI;
02461757;
brexpiprazole 0.5 mg;
2017-04-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94951
REXULTI;
02461765;
brexpiprazole 1 mg;
2017-04-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94952
REXULTI;
02461773;
brexpiprazole 2 mg;
2017-04-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94953
REXULTI;
02461781;
brexpiprazole 3 mg;
2017-04-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94954
REXULTI;
02461803;
brexpiprazole 4 mg;
2017-04-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94955
ALUNBRIG;
02479222;
brigatinib 180 mg;
2018-08-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96984
ALUNBRIG;
02479206;
brigatinib 30 mg;
2018-08-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96982
ALUNBRIG;
02479214;
brigatinib 90 mg;
2018-08-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96983
ONRELTEA;
02421208;
brimonidine (brimonidine tartrate) 0.33 % / w/w;
2014-03-24;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90580
ALPHAGAN P;
02248151;
brimonidine tartrate 0.15 %;
2003-11-05;
Ophthalmic;
Solution;
52:40.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72483
ALPHAGAN;
02236876;
brimonidine tartrate 0.2 %;
1997-12-02;
Ophthalmic;
Liquid;
52:40.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60166
APO-BRIMONIDINE;
02260077;
brimonidine tartrate 0.2 %;
2005-06-02;
Ophthalmic;
Solution;
52:40.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74531
SANDOZ BRIMONIDINE;
02305429;
brimonidine tartrate 0.2 %;
2008-02-08;
Ophthalmic;
Solution;
52:40.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79097
AZOPT;
02238873;
brinzolamide 1 % / w/v;
1998-11-11;
Ophthalmic;
Suspension;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62313
BRIVLERA;
02452936;
brivaracetam 10 mg;
2016-05-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93933
BRIVLERA;
02452987;
brivaracetam 10 mg / ml;
2020-04-06;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93938
BRIVLERA;
02452995;
brivaracetam 10 mg / ml;
2018-10-10;
Intravenous;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93939
BRIVLERA;
02452979;
brivaracetam 100 mg;
2016-05-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93937
BRIVLERA;
02452944;
brivaracetam 25 mg;
2016-05-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93934
BRIVLERA;
02452952;
brivaracetam 50 mg;
2016-05-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93935
BRIVLERA;
02452960;
brivaracetam 75 mg;
2016-05-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93936
SILIQ;
02473623;
brodalumab 210 mg / 1.5 ml;
2018-07-05;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Schedule D;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96302
BEOVU;
02496976;
brolucizumab 6 mg / 0.05 ml;
2020-05-15;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98684
APO-BROMAZEPAM – TAB 3MG;
02177161;
bromazepam 3 mg;
1995-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19056
TEVA-BROMAZEPAM;
02230584;
bromazepam 3 mg;
1997-03-03;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49693
APO-BROMAZEPAM – TAB 6MG;
02177188;
bromazepam 6 mg;
1995-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19047
TEVA-BROMAZEPAM;
02230585;
bromazepam 6 mg;
1997-03-03;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49694
PROLENSA;
02439123;
bromfenac (bromfenac sodium sesquihydrate) 0.07 % / w/v;
2015-09-25;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92351
BROMOCRIPTINE;
02087324;
bromocriptine (bromocriptine mesylate) 2.5 mg;
1994-12-31;
Oral;
Tablet;
28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16195
BROMOCRIPTINE;
02230454;
bromocriptine (bromocriptine mesylate) 5 mg;
1997-01-08;
Oral;
Capsule;
28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49403
PULMICORT NEBUAMP 0.125 MG/ML;
02229099;
budesonide 0.125 mg / ml;
1997-06-16;
Inhalation;
Suspension;
68:04.00 – ADRENALS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43511
TEVA-BUDESONIDE;
02465949;
budesonide 0.125 mg / ml;
2017-11-08;
Inhalation;
Suspension;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95417
PULMICORT NEBUAMP 0.25 MG/ML;
01978918;
budesonide 0.25 mg / ml;
1992-12-31;
Inhalation;
Suspension;
68:04.00 – ADRENALS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13191
PULMICORT NEBUAMP 0.5 MG/ML;
01978926;
budesonide 0.5 mg / ml;
1992-12-31;
Inhalation;
Suspension;
68:04.00 – ADRENALS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13190
TEVA-BUDESONIDE;
02465957;
budesonide 0.5 mg / ml;
2017-11-08;
Inhalation;
Suspension;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95418
JORVEZA;
02493675;
budesonide 1 mg;
2021-01-07;
Oral;
Tablet (Orally Disintegrating);
68:04.00 – ADRENALS;
Prescription;
AVIR PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98367
PULMICORT TURBUHALER;
00852074;
budesonide 100 mcg / act;
1990-12-31;
Inhalation;
Powder (Metered Dose);
68:04.00 – ADRENALS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10667
MYLAN-BUDESONIDE AQ;
02230648;
budesonide 100 mcg / act;
1997-02-12;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49895
PULMICORT TURBUHALER;
00851752;
budesonide 200 mcg / act;
1990-12-31;
Inhalation;
Powder (Metered Dose);
68:04.00 – ADRENALS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10666
ENTOCORT;
02229293;
budesonide 3 mg;
1997-01-30;
Oral;
Capsule (Sustained-Release);
68:04.00 – ADRENALS;
Prescription;
TILLOTTS PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43534
BUDESONIDE;
02483874;
budesonide 3 mg;
2020-01-17;
Oral;
Capsule (Sustained-Release);
68:04.00 – ADRENALS;
Prescription;
TILLOTTS PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97423
PULMICORT TURBUHALER;
00851760;
budesonide 400 mcg / act;
1992-12-31;
Inhalation;
Powder (Metered Dose);
68:04.00 – ADRENALS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12182
RHINOCORT AQUA;
02231923;
budesonide 64 mcg / act;
1997-09-17;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51375
MYLAN-BUDESONIDE AQ;
02241003;
budesonide 64 mcg / act;
1999-11-23;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64595
CORTIMENT;
02455889;
budesonide 9 mg;
2016-07-25;
Oral;
Tablet (Delayed And Extended Release);
68:04.00 – ADRENALS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94275
BURINEX;
00728284;
bumetanide 1 mg;
1993-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14334
BURINEX;
00728276;
bumetanide 5 mg;
1993-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14322
MARCAINE SPINAL;
02241914;
bupivacaine hydrochloride 15 mg / 2 ml;
2000-12-01;
Intraspinal;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65584
MARCAINE;
02241917;
bupivacaine hydrochloride 150 mg / 20 ml;
2001-09-15;
Retrobulbar , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65587
SENSORCAINE;
01976141;
bupivacaine hydrochloride 2.5 mg / ml;
1994-12-31;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16161
BUPIVACAINE INJECTION BP;
02443686;
bupivacaine hydrochloride 2.5 mg / ml;
2016-05-20;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92837
MARCAINE;
02305909;
bupivacaine hydrochloride 250 mg / 50 ml;
2008-09-17;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79145
SENSORCAINE;
01976168;
bupivacaine hydrochloride 5 mg / ml;
1994-12-31;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16164
BUPIVACAINE INJECTION BP;
02443694;
bupivacaine hydrochloride 5 mg / ml;
2016-05-20;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92838
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP;
02460645;
bupivacaine hydrochloride 7.5 mg / ml;
2018-03-13;
Intraspinal;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94807
BUTRANS 10;
02341212;
buprenorphine 10 mcg / hour;
2010-05-26;
Transdermal;
Patch;
28:08.12 – OPIATE PARTIAL AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82675
SUBLOCADE;
02483084;
buprenorphine 100 mg / 0.5 ml;
2020-02-03;
Subcutaneous;
Solution (Extended Release);
28:08.12 – OPIATE PARTIAL AGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97348
BUTRANS 15;
02450771;
buprenorphine 15 mcg / hour;
2016-06-15;
Transdermal;
Patch;
28:08.12 – OPIATE PARTIAL AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93692
BUTRANS 20;
02341220;
buprenorphine 20 mcg / hour;
2010-05-26;
Transdermal;
Patch;
28:08.12 – OPIATE PARTIAL AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82676
SUBLOCADE;
02483092;
buprenorphine 300 mg / 1.5 ml;
2020-02-03;
Subcutaneous;
Solution (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97349
BUTRANS 5;
02341174;
buprenorphine 5 mcg / hour;
2010-05-26;
Transdermal;
Patch;
28:08.12 – OPIATE PARTIAL AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82671
PROBUPHINE;
02474921;
buprenorphine hydrochloride 80 mg;
2018-11-22;
Subcutaneous;
Implant;
28:08.12 – OPIATE PARTIAL AGONISTS;
Narcotic (Cdsa I);
KNIGHT THERAPEUTICS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96515
ODAN BUPROPION SR;
02275074;
bupropion hydrochloride 100 mg;
2006-06-23;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76058
BUPROPION SR;
02331616;
bupropion hydrochloride 100 mg;
2010-02-03;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81729
BUPROPION SR;
02391562;
bupropion hydrochloride 100 mg;
2012-10-01;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87689
ZYBAN;
02238441;
bupropion hydrochloride 150 mg;
1998-08-10;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61860
ODAN BUPROPION SR;
02275082;
bupropion hydrochloride 150 mg;
2006-06-23;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76059
WELLBUTRIN XL;
02275090;
bupropion hydrochloride 150 mg;
2006-02-02;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76060
BUPROPION SR;
02325357;
bupropion hydrochloride 150 mg;
2009-06-22;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81075
MYLAN-BUPROPION XL;
02382075;
bupropion hydrochloride 150 mg;
2013-09-17;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86794
BUPROPION SR;
02391570;
bupropion hydrochloride 150 mg;
2012-10-01;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87690
TEVA-BUPROPION XL;
02439654;
bupropion hydrochloride 150 mg;
2016-05-03;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92405
TARO-BUPROPION XL;
02475804;
bupropion hydrochloride 150 mg;
2019-05-15;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96647
WELLBUTRIN XL;
02275104;
bupropion hydrochloride 300 mg;
2006-02-02;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76061
MYLAN-BUPROPION XL;
02382083;
bupropion hydrochloride 300 mg;
2013-09-17;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86795
TEVA-BUPROPION XL;
02439662;
bupropion hydrochloride 300 mg;
2016-05-03;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92406
TARO-BUPROPION XL;
02475812;
bupropion hydrochloride 300 mg;
2019-05-15;
Oral;
Tablet (Extended-Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96648
CRYSVITA;
02483629;
burosumab 10 mg / ml;
2019-01-28;
Subcutaneous;
Solution;
40:92.00 – ELECTROLYTIC, CALORIC AND WATER BALANCE AGENTS, MISCELLANOUS;
Prescription , Schedule D;
KYOWA KIRIN LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97399
CRYSVITA;
02483637;
burosumab 20 mg / ml;
2019-01-28;
Subcutaneous;
Solution;
40:92.00 – ELECTROLYTIC, CALORIC AND WATER BALANCE AGENTS, MISCELLANOUS;
Prescription , Schedule D;
KYOWA KIRIN LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97400
CRYSVITA;
02483645;
burosumab 30 mg / ml;
2019-01-28;
Subcutaneous;
Solution;
40:92.00 – ELECTROLYTIC, CALORIC AND WATER BALANCE AGENTS, MISCELLANOUS;
Prescription , Schedule D;
KYOWA KIRIN LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97401
SUPREFACT;
02225166;
buserelin (buserelin acetate) 1 mg / ml;
1998-05-05;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43417
SUPREFACT;
02225158;
buserelin (buserelin acetate) 100 mcg / act;
1998-02-03;
Nasal;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43416
SUPREFACT DEPOT 2 MONTHS;
02228955;
buserelin (buserelin acetate) 6.3 mg;
1997-02-10;
Subcutaneous;
Implant;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43499
SUPREFACT DEPOT 3 MONTHS;
02240749;
buserelin (buserelin acetate) 9.45 mg;
2000-02-24;
Subcutaneous;
Implant;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64338
APO-BUSPIRONE;
02211076;
buspirone hydrochloride 10 mg;
1996-12-31;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20011
BUSPIRONE-10;
02223163;
buspirone hydrochloride 10 mg;
1997-01-15;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43349
PMS-BUSPIRONE;
02230942;
buspirone hydrochloride 10 mg;
1997-05-26;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50220
TEVA-BUSPIRONE;
02231492;
buspirone hydrochloride 10 mg;
1997-09-02;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50822
BUSPIRONE;
02447851;
buspirone hydrochloride 10 mg;
2016-02-17;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93348
AURO-BUSPIRONE;
02500213;
buspirone hydrochloride 10 mg;
2020-10-30;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98992
MYLERAN;
00004618;
busulfan 2 mg;
1954-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=959
PMS-BUSULFAN;
02477343;
busulfan 6 mg / ml;
2019-03-29;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96833
BUSULFAN FOR INJECTION;
02463733;
busulfan 60 mg / 10 ml;
2017-10-04;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95184
BUTORPHANOL NASAL SPRAY;
02242504;
butorphanol tartrate 10 mg / ml;
2000-08-01;
Nasal;
Solution;
28:08.12 – OPIATE PARTIAL AGONISTS;
Schedule G (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66247
BERINERT 1500;
02436078;
c1 esterase inhibitor (human) 1500 unit / vial;
2015-05-06;
Intravenous;
Kit , Powder For Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92040
HAEGARDA;
02468069;
c1 esterase inhibitor (human) 2000 unit / vial;
2020-01-23;
Subcutaneous;
Kit , Powder For Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95643
HAEGARDA;
02468077;
c1 esterase inhibitor (human) 3000 unit / vial;
2020-01-23;
Subcutaneous;
Kit , Powder For Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95644
BERINERT 500;
02352575;
c1 esterase inhibitor (human) 500 unit / vial;
2010-10-06;
Intravenous;
Kit , Powder For Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83783
CINRYZE;
02395371;
c1 esterase inhibitor (human) 500 unit / vial;
2016-03-08;
Intravenous;
Powder For Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88048
JEVTANA;
02369524;
cabazitaxel 40 mg / ml;
2011-08-23;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85445
CABAZITAXEL FOR INJECTION;
02495635;
cabazitaxel 40 mg / ml;
2020-06-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98553
CABAZITAXEL FOR INJECTION;
02487497;
cabazitaxel 45 mg / 4.5 ml;
2019-12-18;
Intravenous;
Solution;
#N/A;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97765
CABAZITAXEL FOR INJECTION;
02487500;
cabazitaxel 60 mg / 6 ml;
2019-12-18;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97766
DOSTINEX;
02242471;
cabergoline 0.5 mg;
2000-06-30;
Oral;
Tablet;
28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66198
APO-CABERGOLINE;
02455897;
cabergoline 0.5 mg;
2017-03-23;
Oral;
Tablet;
28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94276
VOCABRIA;
02497204;
cabotegravir (cabotegravir sodium) 30 mg;
2020-09-21;
Oral;
Tablet;
08:18.08 – ANTIRETROVIRALS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98705
CABOMETYX;
02480824;
cabozantinib (cabozantinib malate) 20 mg;
2018-10-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97148
CABOMETYX;
02480832;
cabozantinib (cabozantinib malate) 40 mg;
2018-10-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97149
CABOMETYX;
02480840;
cabozantinib (cabozantinib malate) 60 mg;
2018-10-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97150
PEYONA;
02496771;
caffeine citrate 20 mg / ml;
2020-07-13;
Intravenous , Oral;
Solution;
28:20.32 – Respiratory and CNS Stimulants;
Prescription Recommended;
CHIESI FARMACEUTICI S.P.A.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98662
DOVONEX ONT 50MCG/GM;
01976133;
calcipotriol 50 mcg / g;
1992-12-31;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13340
CALCIMAR;
01926691;
calcitonin (salmon synthetic) 200 unit / ml;
1983-12-31;
Intramuscular , Subcutaneous;
Solution;
68:24.00 – PARATHYROID AND ANTIPARATHYROID AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12837
ROCALTROL;
00481823;
calcitriol 0.25 mcg;
1979-12-31;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3430
CALCITRIOL-ODAN;
02431637;
calcitriol 0.25 mcg;
2014-10-10;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91612
TARO-CALCITRIOL;
02485710;
calcitriol 0.25 mcg;
2019-06-03;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97594
CALCITRIOL CAPSULES;
02495899;
calcitriol 0.25 mcg;
2020-03-09;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98579
ROCALTROL;
00481815;
calcitriol 0.5 mcg;
1979-12-31;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3429
CALCITRIOL-ODAN;
02431645;
calcitriol 0.5 mcg;
2014-10-10;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91613
TARO-CALCITRIOL;
02485729;
calcitriol 0.5 mcg;
2019-06-03;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97595
CALCITRIOL CAPSULES;
02495902;
calcitriol 0.5 mcg;
2020-03-09;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98580
CALCITRIOL INJECTION USP;
02399334;
calcitriol 1 mcg / ml;
2015-03-27;
Intravenous;
Solution;
88:16.00 – VITAMIN D;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88422
SILKIS;
02338572;
calcitriol 3 mcg / g;
2010-04-09;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82422
CALCIUM CHLORIDE INJECTION USP;
00294748;
calcium chloride 100 mg / ml;
1981-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4230
CALCIJECT INJ 100MG/ML;
00821780;
calcium chloride 100 mg / ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10770
CALCIUM-45 0.5-4.5;
02160986;
calcium chloride 14.9 g / bottle;
1995-12-31;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18321
CALCIUM-45 0.25-4.5;
02161060;
calcium chloride 7.45 g / bottle;
1995-12-31;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18310
CALCIUM CHLORIDE FOR HAEMODIALYSIS;
02387549;
calcium chloride 7.45 g / vial;
2013-03-26;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87315
CALCIUM GLUCONATE INJECTION, USP 10%;
02141019;
calcium gluconate 100 mg / ml;
1984-07-19;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18936
RESONIUM CALCIUM;
02017741;
calcium polystyrene sulfonate 999 mg / g;
1979-12-31;
Oral , Rectal;
Powder For Solution;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Ethical;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17205
INVOKANA;
02425483;
canagliflozin 100 mg;
2014-06-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91013
INVOKANA;
02425491;
canagliflozin 300 mg;
2014-05-28;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91014
ILARIS;
02460351;
canakinumab 150 mg / ml;
2017-08-22;
Subcutaneous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94767
ATACAND TAB 16 MG;
02239092;
candesartan cilexetil 16 mg;
1998-12-07;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62548
SANDOZ CANDESARTAN;
02326973;
candesartan cilexetil 16 mg;
2011-04-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81230
APO-CANDESARTAN;
02365367;
candesartan cilexetil 16 mg;
2011-04-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85027
TEVA-CANDESARTAN;
02366320;
candesartan cilexetil 16 mg;
2012-06-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85118
CANDESARTAN;
02377942;
candesartan cilexetil 16 mg;
2012-02-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86373
ACH-CANDESARTAN;
02379287;
candesartan cilexetil 16 mg;
2012-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86516
TARO-CANDESARTAN;
02380706;
candesartan cilexetil 16 mg;
2013-01-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86648
JAMP-CANDESARTAN;
02386526;
candesartan cilexetil 16 mg;
2012-06-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87209
CANDESARTAN;
02388715;
candesartan cilexetil 16 mg;
2012-07-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87424
CANDESARTAN;
02388936;
candesartan cilexetil 16 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87446
PMS-CANDESARTAN;
02391201;
candesartan cilexetil 16 mg;
2012-08-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87656
AURO-CANDESARTAN;
02445808;
candesartan cilexetil 16 mg;
2015-12-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93108
MINT-CANDESARTAN;
02476924;
candesartan cilexetil 16 mg;
2018-10-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96771
AG-CANDESARTAN;
02484781;
candesartan cilexetil 16 mg;
2020-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97508
ATACAND;
02311658;
candesartan cilexetil 32 mg;
2008-07-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79720
TEVA-CANDESARTAN;
02366339;
candesartan cilexetil 32 mg;
2012-06-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85119
ACH-CANDESARTAN;
02379295;
candesartan cilexetil 32 mg;
2012-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86517
TARO-CANDESARTAN;
02380714;
candesartan cilexetil 32 mg;
2013-01-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86649
JAMP-CANDESARTAN;
02386534;
candesartan cilexetil 32 mg;
2012-06-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87210
PMS-CANDESARTAN;
02391228;
candesartan cilexetil 32 mg;
2012-08-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87657
APO-CANDESARTAN;
02399105;
candesartan cilexetil 32 mg;
2013-07-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88401
SANDOZ CANDESARTAN;
02417340;
candesartan cilexetil 32 mg;
2014-03-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90197
CANDESARTAN;
02422069;
candesartan cilexetil 32 mg;
2014-06-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90678
CANDESARTAN;
02435845;
candesartan cilexetil 32 mg;
2015-01-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92019
AURO-CANDESARTAN;
02445816;
candesartan cilexetil 32 mg;
2015-12-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93109
ATACAND;
02239090;
candesartan cilexetil 4 mg;
2005-06-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62546
SANDOZ CANDESARTAN;
02326957;
candesartan cilexetil 4 mg;
2011-04-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81228
APO-CANDESARTAN;
02365340;
candesartan cilexetil 4 mg;
2011-04-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85025
ACH-CANDESARTAN;
02379260;
candesartan cilexetil 4 mg;
2012-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86514
TARO-CANDESARTAN;
02380684;
candesartan cilexetil 4 mg;
2013-01-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86646
CANDESARTAN;
02388901;
candesartan cilexetil 4 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87444
PMS-CANDESARTAN;
02391171;
candesartan cilexetil 4 mg;
2012-08-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87654
AURO-CANDESARTAN;
02445786;
candesartan cilexetil 4 mg;
2015-12-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93106
ATACAND TAB 8MG;
02239091;
candesartan cilexetil 8 mg;
1998-12-07;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62547
SANDOZ CANDESARTAN;
02326965;
candesartan cilexetil 8 mg;
2011-04-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81229
APO-CANDESARTAN;
02365359;
candesartan cilexetil 8 mg;
2011-04-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85026
TEVA-CANDESARTAN;
02366312;
candesartan cilexetil 8 mg;
2012-06-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85116
CANDESARTAN;
02377934;
candesartan cilexetil 8 mg;
2012-02-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86372
ACH-CANDESARTAN;
02379279;
candesartan cilexetil 8 mg;
2012-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86515
TARO-CANDESARTAN;
02380692;
candesartan cilexetil 8 mg;
2013-01-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86647
JAMP-CANDESARTAN;
02386518;
candesartan cilexetil 8 mg;
2012-06-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87208
CANDESARTAN;
02388707;
candesartan cilexetil 8 mg;
2012-07-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87423
CANDESARTAN;
02388928;
candesartan cilexetil 8 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87445
PMS-CANDESARTAN;
02391198;
candesartan cilexetil 8 mg;
2012-08-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87655
AURO-CANDESARTAN;
02445794;
candesartan cilexetil 8 mg;
2015-12-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93107
MINT-CANDESARTAN;
02476916;
candesartan cilexetil 8 mg;
2018-10-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96770
AG-CANDESARTAN;
02484773;
candesartan cilexetil 8 mg;
2020-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97506
XELODA;
02238453;
capecitabine 150 mg;
1998-09-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61873
TEVA-CAPECITABINE;
02400022;
capecitabine 150 mg;
2013-08-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88486
SANDOZ CAPECITABINE;
02421917;
capecitabine 150 mg;
2014-07-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90661
ACH-CAPECITABINE;
02426757;
capecitabine 150 mg;
2014-09-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91132
TARO-CAPECITABINE;
02457490;
capecitabine 150 mg;
2017-08-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94454
XELODA;
02238454;
capecitabine 500 mg;
1998-09-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61874
TEVA-CAPECITABINE;
02400030;
capecitabine 500 mg;
2013-08-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88487
SANDOZ CAPECITABINE;
02421925;
capecitabine 500 mg;
2014-07-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90662
ACH-CAPECITABINE;
02426765;
capecitabine 500 mg;
2014-09-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91133
TARO-CAPECITABINE;
02457504;
capecitabine 500 mg;
2017-08-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94455
CABLIVI;
02496194;
caplacizumab 11 mg / vial;
2020-09-04;
Intravenous , Subcutaneous;
Kit , Powder For Solution;
20:12.92 – ANTITHROMBOTIC AGENTS, MISC.;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98606
APO-CAPTO TAB 100MG;
00893625;
captopril 100 mg;
1990-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10900
TEVA-CAPTOPRIL;
01942999;
captopril 100 mg;
1991-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11765
APO-CAPTO TAB 12.5MG;
00893595;
captopril 12.5 mg;
1990-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10906
TEVA-CAPTOPRIL;
01942964;
captopril 12.5 mg;
1991-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11760
APO-CAPTO TAB 25MG;
00893609;
captopril 25 mg;
1990-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10907
TEVA-CAPTOPRIL;
01942972;
captopril 25 mg;
1991-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11763
APO-CAPTO TAB 50MG;
00893617;
captopril 50 mg;
1990-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10908
TEVA-CAPTOPRIL;
01942980;
captopril 50 mg;
1991-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11764
MIOSTAT OPHTHALMIC LIQ 0.01%;
00042544;
carbachol .01 %;
1980-12-31;
Intraocular;
Solution;
52:40.20 – MIOTICS;
Prescription;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3906
TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG;
02244403;
carbamazepine 100 mg;
2002-04-19;
Oral;
Tablet (Chewable);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68372
TEGRETOL – SUS 100MG/5ML;
02194333;
carbamazepine 100 mg / 5 ml;
1996-12-31;
Oral;
Suspension;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19729
TARO-CARBAMAZEPINE;
02367394;
carbamazepine 100 mg / 5 ml;
2011-10-07;
Oral;
Suspension;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85224
TEGRETOL 200MG;
00010405;
carbamazepine 200 mg;
1969-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=777
TEGRETOL CR TAB 200MG;
00773611;
carbamazepine 200 mg;
1988-12-31;
Oral;
Tablet (Extended-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8373
TEVA-CARBAMAZEPINE;
00782718;
carbamazepine 200 mg;
1988-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9242
PMS-CARBAMAZEPINE-CR;
02231543;
carbamazepine 200 mg;
1998-05-28;
Oral;
Tablet (Extended-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50886
TARO-CARBAMAZEPINE CHEWABLE TABLETS 200MG;
02244404;
carbamazepine 200 mg;
2002-04-19;
Oral;
Tablet (Chewable);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68373
SANDOZ-CARBAMAZEPINE CR;
02261839;
carbamazepine 200 mg;
2006-02-02;
Oral;
Tablet (Extended-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74720
TARO-CARBAMAZEPINE;
02407515;
carbamazepine 200 mg;
2014-05-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89220
TEGRETOL CR TAB 400MG;
00755583;
carbamazepine 400 mg;
1988-12-31;
Oral;
Tablet (Extended-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8374
PMS-CARBAMAZEPINE-CR;
02231544;
carbamazepine 400 mg;
1998-05-28;
Oral;
Tablet (Extended-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50887
SANDOZ-CARBAMAZEPINE CR;
02261847;
carbamazepine 400 mg;
2006-02-02;
Oral;
Tablet (Extended-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74721
DURATOCIN;
02231593;
carbetocin 100 mcg / ml;
1999-08-01;
Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50960
CARBETOCIN INJECTION;
02489244;
carbetocin 100 mcg / ml;
2020-01-21;
Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97932
DURATOCIN;
02496526;
carbetocin 100 mcg / ml;
2020-08-05;
Intramuscular , Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98638
CARBON DIOXIDE 100%;
00572861;
carbon dioxide 100 %;
1911-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5687
CARBON DIOXIDE USP;
02014459;
carbon dioxide 99 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13884
CARBON DIOXIDE U.S.P;
02154730;
carbon dioxide 99 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19263
CARBOPLATIN INJECTION;
02125439;
carboplatin 10 mg / ml;
1994-12-31;
Intravenous;
Liquid;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17830
CARBOPLATIN INJECTION BP;
02126680;
carboplatin 10 mg / ml;
1997-07-30;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43846
CARBOPLATIN INJECTION BP;
02320371;
carboplatin 10 mg / ml;
2015-03-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80581
HEMABATE;
02230417;
carboprost (carboprost tromethamine) 250 mcg / ml;
1997-11-28;
Intramuscular;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49287
PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS;
02242082;
carboxymethylcellulose sodium 0.25 % / w/v;
2002-06-01;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
AKORN CONSUMER HEALTH, A DIVISION OF AKORN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65756
THERATEARS LUBRICANT EYE DROPS;
02248854;
carboxymethylcellulose sodium 0.25 % / w/w;
2004-06-24;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
AKORN CONSUMER HEALTH, A DIVISION OF AKORN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73225
REFRESH PLUS DPS 5MG/ML;
02049260;
carboxymethylcellulose sodium 0.5 %;
2000-01-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27183
REFRESH TEARS;
02231008;
carboxymethylcellulose sodium 0.5 %;
1997-07-25;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50289
REFRESH CONTACTS;
02304015;
carboxymethylcellulose sodium 0.5 %;
2008-03-13;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78932
REFRESH CELLUVISC;
00870153;
carboxymethylcellulose sodium 1 %;
1991-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11138
REFRESH LIQUIGEL;
02244650;
carboxymethylcellulose sodium 1 %;
2001-11-19;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68637
KYPROLIS;
02459930;
carfilzomib 10 mg / vial;
2017-02-13;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94724
KYPROLIS;
02459949;
carfilzomib 30 mg / vial;
2017-02-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94725
KYPROLIS;
02451034;
carfilzomib 60 mg / vial;
2016-02-11;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93728
CARBAGLU;
02439360;
carglumic acid 200 mg;
2015-09-08;
Oral;
Tablet For Suspension;
40:10.00 – AMMONIA DETOXICANTS;
Prescription;
RECORDATI RARE DISEASES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92371
BICNU;
00297763;
carmustine 100 mg / vial;
1975-12-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2153
PMS-CARVEDILOL;
02245916;
carvedilol 12.5 mg;
2003-08-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70036
APO-CARVEDILOL;
02247935;
carvedilol 12.5 mg;
2003-08-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72245
CARVEDILOL;
02248754;
carvedilol 12.5 mg;
2004-04-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73122
TEVA-CARVEDILOL;
02252325;
carvedilol 12.5 mg;
2004-05-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73720
CARVEDILOL;
02324520;
carvedilol 12.5 mg;
2009-06-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80997
CARVEDILOL;
02364948;
carvedilol 12.5 mg;
2011-06-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84981
JAMP-CARVEDILOL;
02368919;
carvedilol 12.5 mg;
2011-06-17;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85388
AURO-CARVEDILOL;
02418517;
carvedilol 12.5 mg;
2014-02-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90308
PMS-CARVEDILOL;
02245917;
carvedilol 25 mg;
2003-08-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70037
APO-CARVEDILOL;
02247936;
carvedilol 25 mg;
2003-08-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72246
CARVEDILOL;
02248755;
carvedilol 25 mg;
2004-04-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73123
TEVA-CARVEDILOL;
02252333;
carvedilol 25 mg;
2004-05-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73721
CARVEDILOL;
02364956;
carvedilol 25 mg;
2011-06-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84982
JAMP-CARVEDILOL;
02368927;
carvedilol 25 mg;
2011-06-17;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85389
AURO-CARVEDILOL;
02418525;
carvedilol 25 mg;
2014-02-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90309
CARVEDILOL;
02324539;
carvedilol 25.0 mg;
2009-06-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80998
PMS-CARVEDILOL;
02245914;
carvedilol 3.125 mg;
2003-08-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70034
APO-CARVEDILOL;
02247933;
carvedilol 3.125 mg;
2003-08-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72243
CARVEDILOL;
02248752;
carvedilol 3.125 mg;
2004-04-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73120
TEVA-CARVEDILOL;
02252309;
carvedilol 3.125 mg;
2004-05-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73718
CARVEDILOL;
02324504;
carvedilol 3.125 mg;
2009-06-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80995
CARVEDILOL;
02364913;
carvedilol 3.125 mg;
2011-06-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84979
JAMP-CARVEDILOL;
02368897;
carvedilol 3.125 mg;
2011-06-17;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85386
AURO-CARVEDILOL;
02418495;
carvedilol 3.125 mg;
2014-02-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90306
PMS-CARVEDILOL;
02245915;
carvedilol 6.25 mg;
2003-08-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70035
APO-CARVEDILOL;
02247934;
carvedilol 6.25 mg;
2003-08-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72244
CARVEDILOL;
02248753;
carvedilol 6.25 mg;
2004-04-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73121
TEVA-CARVEDILOL;
02252317;
carvedilol 6.25 mg;
2004-05-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73719
CARVEDILOL;
02324512;
carvedilol 6.25 mg;
2009-06-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80996
CARVEDILOL;
02364921;
carvedilol 6.25 mg;
2011-06-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84980
JAMP-CARVEDILOL;
02368900;
carvedilol 6.25 mg;
2011-06-17;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85387
AURO-CARVEDILOL;
02418509;
carvedilol 6.25 mg;
2014-02-06;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90307
CANCIDAS;
02244265;
caspofungin (caspofungin acetate) 50 mg / vial;
2001-08-23;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68232
CASPOFUNGIN FOR INJECTION;
02460947;
caspofungin (caspofungin acetate) 50 mg / vial;
2017-04-19;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94846
CASPOFUNGIN FOR INJECTION;
02486989;
caspofungin (caspofungin acetate) 50 mg / vial;
2020-01-27;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97713
CANCIDAS;
02244266;
caspofungin (caspofungin acetate) 70 mg / vial;
2001-10-23;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68233
CASPOFUNGIN FOR INJECTION;
02460955;
caspofungin (caspofungin acetate) 70 mg / vial;
2017-04-19;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94847
CASPOFUNGIN FOR INJECTION;
02486997;
caspofungin (caspofungin acetate) 70 mg / vial;
2020-01-27;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97714
ALLERGENIC EXTRACT-STANDARDIZED CAT HAIR;
02239410;
cat (felis domesticus) pelt and cat dander 10000 unit / ml;
1999-04-19;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62882
TRETTEN;
02389975;
catridecacog 2500 unit / vial;
2013-01-30;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87544
TEVA-CEFADROXIL;
02235134;
cefadroxil (cefadroxil monohydrate) 500 mg;
1999-06-02;
Oral;
Capsule;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=56852
APO-CEFADROXIL;
02240774;
cefadroxil 500 mg;
1999-08-31;
Oral;
Capsule;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64363
CEFAZOLIN FOR INJECTION;
02108127;
cefazolin (cefazolin sodium) 1 g / vial;
1995-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19532
CEFAZOLIN FOR INJECTION USP;
02308959;
cefazolin (cefazolin sodium) 1 g / vial;
2008-04-18;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79456
CEFAZOLIN FOR INJECTION;
02437112;
cefazolin (cefazolin sodium) 1 g / vial;
2015-09-29;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92142
CEFAZOLIN FOR INJECTION, USP;
02237138;
cefazolin (cefazolin sodium) 1.0 g / vial;
1998-10-30;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60453
CEFAZOLIN FOR INJECTION;
02108135;
cefazolin (cefazolin sodium) 10 g / vial;
1995-12-31;
Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19534
CEFAZOLIN FOR INJECTION, USP;
02237140;
cefazolin (cefazolin sodium) 10 g / vial;
1998-10-30;
Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60455
CEFAZOLIN FOR INJECTION USP;
02308967;
cefazolin (cefazolin sodium) 10 g / vial;
2008-04-18;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79457
CEFAZOLIN FOR INJECTION;
02437120;
cefazolin (cefazolin sodium) 10 g / vial;
2015-06-11;
Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92143
CEFAZOLIN FOR INJECTION, USP;
02401029;
cefazolin (cefazolin sodium) 100 g / bag;
2013-06-03;
Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88577
CEFAZOLIN INJECTION, USP;
02496313;
cefazolin (cefazolin sodium) 20 mg / ml;
2021-01-11;
Intravenous;
Solution;
-;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98620
CEFAZOLIN FOR INJECTION;
02108119;
cefazolin (cefazolin sodium) 500 mg / vial;
1995-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19521
CEFAZOLIN FOR INJECTION USP;
02308932;
cefazolin (cefazolin sodium) 500 mg / vial;
2008-04-18;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79454
CEFAZOLIN FOR INJECTION;
02437104;
cefazolin (cefazolin sodium) 500 mg / vial;
2015-09-30;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92141
APO-CEFEPIME;
02467496;
cefepime (cefepime hydrochloride) 1 g / vial;
2018-05-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.16 – FOURTH GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95586
APO-CEFEPIME;
02467518;
cefepime (cefepime hydrochloride) 2 g / vial;
2018-05-14;
Intravenous;
Powder For Solution;
08:12.06.16 – FOURTH GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95587
SUPRAX;
00868965;
cefixime 100 mg / 5 ml;
1990-12-31;
Oral;
Powder For Suspension;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10523
AURO-CEFIXIME;
02468689;
cefixime 100 mg / 5 ml;
2018-01-08;
Oral;
Powder For Suspension;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95716
SUPRAX;
00868981;
cefixime 400 mg;
1990-12-31;
Oral;
Tablet;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10525
AURO-CEFIXIME;
02432773;
cefixime 400 mg;
2014-10-24;
Oral;
Tablet;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91720
CEFOTAXIME SODIUM FOR INJECTION, BP;
02434091;
cefotaxime sodium 1 g / vial;
2015-03-12;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91844
CEFOTAXIME SODIUM FOR INJECTION, BP;
02434105;
cefotaxime sodium 2 g / vial;
2015-03-12;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91845
CEFOXITIN FOR INJECTION;
02128187;
cefoxitin (cefoxitin sodium) 1 g / vial;
1995-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.07.12 – CEPHAMYCINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19200
CEFOXITIN FOR INJECTION;
02240773;
cefoxitin (cefoxitin sodium) 10 g / vial;
2000-01-01;
Intramuscular , Intravenous;
Powder For Solution;
08:12.07.12 – CEPHAMYCINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64362
CEFOXITIN FOR INJECTION;
02128195;
cefoxitin (cefoxitin sodium) 2 g / vial;
1995-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.07.12 – CEPHAMYCINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19201
TARO-CEFPROZIL;
02329204;
cefprozil (cefprozil monohydrate) 125 mg / 5 ml;
2010-01-12;
Oral;
Powder For Suspension;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81489
TARO-CEFPROZIL;
02293528;
cefprozil (cefprozil monohydrate) 250 mg;
2007-04-17;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77887
TARO-CEFPROZIL;
02293579;
cefprozil (cefprozil monohydrate) 250 mg / 5 ml;
2007-04-17;
Oral;
Powder For Suspension;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77893
TARO-CEFPROZIL;
02293536;
cefprozil (cefprozil monohydrate) 500 mg;
2007-04-17;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77888
AURO-CEFPROZIL;
02347253;
cefprozil 500 mg;
2012-01-13;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83266
CEFTAZIDIME FOR INJECTION BP;
02437848;
ceftazidime (ceftazidime pentahydrate) 1 g / vial;
2015-05-28;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92221
CEFTAZIDIME FOR INJECTION BP;
02437856;
ceftazidime (ceftazidime pentahydrate) 2 g / vial;
2015-05-29;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92222
CEFTAZIDIME FOR INJECTION BP;
02437864;
ceftazidime (ceftazidime pentahydrate) 6 g / vial;
2015-06-08;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92223
CEFTAZIDIME FOR INJECTION, USP;
00886971;
ceftazidime 1 g / vial;
1991-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11370
CEFTAZIDIME FOR INJECTION, USP;
00886955;
ceftazidime 2 g / vial;
1991-12-31;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11372
CEFTAZIDIME FOR INJECTION, USP;
00886963;
ceftazidime 6 g / vial;
1991-12-31;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11371
ZEVTERA;
02446685;
ceftobiprole (ceftobiprole medocaril sodium) 500 mg / vial;
2018-03-20;
Intravenous;
Powder For Solution;
08:12.06 – CEPHALOSPORINS;
Prescription;
AVIR PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93212
CEFTRIAXONE SODIUM FOR INJECTION BP;
02250292;
ceftriaxone (ceftriaxone sodium) 1 g / vial;
2007-04-04;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73509
CEFTRIAXONE SODIUM FOR INJECTION;
02287633;
ceftriaxone (ceftriaxone sodium) 1 g / vial;
2007-09-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77304
CEFTRIAXONE SODIUM FOR INJECTION BP;
02292270;
ceftriaxone (ceftriaxone sodium) 1 g / vial;
2007-02-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77763
CEFTRIAXONE SODIUM FOR INJECTION BP;
02325616;
ceftriaxone (ceftriaxone sodium) 1 g / vial;
2011-03-21;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81098
CEFTRIAXONE SODIUM FOR INJECTION;
02287668;
ceftriaxone (ceftriaxone sodium) 10 g / vial;
2007-09-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77306
CEFTRIAXONE SODIUM FOR INJECTION BP;
02292297;
ceftriaxone (ceftriaxone sodium) 10 g / vial;
2007-02-23;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77765
CEFTRIAXONE SODIUM FOR INJECTION BP;
02325632;
ceftriaxone (ceftriaxone sodium) 10 g / vial;
2011-03-21;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81100
CEFTRIAXONE FOR INJECTION;
02409968;
ceftriaxone (ceftriaxone sodium) 100 g / bag;
2014-06-05;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89462
CEFTRIAXONE INJECTION, USP;
02499711;
ceftriaxone (ceftriaxone sodium) 1000 mg / 50 ml;
2021-03-18;
Intravenous;
Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98943
CEFTRIAXONE SODIUM FOR INJECTION BP;
02292289;
ceftriaxone (ceftriaxone sodium) 2 g / vial;
2007-02-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77764
CEFTRIAXONE SODIUM FOR INJECTION BP;
02325624;
ceftriaxone (ceftriaxone sodium) 2 g / vial;
2011-01-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81099
CEFTRIAXONE INJECTION, USP;
02499738;
ceftriaxone (ceftriaxone sodium) 2000 mg / 50 ml;
2021-03-18;
Intravenous;
Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98944
CEFTRIAXONE SODIUM FOR INJECTION BP;
02250276;
ceftriaxone (ceftriaxone sodium) 250 mg / vial;
2007-04-30;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73507
CEFTRIAXONE SODIUM FOR INJECTION BP;
02292262;
ceftriaxone (ceftriaxone sodium) 250 mg / vial;
2007-02-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77762
CEFTRIAXONE SODIUM FOR INJECTION BP;
02325594;
ceftriaxone (ceftriaxone sodium) 250 mg / vial;
2011-04-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81096
CEFTIN;
02212307;
cefuroxime (cefuroxime axetil) 125 mg / 5 ml;
1999-09-13;
Oral;
Granules For Suspension;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43089
APO-CEFUROXIME;
02244393;
cefuroxime (cefuroxime axetil) 250 mg;
2001-08-29;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68362
AURO-CEFUROXIME;
02344823;
cefuroxime (cefuroxime axetil) 250 mg;
2012-01-13;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83030
APO-CEFUROXIME;
02244394;
cefuroxime (cefuroxime axetil) 500 mg;
2001-08-29;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68363
PRO-CEFUROXIME – 500;
02311453;
cefuroxime (cefuroxime axetil) 500 mg;
2008-07-04;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79704
AURO-CEFUROXIME;
02344831;
cefuroxime (cefuroxime axetil) 500 mg;
2012-01-13;
Oral;
Tablet;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83031
CEFUROXIME FOR INJECTION, USP;
02241639;
cefuroxime (cefuroxime sodium) 1.5 g / vial;
2002-12-10;
Intravenous;
Powder For Solution;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65299
CEFUROXIME FOR INJECTION, USP;
02422301;
cefuroxime (cefuroxime sodium) 1.5 g / vial;
2015-03-24;
Intravenous;
Powder For Solution;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90700
CEFUROXIME FOR INJECTION, USP;
02422328;
cefuroxime (cefuroxime sodium) 7.5 g / vial;
2015-05-04;
Intravenous;
Powder For Solution;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90701
CEFUROXIME FOR INJECTION, USP;
02241638;
cefuroxime (cefuroxime sodium) 750 mg / vial;
2002-12-05;
Intravenous;
Powder For Solution;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65298
CEFUROXIME FOR INJECTION, USP;
02422298;
cefuroxime (cefuroxime sodium) 750 mg / vial;
2015-03-24;
Intravenous;
Powder For Solution;
08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90699
CELEBREX;
02239941;
celecoxib 100 mg;
1999-04-19;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63442
PMS-CELECOXIB;
02355442;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84067
TARO-CELECOXIB;
02412373;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89700
MINT-CELECOXIB;
02412497;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89713
APO-CELECOXIB;
02418932;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90347
MAR-CELECOXIB;
02420058;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90466
ACT CELECOXIB;
02420155;
celecoxib 100 mg;
2014-11-21;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90476
CELECOXIB;
02424371;
celecoxib 100 mg;
2014-11-21;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90908
JAMP-CELECOXIB;
02424533;
celecoxib 100 mg;
2014-11-27;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90922
RIVA-CELECOX;
02425386;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91003
PRIVA-CELECOXIB;
02426366;
celecoxib 100 mg;
2014-12-31;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91095
BIO-CELECOXIB;
02426382;
celecoxib 100 mg;
2014-12-05;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91097
CELECOXIB;
02429675;
celecoxib 100 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91412
CELECOXIB;
02436299;
celecoxib 100 mg;
2015-02-05;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92062
AG-CELECOXIB;
02437570;
celecoxib 100 mg;
2018-06-22;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92190
SDZ CELECOXIB;
02442639;
celecoxib 100 mg;
2016-05-15;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92698
AURO-CELECOXIB;
02445670;
celecoxib 100 mg;
2015-12-02;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93095
CELECOXIB;
02477661;
celecoxib 100 mg;
2019-05-16;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96802
NRA-CELECOXIB;
02479737;
celecoxib 100 mg;
2019-07-02;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97003
M-CELECOXIB;
02495465;
celecoxib 100 mg;
2020-03-24;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98538
CELEBREX;
02239942;
celecoxib 200 mg;
1999-04-19;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63443
PMS-CELECOXIB;
02355450;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84068
TARO-CELECOXIB;
02412381;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89701
MINT-CELECOXIB;
02412500;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89714
APO-CELECOXIB;
02418940;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90348
MAR-CELECOXIB;
02420066;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90467
ACT CELECOXIB;
02420163;
celecoxib 200 mg;
2014-11-21;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90477
CELECOXIB;
02424398;
celecoxib 200 mg;
2014-11-21;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90909
JAMP-CELECOXIB;
02424541;
celecoxib 200 mg;
2014-11-27;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90923
RIVA-CELECOX;
02425394;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91004
PRIVA-CELECOXIB;
02426374;
celecoxib 200 mg;
2014-12-31;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91096
BIO-CELECOXIB;
02426390;
celecoxib 200 mg;
2014-12-05;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91098
CELECOXIB;
02429683;
celecoxib 200 mg;
2014-11-17;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91413
CELECOXIB;
02436302;
celecoxib 200 mg;
2015-02-05;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92063
AG-CELECOXIB;
02437589;
celecoxib 200 mg;
2018-06-22;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92191
SDZ CELECOXIB;
02442647;
celecoxib 200 mg;
2016-05-15;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92699
AURO-CELECOXIB;
02445689;
celecoxib 200 mg;
2015-12-02;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93096
CELECOXIB;
02477688;
celecoxib 200 mg;
2019-05-16;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96803
NRA-CELECOXIB;
02479745;
celecoxib 200 mg;
2019-07-02;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97004
M-CELECOXIB;
02495473;
celecoxib 200 mg;
2020-03-24;
Oral;
Capsule;
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98539
LIBTAYO;
02487152;
cemiplimab 250 mg / 5 ml;
2019-05-24;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97727
LIBTAYO;
02487144;
cemiplimab 350 mg / 7 ml;
2019-05-24;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97728
TEVA-CEPHALEXIN 125;
00342106;
cephalexin (cephalexin monohydrate) 125 mg / 5 ml;
1982-12-31;
Oral;
Powder For Suspension;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5073
LUPIN-CEPHALEXIN;
02469170;
cephalexin (cephalexin monohydrate) 125 mg / 5 ml;
2018-12-04;
Oral;
Powder For Suspension;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
LUPIN PHARMA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95784
AURO-CEPHALEXIN;
02497743;
cephalexin (cephalexin monohydrate) 125 mg / 5 ml;
2020-07-23;
Oral;
Powder For Suspension;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98755
TEVA-CEPHALEXIN;
00342084;
cephalexin (cephalexin monohydrate) 250 mg;
1979-12-31;
Oral;
Capsule;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3945
TEVA-CEPHALEXIN;
00583413;
cephalexin (cephalexin monohydrate) 250 mg;
1983-12-31;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5181
APO-CEPHALEX;
00768723;
cephalexin (cephalexin monohydrate) 250 mg;
1988-12-31;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9171
AURO-CEPHALEXIN;
02470578;
cephalexin (cephalexin monohydrate) 250 mg;
2018-07-30;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95956
TEVA-CEPHALEXIN 250;
00342092;
cephalexin (cephalexin monohydrate) 250 mg / 5 ml;
1982-12-31;
Oral;
Powder For Suspension;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5072
LUPIN-CEPHALEXIN;
02469189;
cephalexin (cephalexin monohydrate) 250 mg / 5 ml;
2018-12-04;
Oral;
Powder For Suspension;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
LUPIN PHARMA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95785
AURO-CEPHALEXIN;
02497751;
cephalexin (cephalexin monohydrate) 250 mg / 5 ml;
2020-07-23;
Oral;
Powder For Suspension;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98756
TEVA-CEPHALEXIN;
00342114;
cephalexin (cephalexin monohydrate) 500 mg;
1979-12-31;
Oral;
Capsule;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3946
TEVA-CEPHALEXIN;
00583421;
cephalexin (cephalexin monohydrate) 500 mg;
1983-12-31;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5182
APO-CEPHALEX;
00768715;
cephalexin (cephalexin monohydrate) 500 mg;
1988-12-31;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9170
CEPHALEXIN-500;
00828866;
cephalexin (cephalexin monohydrate) 500 mg;
1989-12-31;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9908
AURO-CEPHALEXIN;
02470586;
cephalexin (cephalexin monohydrate) 500 mg;
2018-07-30;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95957
CEPHALEXIN;
02495651;
cephalexin (cephalexin monohydrate) 500 mg;
2020-10-22;
Oral;
Tablet;
08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98555
ZYKADIA;
02436779;
ceritinib 150 mg;
2015-04-29;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92108
BRINEURA;
02484013;
cerliponase alfa 150 mg / 5 ml;
2019-03-18;
Intracerebroventricular;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
BIOMARIN INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97435
CIMZIA;
02331675;
certolizumab pegol 200 mg / ml;
2009-08-31;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81737
CIMZIA;
02465574;
certolizumab pegol 200 mg / ml;
2017-08-04;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95373
REACTINE;
02223554;
cetirizine hydrochloride 10 mg;
1997-03-06;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43370
APO-CETIRIZINE;
02231603;
cetirizine hydrochloride 10 mg;
1998-10-21;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50975
ALLERGY RELIEF;
02240266;
cetirizine hydrochloride 10 mg;
1999-08-17;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63803
EXTRA STRENGTH ALLERGY RELIEF;
02315955;
cetirizine hydrochloride 10 mg;
2009-08-20;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80148
REACTINE FAST MELT JUNIOR;
02358352;
cetirizine hydrochloride 10 mg;
2014-03-21;
Oral;
Tablet (Orally Disintegrating);
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84341
REACTINE ALLERGY LIQUID GELS;
02368064;
cetirizine hydrochloride 10 mg;
2012-04-01;
Oral;
Capsule (Immediate Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85288
MAR-CETIRIZINE;
02427133;
cetirizine hydrochloride 10 mg;
2015-10-13;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91166
ALLERGY RELIEF LIQUID GELS;
02432722;
cetirizine hydrochloride 10 mg;
2015-03-17;
Oral;
Capsule;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91716
JAMP-CETIRIZINE;
02451778;
cetirizine hydrochloride 10 mg;
2016-04-05;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93812
REACTINE RAPID DISSOLVE;
02467577;
cetirizine hydrochloride 10 mg;
2018-03-05;
Oral;
Tablet (Orally Disintegrating);
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95593
NAT-CETIRIZINE;
02496461;
cetirizine hydrochloride 10 mg;
2020-08-20;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98634
REACTINE 20MG TABLET;
01900978;
cetirizine hydrochloride 20 mg;
2002-01-14;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46803
PMS-CETIRIZINE;
02315963;
cetirizine hydrochloride 20 mg;
2008-10-14;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80149
MAR-CETIRIZINE;
02427141;
cetirizine hydrochloride 20 mg;
2015-10-13;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91167
PRIVA-CETIRIZINE;
02427192;
cetirizine hydrochloride 20 mg;
2015-10-19;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91172
CETIRIZINE;
02450526;
cetirizine hydrochloride 20 mg;
2016-06-13;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93668
APO-CETIRIZINE;
02453363;
cetirizine hydrochloride 20 mg;
2016-04-22;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93991
JAMP-CETIRIZINE;
02466171;
cetirizine hydrochloride 20 mg;
2017-10-05;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95446
MINT-CETIRIZINE;
02491125;
cetirizine hydrochloride 20 mg;
2019-11-28;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98114
NAT-CETIRIZINE;
02496488;
cetirizine hydrochloride 20 mg;
2020-08-19;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98635
M-CETIRIZINE;
02512025;
cetirizine hydrochloride 20 mg;
2021-04-20;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100119
REACTINE;
02223546;
cetirizine hydrochloride 5 mg;
1997-03-06;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43369
REACTINE;
02238337;
cetirizine hydrochloride 5 mg / 5 ml;
1999-12-21;
Oral;
Syrup;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61744
REACTINE ALLERGY;
02486954;
cetirizine hydrochloride 5 mg / 5 ml;
2020-02-06;
Oral;
Syrup;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97710
CETRIMIDE TINCTURE 0.5%;
00873195;
cetrimonium bromide .5 %;
1990-12-31;
Topical;
Tincture;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10565
CETRIMIDE CREAM 0.5%;
00874426;
cetrimonium bromide .5 %;
1992-12-31;
Topical;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12864
CETROTIDE;
02247766;
cetrorelix (cetrorelix acetate) 0.25 mg / vial;
2004-03-03;
Subcutaneous;
Powder For Solution;
92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
Prescription;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72060
ERBITUX;
02271249;
cetuximab 2 mg / ml;
2008-10-28;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
IMCLONE, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75672
RINCE BOUCHE ANTISEPTIQUE;
00609900;
cetylpyridinium chloride 0.05 %;
1984-12-31;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5812
ANTISEPTIC ORAL RINSE;
02243571;
cetylpyridinium chloride 0.05 %;
2006-03-22;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
SAGE PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67489
THERABREATH HEALTHY GUMS ORAL RINSE;
02486938;
cetylpyridinium chloride 0.05 % / w/w;
2020-03-26;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
DR. HAROLD KATZ, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97708
CREST PRO-HEALTH MULTI PROTECTION;
02268884;
cetylpyridinium chloride 0.07 % / w/w;
2007-11-09;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75427
CREST PRO-HEALTH INVIGORATING CLEAN MULTI-PROTECTION;
02375028;
cetylpyridinium chloride 0.07 % / w/w;
2012-07-23;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86042
CETYLPYRIDINIUM CHLORIDE ANTISEPTIC ORAL RINSE 0.07 % W/W;
02420945;
cetylpyridinium chloride 0.07 % / w/w;
2015-03-05;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90554
CREST GUM CARE;
02495198;
cetylpyridinium chloride 0.07 % / w/w;
2020-07-06;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98513
CREST PRO-HEALTH BACTERIA GUARD;
02504340;
cetylpyridinium chloride 0.07 % / w/w;
2021-01-04;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99377
COLGATE TOTAL;
02443783;
cetylpyridinium chloride 0.075 % / w/w;
2016-02-01;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
COLGATE-PALMOLIVE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92853
ZERO FRESH BREATH;
02495112;
cetylpyridinium chloride 0.075 % / w/w;
2020-06-26;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
COLGATE-PALMOLIVE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98507
ZERO HEALTHY GUMS;
02495120;
cetylpyridinium chloride 0.075 % / w/w;
2020-06-26;
Buccal;
Mouthwash;
52:28.00 – MOUTHWASHES AND GARGLES;
Otc;
COLGATE-PALMOLIVE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98508
ASTRAZENECA COVID-19 VACCINE;
02510847;
chadox1-s [recombinant] 50000000000 vp / 0.5 ml;
2021-04-01;
Intramuscular;
Solution;
-;
Covid-19 – Io – Authorization , Schedule D;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100004
COVISHIELD;
02512947;
chadox1-s [recombinant] 50000000000 vp / 0.5 ml;
2021-03-03;
Intramuscular;
Solution;
-;
Covid-19 – Io – Authorization , Schedule D;
VERITY PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100219
CHARAC-25;
02056429;
charcoal activated 222 mg / ml;
1985-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16533
ACTIVATED CHARCOAL;
02236563;
charcoal activated 225 mg;
1998-10-07;
Oral;
Capsule;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
LABORATOIRE LEO DESILETS M.H. INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59931
WAMPOLE ACTIVATED CHARCOAL;
02395517;
charcoal activated 225 mg;
2013-03-19;
Oral;
Capsule;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88060
ACTIVATED CHARCOAL 260MG;
00789674;
charcoal activated 260 mg;
1998-12-07;
Oral;
Capsule;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
EXZELL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22917
PREMIUM ACTIVATED CHARCOAL USP;
02305151;
charcoal activated 260 mg;
2008-02-04;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
SOURCE OF LIFE PRODUCTS, DIVISION OF CHEMIMEX ENT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79065
CHARCO CAPS;
02423715;
charcoal activated 260 mg;
2016-01-15;
Oral;
Capsule;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
DSE HEALTHCARE SOLUTIONS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90843
CHARAC-50;
00637955;
charcoal activated 50 g / 225 ml;
1985-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6317
CHARACTOL-50;
00649236;
charcoal activated 50 g / 250 ml;
1985-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7267
CHLORAL HYDRATE SYRUP ODAN;
02247621;
chloral hydrate 500 mg / 5 ml;
2003-08-06;
Oral;
Syrup;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71882
LEUKERAN;
00004626;
chlorambucil 2 mg;
1957-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1193
CHLOROMYCETIN SUCCINATE INJECTION 1GM;
00312363;
chloramphenicol (chloramphenicol sodium succinate) 1 g / vial;
1959-12-31;
Intravenous;
Powder For Solution;
08:12.08 – CHLORAMPHENICOL;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2789
CHLORDIAZEPOXIDE;
00522988;
chlordiazepoxide hydrochloride 10 mg;
1981-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4278
CHLORDIAZEPOXIDE;
00522996;
chlordiazepoxide hydrochloride 25 mg;
1981-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4279
CHLORDIAZEPOXIDE;
00522724;
chlordiazepoxide hydrochloride 5 mg;
1981-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4277
PREVORA STAGE 1;
02046245;
chlorhexidine acetate 10 %;
1993-12-31;
Dental;
Solution , Kit;
34:00.00 – DENTAL AGENTS;
Prescription;
CHX TECHNOLOGIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15801
CHLORHEXIDINE GLUCONATE SOLUTION 0.05%;
00832146;
chlorhexidine gluconate 0.05 %;
1992-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17006
SOLUPREP LD SPONGE;
02072955;
chlorhexidine gluconate 0.05 % / w/v;
1997-09-03;
Topical (Hospital/Hc Facilities);
Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27903
ORO-CLENSE;
02209055;
chlorhexidine gluconate 0.12 %;
1996-12-31;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20216
PERIDEX ORAL RINSE;
02237452;
chlorhexidine gluconate 0.12 %;
1998-08-31;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60786
PERICHLOR;
02240433;
chlorhexidine gluconate 0.12 %;
2000-02-09;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63982
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12%;
02240526;
chlorhexidine gluconate 0.12 %;
1999-11-26;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
AMD MEDICOM INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64096
ORO CLEAR;
02291096;
chlorhexidine gluconate 0.12 %;
2016-01-25;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77648
GUM PAROEX;
02384272;
chlorhexidine gluconate 0.12 %;
2012-10-01;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
SUNSTAR AMERICAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87001
CHLORHEXIDINE;
02462842;
chlorhexidine gluconate 0.12 % / w/v;
2017-10-19;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95071
CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP;
02436892;
chlorhexidine gluconate 0.12 % / w/w;
2016-02-03;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
SAGE PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92121
PERIOGARD;
02467534;
chlorhexidine gluconate 0.12 % / w/w;
2018-10-11;
Buccal;
Mouthwash;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Prescription;
COLGATE-PALMOLIVE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95589
BAXEDIN PRE-OP;
01936441;
chlorhexidine gluconate 0.5 %;
1999-03-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22030
GERMI STAT GEL 2%;
01930079;
chlorhexidine gluconate 2 %;
1991-12-31;
Topical;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11826
DEXIDIN 2 SOLUTION;
02238982;
chlorhexidine gluconate 2 %;
2000-03-28;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62430
ENDURE 420 CIDA-STAT;
02240416;
chlorhexidine gluconate 2 %;
1999-12-15;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63965
SOLUPREP AQ;
02242513;
chlorhexidine gluconate 2 %;
2001-01-03;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66260
ANTISEPTIC BODY CLEANSER;
02245741;
chlorhexidine gluconate 2 %;
2006-02-14;
Topical;
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SAGE PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69848
PROVON ANTISEPTIC LOTION SOAP WITH 2% CHG;
02246121;
chlorhexidine gluconate 2 %;
2002-09-09;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70264
HYGIENIPAK 2% CHG FOAMING SKIN CLEANSER;
02267144;
chlorhexidine gluconate 2 %;
2005-07-29;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DEB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75254
CHLORHEXIDINE SOLUTION;
02295253;
chlorhexidine gluconate 2 %;
2008-03-03;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PARTNAR ANIMAL HEALTH INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78057
DEXIDIN 2 DETERGENT;
00832138;
chlorhexidine gluconate 2 % / w/v;
1990-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10669
LORIS 2% CHG WIPE/SERVIETTE;
02355965;
chlorhexidine gluconate 2 % / w/v;
2016-10-07;
Topical (Household);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LERNAPHARM (LORIS) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84115
LORIS 2% CHG SOLUTION;
02358018;
chlorhexidine gluconate 2 % / w/v;
2014-07-10;
Topical (Household);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LERNAPHARM (LORIS) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84308
SOLUPREP AQ SPONGE;
02408430;
chlorhexidine gluconate 2 % / w/v;
2014-02-20;
Topical (Hospital/Hc Facilities);
Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89318
SOLUPREP AQ SWAB;
02431483;
chlorhexidine gluconate 2 % / w/v;
2015-09-10;
Topical (Hospital/Hc Facilities);
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91589
SOLUPREP AQ WIPE;
02431491;
chlorhexidine gluconate 2 % / w/v;
2015-09-17;
Topical (Hospital/Hc Facilities);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91590
STERI-CLEAN;
02412438;
chlorhexidine gluconate 2 % / w/w;
2016-07-25;
Topical (Household);
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LANDCO IMPORT INTERNATIONAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89704
DEXIDIN 20;
00832030;
chlorhexidine gluconate 20 %;
1989-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9824
BAXEDIN LIQ 20%;
00658413;
chlorhexidine gluconate 20 %;
1990-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10767
CHLORHEXIDINE GLUCONATE SOLUTION USP 20%;
02053632;
chlorhexidine gluconate 20 % / w/v;
1994-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16498
GERMI STAT GEL 4%;
01930087;
chlorhexidine gluconate 4 %;
1992-12-31;
Topical;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12713
ENDURE 400 SCRUB-STAT 4;
02239252;
chlorhexidine gluconate 4 %;
1999-02-28;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62715
CHLORHEXIDINE 4% ANTISEPTIC HAND WASH;
02295679;
chlorhexidine gluconate 4 %;
2008-03-03;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PARTNAR ANIMAL HEALTH INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78102
DEXIDIN LIQ 4%;
00832111;
chlorhexidine gluconate 4 % / w/v;
1990-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10668
E-Z SCRUB 747 4%;
01939947;
chlorhexidine gluconate 4 % / w/v;
1991-12-31;
Topical (Hospital/Hc Facilities);
Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BECTON DICKINSON
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13003
HENRY SCHEIN ANTIMICROBIAL SKIN CLEANSER;
01994042;
chlorhexidine gluconate 4 % / w/v;
1993-12-31;
Topical;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ABJ CUSTOM PACKAGING
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14496
SOLUPREP ANTISEPTIC SKIN CLEANSER SPONGE;
01925202;
chlorhexidine gluconate 4 % / w/v;
1996-12-31;
Topical (Hospital/Hc Facilities);
Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19810
DERMSAFE CHLORHEXIDINE GLUCONATE HAND SANITIZER LOTION;
02310589;
chlorhexidine gluconate 4 % / w/v;
2020-03-11;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SKINVISIBLE PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79621
DERMSAFE PC;
02355558;
chlorhexidine gluconate 4 % / w/v;
2012-02-23;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SKINVISIBLE PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84077
GERMICIDAL HAND SOAP LIQ 0.6%;
01977873;
chloroxylenol .6 %;
1992-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OSTREM CHEMICAL CO LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12639
MICRELL ANTIBACTERIAL LOTION SOAP WITH CHLOROXYLENOL;
02241648;
chloroxylenol 0.3 %;
2000-08-18;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65308
GOJO ANTIBACTERIAL LUXURY FOAM HANDWASH;
02251094;
chloroxylenol 0.3 %;
2004-11-14;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73604
SEPTILINE II ANTIMICROBIAL LOTION SOAP;
02264897;
chloroxylenol 0.3 %;
2005-08-15;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75040
PRIME SOURCE ANTIMICROBIAL FOAMING HAND SOAP WITH CHLOROXYLENOL;
02273527;
chloroxylenol 0.3 %;
2006-03-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75901
GOJO PREMIUM FOAM ANTIBACTERIAL HANDWASH;
02287455;
chloroxylenol 0.3 %;
2007-01-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77286
ANTIBACTERIAL HAND SOAP;
02500191;
chloroxylenol 0.5 % / v/v;
2020-09-08;
Topical (Household);
Emulsion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CONTRACT PACKAGING DISTRIBUTION INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98990
APPLAUD AB ANTISEPTIC LOTIONIZED HAND SOAP;
02480506;
chloroxylenol 0.5 % / w/w;
2019-08-02;
Topical (Commercial);
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ZEP MANUFACTURING COMPANY OF CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97106
VIONEX ANTIMICROBIAL LIQUID SOAP;
02238251;
chloroxylenol 0.52 %;
1998-08-14;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
METREX RESEARCH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61646
VIROBEX-P;
02131471;
chloroxylenol 0.6 %;
1989-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18208
PHENREX MVD;
02314126;
chloroxylenol 0.6 % / w/w;
2009-11-10;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
IMREX INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79962
SOFTCIDE HANDWASH;
00877220;
chloroxylenol 1 %;
2002-09-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
NEW ERIE SCIENTIFIC LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=45065
DIGICLEAN E FOAM HAND SOAP;
02242847;
chloroxylenol 1 %;
2001-03-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66677
GOJO E2 FOAM SANITIZING SOAP;
02270021;
chloroxylenol 1 %;
2006-03-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75542
QUICK CLEAN;
02276917;
chloroxylenol 1 %;
2010-10-01;
Topical;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SPRAKITA PRODUCTS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76258
SOFT CARE DEFEND FOAM;
02448866;
chloroxylenol 1 %;
2017-02-28;
Topical (Commercial);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DIVERSEY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93459
SOFT CARE DEFEND;
02449420;
chloroxylenol 1 % / w/w;
2017-02-28;
Topical (Commercial);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DIVERSEY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93526
PURKLENZ;
02440458;
chloroxylenol 3 % / w/v;
2015-08-18;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PURKLENZ FORMULATIONS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92481
DETTOL;
00373435;
chloroxylenol 4.8 %;
1938-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41477
TEVA-PHENIRAM;
00021288;
chlorpheniramine maleate 4 mg;
1967-12-31;
Oral;
Tablet;
04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=579
TEVA-CHLORPROMAZINE;
00232831;
chlorpromazine (chlorpromazine hydrochloride) 100 mg;
1967-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1295
TEVA-CHLORPROMAZINE;
00232823;
chlorpromazine (chlorpromazine hydrochloride) 25.0 mg;
1967-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1294
TEVA-CHLORPROMAZINE;
00232807;
chlorpromazine (chlorpromazine hydrochloride) 50.0 mg;
1967-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1293
CHLORTHALIDONE;
00360279;
chlorthalidone 50 mg;
1976-12-31;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2467
OLESTYR;
00890960;
cholestyramine resin 4 g / sachet;
1993-12-31;
Oral;
Powder For Suspension;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14332
OLESTYR;
02210320;
cholestyramine resin 4 g / sachet;
1996-03-15;
Oral;
Powder For Suspension;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19757
CHOLESTYRAMINE-ODAN;
02455609;
cholestyramine resin 4 g / sachet;
2016-12-23;
Oral;
Powder For Suspension;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94242
JAMP-CHOLESTYRAMINE;
02478595;
cholestyramine resin 4 g / sachet;
2020-02-10;
Oral;
Powder For Suspension;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96937
OVIDREL;
02262088;
choriogonadotropin alfa 250 mcg / 0.5 ml;
2004-12-20;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74742
OVIDREL;
02371588;
choriogonadotropin alfa 250 mcg / 0.5 ml;
2013-05-28;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85673
PREGNYL;
02182904;
chorionic gonadotropin 10000 unit / vial;
1997-08-13;
Intramuscular;
Kit , Powder For Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44257
CHORIONIC GONADOTROPIN FOR INJECTION, USP;
02247459;
chorionic gonadotropin 10000 unit / vial;
2004-09-13;
Intramuscular , Subcutaneous;
Powder For Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71705
MICRO CR;
00786985;
chromium (chromic chloride) 4 mcg / ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13523
ALVESCO;
02285606;
ciclesonide 100 mcg / act;
2006-09-27;
Inhalation;
Aerosol, Metered Dose;
68:04.00 – ADRENALS;
Prescription;
COVIS PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77111
ALVESCO;
02285614;
ciclesonide 200 mcg / act;
2006-09-27;
Inhalation;
Aerosol, Metered Dose;
68:04.00 – ADRENALS;
Prescription;
COVIS PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77112
OMNARIS;
02303671;
ciclesonide 50 mcg / act;
2008-04-10;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
COVIS PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78899
PENLAC;
02250535;
ciclopirox 8 % / w/w;
2004-07-28;
Topical;
Solution;
84:04.08.20 – HYDROXYPYRIDONES;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73535
APO-CICLOPIROX;
02298953;
ciclopirox 8 % / w/w;
2008-04-18;
Topical;
Solution;
84:04.08.20 – HYDROXYPYRIDONES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78435
TARO-CICLOPIROX;
02353288;
ciclopirox 8 % / w/w;
2011-10-25;
Topical;
Solution;
84:04.08.20 – HYDROXYPYRIDONES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83849
LOPROX;
02221802;
ciclopirox olamine 1 % / w/w;
1996-12-03;
Topical;
Cream;
84:04.08.20 – HYDROXYPYRIDONES;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43306
LOPROX;
02221810;
ciclopirox olamine 1 % / w/w;
1997-03-24;
Topical;
Lotion;
84:04.08.20 – HYDROXYPYRIDONES;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43307
STIEPROX SHAMPOO;
02247228;
ciclopirox olamine 1.5 %;
2003-11-17;
Topical;
Shampoo;
84:04.08.20 – HYDROXYPYRIDONES;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71470
MAR-CIDOFOVIR;
02473925;
cidofovir (cidofovir dihydrate) 375 mg / 5 ml;
2018-07-11;
Intravenous;
Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96392
MYLAN-CILAZAPRIL;
02283778;
cilazapril (cilazapril monohydrate) 1 mg;
2006-07-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76935
INHIBACE;
01911473;
cilazapril (cilazapril monohydrate) 2.5 mg;
1993-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13835
MYLAN-CILAZAPRIL;
02283786;
cilazapril (cilazapril monohydrate) 2.5 mg;
2006-07-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76936
APO-CILAZAPRIL;
02291142;
cilazapril (cilazapril monohydrate) 2.5 mg;
2007-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77652
INHIBACE;
01911481;
cilazapril (cilazapril monohydrate) 5 mg;
1993-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13834
APO-CILAZAPRIL;
02291150;
cilazapril (cilazapril monohydrate) 5 mg;
2007-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77653
MYLAN-CILAZAPRIL;
02283794;
cilazapril (cilazapril monohydrate) 5.0 mg;
2006-07-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76937
CIMETIDINE;
00584215;
cimetidine 200 mg;
1982-12-31;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5195
CIMETIDINE;
00487872;
cimetidine 300 mg;
1982-12-31;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5196
SENSIPAR;
02257130;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2004-09-16;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74235
MYLAN-CINACALCET;
02434539;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2016-06-29;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91886
TEVA-CINACALCET;
02441624;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2016-12-06;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92601
APO-CINACALCET;
02452693;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2016-05-20;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93910
AURO-CINACALCET;
02478900;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2019-02-01;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96960
MAR-CINACALCET;
02480298;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2018-11-29;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97082
M-CINACALCET;
02481987;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2018-12-11;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97245
PRIVA-CINACALCET;
02499355;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2020-08-04;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98909
JAMP CINACALCET TABLETS;
02500094;
cinacalcet (cinacalcet hydrochloride) 30 mg;
2021-02-15;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98980
SENSIPAR;
02257149;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2004-09-16;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74236
MYLAN-CINACALCET;
02434547;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2016-12-22;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91887
TEVA-CINACALCET;
02441632;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2016-12-06;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92602
APO-CINACALCET;
02452707;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2016-05-20;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93911
AURO-CINACALCET;
02478919;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2019-02-01;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96962
MAR-CINACALCET;
02480301;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2018-11-29;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97083
M-CINACALCET;
02481995;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2018-12-11;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97246
PRIVA-CINACALCET;
02499363;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2020-08-04;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98910
JAMP CINACALCET TABLETS;
02500108;
cinacalcet (cinacalcet hydrochloride) 60 mg;
2021-02-15;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98981
SENSIPAR;
02257157;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2004-09-16;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74237
MYLAN-CINACALCET;
02434555;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2016-12-22;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91888
TEVA-CINACALCET;
02441640;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2016-12-06;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92603
APO-CINACALCET;
02452715;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2016-05-20;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93912
AURO-CINACALCET;
02478943;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2019-02-01;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96965
MAR-CINACALCET;
02480328;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2018-11-29;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97084
M-CINACALCET;
02482002;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2018-12-11;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97247
PRIVA-CINACALCET;
02499371;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2020-08-04;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98911
JAMP CINACALCET TABLETS;
02500116;
cinacalcet (cinacalcet hydrochloride) 90 mg;
2021-02-15;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98982
CIPRO XL;
02251787;
ciprofloxacin (ciprofloxacin – ciprofloxacin hydrochloride) 1000 mg;
2004-04-08;
Oral;
Tablet (Immediate And Extended Release);
08:12.18 – QUINOLONES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73669
CIPRO XL;
02247916;
ciprofloxacin (ciprofloxacin – ciprofloxacin hydrochloride) 500 mg;
2003-08-07;
Oral;
Tablet (Immediate And Extended Release);
08:12.18 – QUINOLONES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72225
PMS-CIPROFLOXACIN XL;
02416433;
ciprofloxacin (ciprofloxacin – ciprofloxacin hydrochloride) 500 mg;
2014-01-14;
Oral;
Tablet (Immediate And Extended Release);
08:12.18 – QUINOLONES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90104
SANDOZ CIPROFLOXACIN;
02387131;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 %;
2012-07-03;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87272
CILOXAN;
01945270;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v;
1992-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12953
CILOXAN;
02200864;
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/w;
1998-10-07;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42964
ACT CIPROFLOXACIN;
02247339;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71582
PMS-CIPROFLOXACIN;
02248437;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72788
SANDOZ CIPROFLOXACIN;
02248756;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73124
TARO-CIPROFLOX;
02303728;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2008-01-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78902
PRO-CIPROFLOXACIN;
02317796;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2008-10-27;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80332
CIPROFLOXACIN;
02353318;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2010-07-26;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83851
MAR-CIPROFLOXACIN;
02379686;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2012-09-06;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86555
JAMP-CIPROFLOXACIN;
02380358;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2012-03-13;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86616
AURO-CIPROFLOXACIN;
02381907;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2012-06-13;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86775
CIPROFLOXACIN;
02386119;
ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
2012-06-12;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87170
ACT CIPROFLOXACIN;
02247340;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71583
PMS-CIPROFLOXACIN;
02248438;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72789
SANDOZ CIPROFLOXACIN;
02248757;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73125
RIVA-CIPROFLOXACIN;
02251248;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2004-03-25;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73619
TARO-CIPROFLOX;
02303736;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2008-01-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78903
PRO-CIPROFLOXACIN;
02317818;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2008-10-27;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80333
CIPROFLOXACIN;
02353326;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2010-07-26;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83852
MAR-CIPROFLOXACIN;
02379694;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2012-09-06;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86556
JAMP-CIPROFLOXACIN;
02380366;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2012-03-13;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86617
AURO-CIPROFLOXACIN;
02381923;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2012-06-13;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86776
CIPROFLOXACIN;
02386127;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2012-06-12;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87171
MINT-CIPROFLOX;
02423561;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2014-06-02;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90828
BIO-CIPROFLOXACIN;
02444887;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2016-06-17;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93011
PRIVA-CIPROFLOXACIN;
02445344;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2016-06-17;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93057
AG-CIPROFLOXACIN;
02476592;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2020-01-20;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96666
NRA-CIPROFLOXACIN;
02492008;
ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
2020-12-03;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98201
ACT CIPROFLOXACIN;
02247341;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71584
PMS-CIPROFLOXACIN;
02248439;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72790
SANDOZ CIPROFLOXACIN;
02248758;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2004-02-18;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73126
TARO-CIPROFLOX;
02303744;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2008-01-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78904
MAR-CIPROFLOXACIN;
02379708;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2012-09-06;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86557
JAMP-CIPROFLOXACIN;
02380374;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2012-03-13;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86618
MINT-CIPROFLOX;
02423588;
ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
2014-06-02;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90829
CIPROFLOXACIN INJECTION USP;
02301903;
ciprofloxacin 2 mg / ml;
2008-04-08;
Intravenous;
Solution;
08:12.18 – QUINOLONES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78723
CIPROFLOXACIN INTRAVENOUS INFUSION BP;
02304759;
ciprofloxacin 2 mg / ml;
2008-03-27;
Intravenous;
Solution;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79003
CIPRO ORAL SUSPENSION;
02237514;
ciprofloxacin 500 mg / 5 ml;
1998-09-15;
Oral;
Suspension;
08:12.18 – QUINOLONES;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60849
CISATRACURIUM OMEGA MULTIDOSE;
02408813;
cisatracurium (cisatracurium besylate) 2 mg / ml;
2014-01-20;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89357
CISPLATIN INJECTION BP;
02126613;
cisplatin 1 mg / ml;
1997-05-09;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43840
CISPLATIN INJECTION, BP;
02355183;
cisplatin 1 mg / ml;
2012-04-10;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84044
CISPLATIN INJECTION BP;
02366711;
cisplatin 1 mg / ml;
2011-09-29;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85155
CISPLATIN INJECTION;
02403188;
cisplatin 1.0 mg / ml;
2013-08-29;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88800
PMS-CITALOPRAM;
02270609;
citalopram (citalopram hydrobromide) 10 mg;
2005-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75597
RIVA-CITALOPRAM;
02303256;
citalopram (citalopram hydrobromide) 10 mg;
2008-01-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78858
TEVA-CITALOPRAM;
02312336;
citalopram (citalopram hydrobromide) 10 mg;
2008-12-15;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79783
CITALOPRAM-10;
02325047;
citalopram (citalopram hydrobromide) 10 mg;
2009-06-25;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81046
MAR-CITALOPRAM;
02371871;
citalopram (citalopram hydrobromide) 10 mg;
2012-09-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85700
AG-CITALOPRAM;
02374617;
citalopram (citalopram hydrobromide) 10 mg;
2014-08-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85994
CITALOPRAM;
02387948;
citalopram (citalopram hydrobromide) 10 mg;
2012-06-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87351
NAT-CITALOPRAM;
02409003;
citalopram (citalopram hydrobromide) 10 mg;
2014-02-12;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89374
MINT-CITALOPRAM;
02429691;
citalopram (citalopram hydrobromide) 10 mg;
2015-10-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91414
CITALOPRAM;
02430517;
citalopram (citalopram hydrobromide) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91495
PRIVA-CITALOPRAM;
02440237;
citalopram (citalopram hydrobromide) 10 mg;
2016-02-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92461
CITALOPRAM;
02445719;
citalopram (citalopram hydrobromide) 10 mg;
2015-10-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93099
NRA-CITALOPRAM;
02477637;
citalopram (citalopram hydrobromide) 10 mg;
2018-08-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96828
CELEXA 20 MG;
02239607;
citalopram (citalopram hydrobromide) 20 mg;
1999-03-08;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63077
APO-CITALOPRAM;
02246056;
citalopram (citalopram hydrobromide) 20 mg;
2004-01-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70187
PMS-CITALOPRAM;
02248010;
citalopram (citalopram hydrobromide) 20 mg;
2004-01-15;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72326
SANDOZ CITALOPRAM;
02248170;
citalopram (citalopram hydrobromide) 20 mg;
2004-01-30;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72503
CITALOPRAM-20;
02257513;
citalopram (citalopram hydrobromide) 20 mg;
2004-12-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74277
AURO-CITALOPRAM;
02275562;
citalopram (citalopram hydrobromide) 20 mg;
2011-11-28;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76120
RAN-CITALO;
02285622;
citalopram (citalopram hydrobromide) 20 mg;
2006-12-07;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77113
TEVA-CITALOPRAM;
02293218;
citalopram (citalopram hydrobromide) 20 mg;
2007-09-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77858
RIVA-CITALOPRAM;
02303264;
citalopram (citalopram hydrobromide) 20 mg;
2008-01-28;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78859
AG-CITALOPRAM;
02339390;
citalopram (citalopram hydrobromide) 20 mg;
2014-09-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82501
CITALOPRAM;
02353660;
citalopram (citalopram hydrobromide) 20 mg;
2010-07-30;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83886
MAR-CITALOPRAM;
02371898;
citalopram (citalopram hydrobromide) 20 mg;
2012-09-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85701
CITALOPRAM;
02387956;
citalopram (citalopram hydrobromide) 20 mg;
2012-06-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87352
NAT-CITALOPRAM;
02409011;
citalopram (citalopram hydrobromide) 20 mg;
2014-02-12;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89375
MINT-CITALOPRAM;
02429705;
citalopram (citalopram hydrobromide) 20 mg;
2015-10-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91415
CITALOPRAM;
02430541;
citalopram (citalopram hydrobromide) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91496
CCP-CITALOPRAM;
02459914;
citalopram (citalopram hydrobromide) 20 mg;
2017-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94722
NRA-CITALOPRAM;
02477645;
citalopram (citalopram hydrobromide) 20 mg;
2018-08-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96829
CTP 30;
02296152;
citalopram (citalopram hydrobromide) 30 mg;
2007-10-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78149
CELEXA 40 MG;
02239608;
citalopram (citalopram hydrobromide) 40 mg;
1999-03-08;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63078
APO-CITALOPRAM;
02246057;
citalopram (citalopram hydrobromide) 40 mg;
2004-01-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70188
PMS-CITALOPRAM;
02248011;
citalopram (citalopram hydrobromide) 40 mg;
2004-01-15;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72327
SANDOZ CITALOPRAM;
02248171;
citalopram (citalopram hydrobromide) 40 mg;
2004-01-30;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72504
CITALOPRAM-40;
02257521;
citalopram (citalopram hydrobromide) 40 mg;
2004-12-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74278
AURO-CITALOPRAM;
02275570;
citalopram (citalopram hydrobromide) 40 mg;
2011-11-28;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76121
TEVA-CITALOPRAM;
02293226;
citalopram (citalopram hydrobromide) 40 mg;
2007-12-03;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77859
RIVA-CITALOPRAM;
02303272;
citalopram (citalopram hydrobromide) 40 mg;
2008-01-28;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78860
AG-CITALOPRAM;
02339404;
citalopram (citalopram hydrobromide) 40 mg;
2014-09-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82502
CITALOPRAM;
02353679;
citalopram (citalopram hydrobromide) 40 mg;
2010-07-30;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83887
MAR-CITALOPRAM;
02371901;
citalopram (citalopram hydrobromide) 40 mg;
2012-09-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85702
CITALOPRAM;
02387964;
citalopram (citalopram hydrobromide) 40 mg;
2012-06-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87353
NAT-CITALOPRAM;
02409038;
citalopram (citalopram hydrobromide) 40 mg;
2014-02-12;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89376
MINT-CITALOPRAM;
02429713;
citalopram (citalopram hydrobromide) 40 mg;
2015-10-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91416
CITALOPRAM;
02430568;
citalopram (citalopram hydrobromide) 40 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91497
PRIVA-CITALOPRAM;
02440253;
citalopram (citalopram hydrobromide) 40 mg;
2016-02-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92463
CCP-CITALOPRAM;
02459922;
citalopram (citalopram hydrobromide) 40 mg;
2017-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94723
NRA-CITALOPRAM;
02477653;
citalopram (citalopram hydrobromide) 40 mg;
2018-08-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96830
CLADRIBINE INJECTION;
02319918;
cladribine 1 mg / ml;
2009-06-30;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80536
CLADRIBINE INJECTION;
02494574;
cladribine 1 mg / ml;
2020-08-19;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98457
MAVENCLAD;
02470179;
cladribine 10 mg;
2017-11-30;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95915
BIAXIN;
02146908;
clarithromycin 125 mg / 5 ml;
1995-12-31;
Oral;
Granules For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18066
TARO-CLARITHROMYCIN;
02390442;
clarithromycin 125 mg / 5 ml;
2012-09-04;
Oral;
Granules For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87588
CLARITHROMYCIN;
02408988;
clarithromycin 125 mg / 5 ml;
2013-09-05;
Oral;
Granules For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89372
BIAXIN BID;
01984853;
clarithromycin 250 mg;
1992-12-31;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12779
PMS-CLARITHROMYCIN;
02247573;
clarithromycin 250 mg;
2007-08-10;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71828
TEVA-CLARITHROMYCIN;
02248804;
clarithromycin 250 mg;
2012-05-09;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73173
SANDOZ CLARITHROMYCIN;
02266539;
clarithromycin 250 mg;
2008-06-06;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75196
APO-CLARITHROMYCIN;
02274744;
clarithromycin 250 mg;
2007-07-26;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76021
CLARITHROMYCIN;
02324482;
clarithromycin 250 mg;
2009-10-08;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80993
RAN-CLARITHROMYCIN;
02361426;
clarithromycin 250 mg;
2011-02-01;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84648
CLARITHROMYCIN;
02442469;
clarithromycin 250 mg;
2015-07-22;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92681
CLARITHROMYCIN;
02466120;
clarithromycin 250 mg;
2017-10-20;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95443
M-CLARITHROMYCIN;
02471388;
clarithromycin 250 mg;
2018-03-07;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96049
BIAXIN;
02244641;
clarithromycin 250 mg / 5 ml;
2002-05-28;
Oral;
Granules For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68628
TARO-CLARITHROMYCIN;
02390450;
clarithromycin 250 mg / 5 ml;
2012-09-04;
Oral;
Granules For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87587
CLARITHROMYCIN;
02408996;
clarithromycin 250 mg / 5 ml;
2013-09-05;
Oral;
Granules For Suspension;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89373
BIAXIN BID;
02126710;
clarithromycin 500 mg;
1994-12-31;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17240
PMS-CLARITHROMYCIN;
02247574;
clarithromycin 500 mg;
2007-08-10;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71829
TEVA-CLARITHROMYCIN;
02248805;
clarithromycin 500 mg;
2012-05-09;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73174
SANDOZ CLARITHROMYCIN;
02266547;
clarithromycin 500 mg;
2008-06-06;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75197
APO-CLARITHROMYCIN;
02274752;
clarithromycin 500 mg;
2007-07-26;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76022
CLARITHROMYCIN;
02324490;
clarithromycin 500 mg;
2009-10-08;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80994
RIVA-CLARITHROMYCIN;
02346532;
clarithromycin 500 mg;
2010-06-16;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83196
RAN-CLARITHROMYCIN;
02361434;
clarithromycin 500 mg;
2011-02-01;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84649
ACT CLARITHROMYCIN XL;
02403196;
clarithromycin 500 mg;
2014-12-01;
Oral;
Tablet (Extended-Release);
08:12.12.92 – OTHER MACROLIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88801
APO-CLARITHROMYCIN XL;
02413345;
clarithromycin 500 mg;
2014-09-03;
Oral;
Tablet (Extended-Release);
08:12.12.92 – OTHER MACROLIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89802
CLARITHROMYCIN;
02442485;
clarithromycin 500 mg;
2015-07-22;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92683
M-CLARITHROMYCIN;
02471396;
clarithromycin 500 mg;
2018-03-07;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96050
DALACIN C FLAVOURED GRANULES;
00225851;
clindamycin (clindamycin 2-palmitate hydrochloride) 75 mg / 5 ml;
1972-12-31;
Oral;
Granules For Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1225
DALACIN C 150 MG;
00030570;
clindamycin (clindamycin hydrochloride) 150 mg;
1970-12-31;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=874
TEVA-CLINDAMYCIN;
02241709;
clindamycin (clindamycin hydrochloride) 150 mg;
2000-02-18;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65371
AURO-CLINDAMYCIN;
02436906;
clindamycin (clindamycin hydrochloride) 150 mg;
2015-03-02;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92122
RIVA-CLINDAMYCIN;
02468476;
clindamycin (clindamycin hydrochloride) 150 mg;
2017-10-13;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95690
M-CLINDAMYCIN;
02479923;
clindamycin (clindamycin hydrochloride) 150 mg;
2019-05-28;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97049
JAMP CLINDAMYCIN;
02483734;
clindamycin (clindamycin hydrochloride) 150 mg;
2019-09-27;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97408
AG-CLINDAMYCIN;
02485109;
clindamycin (clindamycin hydrochloride) 150 mg;
2020-02-27;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97536
NRA-CLINDAMYCIN;
02493748;
clindamycin (clindamycin hydrochloride) 150 mg;
2020-07-06;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98373
DALACIN C 300 MG;
02182866;
clindamycin (clindamycin hydrochloride) 300 mg;
1995-12-31;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19455
TEVA-CLINDAMYCIN;
02241710;
clindamycin (clindamycin hydrochloride) 300 mg;
2000-02-18;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65372
AURO-CLINDAMYCIN;
02436914;
clindamycin (clindamycin hydrochloride) 300 mg;
2015-03-02;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92123
RIVA-CLINDAMYCIN;
02468484;
clindamycin (clindamycin hydrochloride) 300 mg;
2017-10-13;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95691
M-CLINDAMYCIN;
02479931;
clindamycin (clindamycin hydrochloride) 300 mg;
2019-05-28;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97050
JAMP CLINDAMYCIN;
02483742;
clindamycin (clindamycin hydrochloride) 300 mg;
2019-09-27;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97409
AG-CLINDAMYCIN;
02485117;
clindamycin (clindamycin hydrochloride) 300 mg;
2020-01-27;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97537
NRA-CLINDAMYCIN;
02493756;
clindamycin (clindamycin hydrochloride) 300 mg;
2020-07-06;
Oral;
Capsule;
08:12.28.20 – LINCOMYCINS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98374
TARO-CLINDAMYCIN;
02266938;
clindamycin (clindamycin phosphate) 1 % / w/v;
2005-10-03;
Topical;
Solution;
84:04.04 – ANTIBIOTICS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75233
CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP;
02483769;
clindamycin (clindamycin phosphate) 1 % / w/v;
2019-12-11;
Topical;
Solution;
84:04.04 – ANTIBIOTICS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97411
CLINDAMYCIN IV INFUSION;
02408511;
clindamycin (clindamycin phosphate) 12 mg / ml;
2013-12-05;
Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89326
DALACIN C PHOSPHATE;
00260436;
clindamycin (clindamycin phosphate) 150 mg / ml;
1973-12-31;
Intramuscular , Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1620
CLINDAMYCIN INJECTION USP;
02230535;
clindamycin (clindamycin phosphate) 150 mg / ml;
1999-01-15;
Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49605
CLINDAMYCIN INJECTION USP;
02230540;
clindamycin (clindamycin phosphate) 150 mg / ml;
1999-01-19;
Intramuscular , Intravenous;
Liquid;
08:12.28.20 – LINCOMYCINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49612
CLINDAMYCIN IV INFUSION;
02408538;
clindamycin (clindamycin phosphate) 18 mg / ml;
2013-12-05;
Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89327
DALACIN VAGINAL CREAM;
02060604;
clindamycin (clindamycin phosphate) 20 mg / g;
1994-12-31;
Vaginal;
Cream;
84:04.04 – ANTIBIOTICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15942
CLINDAMYCIN INJECTION IN 5% DEXTROSE;
02485451;
clindamycin (clindamycin phosphate) 300 mg / 50 ml;
2019-11-20;
Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97570
CLINDAMYCIN INJECTION IN 5% DEXTROSE;
02485478;
clindamycin (clindamycin phosphate) 600 mg / 50 ml;
2019-11-26;
Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97571
CLINDAMYCIN INJECTION IN 5% DEXTROSE;
02485486;
clindamycin (clindamycin phosphate) 900 mg / 50 ml;
2019-12-03;
Intravenous;
Solution;
08:12.28.20 – LINCOMYCINS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97572
TEVA-CLOBAZAM;
02238334;
clobazam 10 mg;
1998-07-07;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61740
APO-CLOBAZAM;
02244638;
clobazam 10 mg;
2001-11-28;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68625
DERMOVATE OINTMENT;
02213273;
clobetasol propionate .05 %;
1999-12-20;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36953
DERMOVATE SCALP APPLICATION;
02213281;
clobetasol propionate .05 %;
2001-06-25;
Topical;
Solution;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36954
TEVA-CLOBETASOL;
01910272;
clobetasol propionate 0.05 %;
1992-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13437
TEVA-CLOBETASOL;
01910299;
clobetasol propionate 0.05 %;
1992-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13438
TEVA-CLOBETASOL;
01910280;
clobetasol propionate 0.05 %;
1992-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13439
MYLAN-CLOBETASOL CREAM;
02024187;
clobetasol propionate 0.05 %;
1993-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14381
MYLAN-CLOBETASOL OINTMENT;
02026767;
clobetasol propionate 0.05 %;
1993-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14382
DERMOVATE CREAM;
02213265;
clobetasol propionate 0.05 %;
1999-09-07;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36952
MYLAN-CLOBETASOL SCALP APPLICATION;
02216213;
clobetasol propionate 0.05 %;
1996-09-10;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43175
TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%;
02245522;
clobetasol propionate 0.05 %;
2002-04-22;
Topical;
Solution;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69609
TARO-CLOBETASOL CREAM USP, 0.05%;
02245523;
clobetasol propionate 0.05 %;
2002-04-22;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69610
TARO-CLOBETASOL OINTMENT USP, 0.05%;
02245524;
clobetasol propionate 0.05 %;
2002-04-22;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69611
CLOBEX SHAMPOO;
02256371;
clobetasol propionate 0.05 %;
2004-12-15;
Topical;
Shampoo;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74161
CLOBEX SPRAY;
02299739;
clobetasol propionate 0.05 % / w/w;
2007-12-19;
Topical;
Spray;
84:06.08 – CORTICOSTEROIDS;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78510
APO-CLOBETASOL SPRAY;
02475162;
clobetasol propionate 0.05 % / w/w;
2018-07-17;
Topical;
Spray;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96546
TARO-CLOBETASOL SPRAY;
02489619;
clobetasol propionate 0.05 % / w/w;
2019-08-26;
Topical;
Spray;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97970
ODAN CLOBETASOL SPRAY;
02490706;
clobetasol propionate 0.05 % / w/w;
2019-09-26;
Topical;
Spray;
84:06.08 – CORTICOSTEROIDS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98076
SANDOZ CLOBETASOL;
02495023;
clobetasol propionate 0.05 % / w/w;
2020-04-23;
Topical;
Spray;
84:06.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98498
TARO-CLOBETASOL SHAMPOO;
02506203;
clobetasol propionate 0.05 % / w/w;
2020-12-22;
Topical;
Shampoo;
84:06.08 – CORTICOSTEROIDS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99554
SPECTRO ECZEMACARE MEDICATED CREAM;
02214415;
clobetasone butyrate 0.05 % / w/w;
1999-09-27;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37001
CLASTEON;
02245828;
clodronate disodium 400 mg;
2004-05-13;
Oral;
Capsule;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69944
CLOLAR;
02330407;
clofarabine 1 mg / ml;
2010-02-10;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81614
ULONE;
01966294;
clofedanol hydrochloride 25 mg / 5 ml;
1962-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13907
ANAFRANIL;
00330566;
clomipramine hydrochloride 10 mg;
1975-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2164
ANAFRANIL;
00324019;
clomipramine hydrochloride 25 mg;
1973-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2039
TARO-CLOMIPRAMINE;
02497506;
clomipramine hydrochloride 25 mg;
2020-05-07;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98731
ANAFRANIL;
00402591;
clomipramine hydrochloride 50 mg;
1981-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4382
TARO-CLOMIPRAMINE;
02497514;
clomipramine hydrochloride 50 mg;
2020-05-07;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98733
PMS-CLONAZEPAM- TAB 0.25MG;
02179660;
clonazepam 0.25 mg;
1995-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19221
RIVOTRIL 0.5TAB;
00382825;
clonazepam 0.5 mg;
1977-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2568
PMS-CLONAZEPAM TAB 0.5MG;
02048701;
clonazepam 0.5 mg;
1993-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14588
APO-CLONAZEPAM – TAB 0.5MG;
02177889;
clonazepam 0.5 mg;
1995-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19063
PMS-CLONAZEPAM-R;
02207818;
clonazepam 0.5 mg;
1996-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19628
TEVA-CLONAZEPAM;
02239024;
clonazepam 0.5 mg;
1999-08-16;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62475
RIVA-CLONAZEPAM;
02242077;
clonazepam 0.5 mg;
2000-05-23;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65751
PRO-CLONAZEPAM;
02311593;
clonazepam 0.5 mg;
2008-07-28;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79715
PMS-CLONAZEPAM TAB 1.0MG;
02048728;
clonazepam 1 mg;
1993-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14587
PRO-CLONAZEPAM;
02311607;
clonazepam 1 mg;
2008-07-09;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79716
RIVOTRIL 2TAB;
00382841;
clonazepam 2 mg;
1977-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2569
PMS-CLONAZEPAM TAB 2MG;
02048736;
clonazepam 2 mg;
1993-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14589
APO-CLONAZEPAM – TAB 2MG;
02177897;
clonazepam 2 mg;
1995-12-31;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19048
TEVA-CLONAZEPAM;
02239025;
clonazepam 2 mg;
1999-08-16;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62476
RIVA-CLONAZEPAM;
02242078;
clonazepam 2 mg;
2000-05-23;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65752
PRO-CLONAZEPAM;
02311615;
clonazepam 2 mg;
2008-07-09;
Oral;
Tablet;
28:12.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79718
TEVA-CLONIDINE;
02304163;
clonidine hydrochloride 0.025 mg;
2008-06-26;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78947
TEVA-CLONIDINE;
02046121;
clonidine hydrochloride 0.1 mg;
1993-12-31;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14715
MINT-CLONIDINE;
02462192;
clonidine hydrochloride 0.1 mg;
2017-06-23;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94992
TEVA-CLONIDINE;
02046148;
clonidine hydrochloride 0.2 mg;
1993-12-31;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14713
MINT-CLONIDINE;
02462206;
clonidine hydrochloride 0.2 mg;
2017-06-23;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94993
TEVA-CLOPIDOGREL;
02388065;
clopidogrel (clopidogrel bisulfate) 300 mg;
2013-01-02;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87363
APO-CLOPIDOGREL;
02398591;
clopidogrel (clopidogrel bisulfate) 300 mg;
2013-01-21;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88354
PLAVIX;
02238682;
clopidogrel (clopidogrel bisulfate) 75 mg;
1998-10-13;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62114
APO-CLOPIDOGREL;
02252767;
clopidogrel (clopidogrel bisulfate) 75 mg;
2011-12-19;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73770
TEVA-CLOPIDOGREL;
02293161;
clopidogrel (clopidogrel bisulfate) 75 mg;
2011-12-14;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77854
ACT CLOPIDOGREL;
02303027;
clopidogrel (clopidogrel bisulfate) 75 mg;
2011-12-07;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78834
PMS-CLOPIDOGREL;
02348004;
clopidogrel (clopidogrel bisulfate) 75 mg;
2011-12-14;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83336
SANDOZ CLOPIDOGREL;
02359316;
clopidogrel (clopidogrel bisulfate) 75 mg;
2011-12-07;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84434
TARO-CLOPIDOGREL;
02379813;
clopidogrel (clopidogrel bisulfate) 75 mg;
2012-04-30;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86568
CLOPIDOGREL;
02385813;
clopidogrel (clopidogrel bisulfate) 75 mg;
2012-06-11;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87143
RIVA-CLOPIDOGREL;
02388529;
clopidogrel (clopidogrel bisulfate) 75 mg;
2012-07-24;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87405
CLOPIDOGREL;
02394820;
clopidogrel (clopidogrel bisulfate) 75 mg;
2012-11-22;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87998
CLOPIDOGREL;
02400553;
clopidogrel (clopidogrel bisulfate) 75 mg;
2013-02-13;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88535
JAMP-CLOPIDOGREL;
02415550;
clopidogrel (clopidogrel bisulfate) 75 mg;
2014-01-15;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90014
AURO-CLOPIDOGREL;
02416387;
clopidogrel (clopidogrel bisulfate) 75 mg;
2014-02-06;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90094
MAR-CLOPIDOGREL;
02422255;
clopidogrel (clopidogrel bisulfate) 75 mg;
2015-01-21;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90695
BIO-CLOPIDOGREL;
02444895;
clopidogrel (clopidogrel bisulfate) 75 mg;
2019-09-23;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93012
PRIVA-CLOPIDOGREL;
02445336;
clopidogrel (clopidogrel bisulfate) 75 mg;
2020-12-11;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93056
NRA-CLOPIDOGREL;
02482037;
clopidogrel (clopidogrel bisulfate) 75 mg;
2020-03-05;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97237
M-CLOPIDOGREL;
02502283;
clopidogrel (clopidogrel bisulfate) 75 mg;
2020-11-03;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99186
CLORAZEPATE;
00860697;
clorazepate dipotassium 15 mg;
1990-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10899
CLORAZEPATE;
00860689;
clorazepate dipotassium 3.75 mg;
1990-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10902
CLORAZEPATE;
00860700;
clorazepate dipotassium 7.5 mg;
1990-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10903
CLOTRIMADERM CREAM 1%;
00812382;
clotrimazole 1 %;
1988-12-31;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11893
CANESTEN 1% TOPICAL CREAM;
02150867;
clotrimazole 1 %;
1995-12-31;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19487
CLOTRIMAZOLE VAGINAL 6;
02229378;
clotrimazole 1 %;
2005-04-29;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47168
CLOTRIMAZOLE CREAM USP 1%;
02229380;
clotrimazole 1 %;
1996-12-31;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47181
CANESTEN EXTERNAL CREAM;
02311720;
clotrimazole 1 %;
2010-03-10;
Topical , Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79727
CLOTRIMADERM VAGINAL 6;
00812366;
clotrimazole 1 % / w/w;
1989-12-31;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9926
CANESTEN 6 DAY INTERNAL CREAM;
02150891;
clotrimazole 1 % / w/w;
1995-12-31;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19483
CANESTEN EXTERNAL ANTIFUNGAL CREAM;
02239432;
clotrimazole 1 % / w/w;
2000-06-02;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62905
CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM;
02462397;
clotrimazole 1 % / w/w;
2018-05-29;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95015
CANESTEN 1 DAY INTERNAL CREAM;
02150883;
clotrimazole 10 % / w/w;
1997-06-11;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44016
CLOTRIMAZOLE VAGINAL 3;
02229379;
clotrimazole 2 %;
1996-12-31;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47180
CLOTRIMADERM VAGINAL 3;
00812374;
clotrimazole 2 % / w/w;
1989-12-31;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9927
CANESTEN 3 DAY INTERNAL CREAM;
02150905;
clotrimazole 2 % / w/w;
1995-12-31;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19484
CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM;
02490927;
clotrimazole 2 % / w/w;
2020-02-14;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98096
CANESTEN COMFORTAB 3;
02150840;
clotrimazole 200 mg;
1995-12-31;
Vaginal;
Vaginal Tablet;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19479
CANESTEN COMFORTAB 1;
02150859;
clotrimazole 500 mg;
1995-12-31;
Vaginal;
Vaginal Tablet;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19480
CLOXACILLIN FOR INJECTION;
02367416;
cloxacillin (cloxacillin sodium) 1 g / vial;
2011-07-28;
Intravenous;
Powder For Solution;
08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85226
CLOXACILLIN FOR INJECTION;
02400081;
cloxacillin (cloxacillin sodium) 10 g / vial;
2013-04-03;
Intravenous;
Powder For Solution;
08:12.16 – PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88492
TEVA-CLOXACILLIN;
00337757;
cloxacillin (cloxacillin sodium) 125 mg / 5 ml;
1980-12-31;
Oral;
Granules For Solution;
08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3794
CLOXACILLIN FOR INJECTION;
02367424;
cloxacillin (cloxacillin sodium) 2 g / vial;
2011-07-28;
Intravenous;
Powder For Solution;
08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85227
TEVA-CLOXACILLIN;
00337765;
cloxacillin (cloxacillin sodium) 250 mg;
1975-12-31;
Oral;
Capsule;
08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2233
TEVA-CLOXACILLIN;
00337773;
cloxacillin (cloxacillin sodium) 500 mg;
1975-12-31;
Oral;
Capsule;
08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2234
CLOXACILLIN FOR INJECTION;
02367408;
cloxacillin (cloxacillin sodium) 500 mg / vial;
2011-09-14;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85225
CLOZARIL;
00894745;
clozapine 100 mg;
1991-12-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
HLS THERAPEUTICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11421
GEN-CLOZAPINE;
02247244;
clozapine 100 mg;
2003-03-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71486
AA-CLOZAPINE;
02248035;
clozapine 100 mg;
2004-01-27;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72355
GEN-CLOZAPINE;
02305011;
clozapine 200 mg;
2008-02-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79039
AA-CLOZAPINE;
02458756;
clozapine 200 mg;
2017-02-27;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94590
CLOZARIL;
02490676;
clozapine 200 mg;
2019-12-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
HLS THERAPEUTICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98073
CLOZARIL;
00894737;
clozapine 25 mg;
1991-12-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
HLS THERAPEUTICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11422
GEN-CLOZAPINE;
02247243;
clozapine 25 mg;
2003-03-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71485
AA-CLOZAPINE;
02248034;
clozapine 25 mg;
2004-01-27;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72354
GEN-CLOZAPINE;
02305003;
clozapine 50 mg;
2008-02-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79038
AA-CLOZAPINE;
02458748;
clozapine 50 mg;
2017-02-27;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94589
CLOZARIL;
02490668;
clozapine 50 mg;
2019-12-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
HLS THERAPEUTICS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98072
IMMUNINE VH;
02206021;
coagulation factor ix (human) 720 unit / 5 ml;
1996-10-18;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43011
IDELVION;
02451352;
coagulation factor ix (recombinant) – albumin fusion protein (rix-fp) 1000 unit / vial;
2019-07-04;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93760
REBINYN;
02470268;
coagulation factor ix (recombinant) – pegylated 1000 unit / vial;
2018-03-23;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95924
REBINYN;
02470276;
coagulation factor ix (recombinant) – pegylated 2000 unit / vial;
2018-03-23;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95925
REBINYN;
02470187;
coagulation factor ix (recombinant) – pegylated 500 unit / vial;
2018-03-23;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95917
BENEFIX;
02293781;
coagulation factor ix (recombinant) 1000 unit / vial;
2007-04-14;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77917
BENEFIX;
02293803;
coagulation factor ix (recombinant) 2000 unit / vial;
2008-07-12;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77918
BENEFIX;
02392984;
coagulation factor ix (recombinant) 3000 unit / vial;
2013-02-12;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87824
BENEFIX;
02293773;
coagulation factor ix (recombinant) 500 unit / vial;
2007-04-14;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77916
NEUTROGENA T/GEL THERAPEUTIC SHAMPOO;
02240645;
coal tar 0.50 %;
2000-09-01;
Topical;
Shampoo;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64224
T/GEL THERAPEUTIC SHAMPOO EXTRA STRENGTH;
02307146;
coal tar 1 %;
2008-09-30;
Topical;
Shampoo;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79280
PSORIASIN GEL;
02240152;
coal tar 1.25 %;
1999-11-30;
Topical;
Gel;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ALVA-AMCO PHARMACAL COMPANIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63668
TARGEL;
00344508;
coal tar 10 %;
1975-12-31;
Topical;
Gel;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2197
DERM OIL;
02448963;
coal tar 10 % / w/v;
2016-08-01;
Topical;
Solution;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
DERMTEK PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93479
DOAK OIL;
02458837;
coal tar 2 %;
2018-02-06;
Topical;
Solution;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94601
PSORIASIN OINTMENT;
02293978;
coal tar 2.0 %;
2007-08-28;
Topical;
Ointment;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ALVA-AMCO PHARMACAL COMPANIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77934
ODANS LIQUOR CARBONIS DETERGENS;
00358495;
coal tar 20 %;
1976-12-31;
Topical;
Solution;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2317
COTELLIC;
02452340;
cobimetinib (cobimetinib fumarate) 20 mg;
2016-04-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93872
CODEINE CONTIN 100MG CONTROLLED RELEASE TAB;
02163748;
codeine (codeine monohydrate – codeine sulfate trihydrate) 100 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19050
CODEINE CONTIN 150MG CONTROLLED RELEASE TAB;
02163780;
codeine (codeine monohydrate – codeine sulfate trihydrate) 150 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19051
CODEINE CONTIN 200MG CONTROLLED RELEASE TAB;
02163799;
codeine (codeine monohydrate – codeine sulfate trihydrate) 200 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19049
CODEINE CONTIN 50MG CONTROLLED RELEASE TAB;
02230302;
codeine (codeine monohydrate – codeine sulfate trihydrate) 50 mg;
1997-03-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49057
LINCTUS CODEINE BLANC;
00380571;
codeine phosphate 10 mg / 5 ml;
1978-12-31;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2982
TEVA-CODEINE;
00593435;
codeine phosphate 15 mg;
1983-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6415
CODEINE 15;
02009889;
codeine phosphate 15 mg;
1994-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16475
CODEINE PHOSPHATE SYRUP;
00050024;
codeine phosphate 25 mg / 5 ml;
1986-12-18;
Oral;
Syrup;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=943
TEVA-CODEINE;
00593451;
codeine phosphate 30 mg;
1983-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6416
CODEINE 30;
02009757;
codeine phosphate 30 mg;
1994-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16474
CODEINE PHOSPHATE INJECTION USP;
00544884;
codeine phosphate 30 mg / 1 ml;
1978-12-31;
Intramuscular , Subcutaneous;
Liquid;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4806
SANDOZ COLCHICINE;
00287873;
colchicine 0.6 mg;
1974-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1931
COLCHICINE TAB 0.6MG;
00572349;
colchicine 0.6 mg;
1982-12-31;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5069
JAMP-COLCHICINE;
02373823;
colchicine 0.6 mg;
2011-10-07;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85904
PMS-COLCHICINE;
02402181;
colchicine 0.6 mg;
2013-02-27;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88705
EURO-COLCHICINE;
02456559;
colchicine 0.6 mg;
2019-10-10;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94355
LODALIS;
02432463;
colesevelam hydrochloride 3.75 g / sachet;
2015-04-02;
Oral;
Powder For Suspension;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91692
LODALIS;
02373955;
colesevelam hydrochloride 625 mg;
2012-02-06;
Oral;
Tablet;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85917
APO-COLESEVELAM;
02494051;
colesevelam hydrochloride 625 mg;
2020-07-23;
Oral;
Tablet;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98409
COLESTID TABLETS;
02132680;
colestipol hydrochloride 1 g;
1995-12-31;
Oral;
Tablet;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18627
COLESTID GRANULES;
00642975;
colestipol hydrochloride 5 g / sachet;
1985-12-31;
Oral;
Granules;
24:06.04 – BILE ACID SEQUESTRANTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7199
COLY-MYCIN M PARENTERAL;
00476420;
colistin (colistimethate sodium) 150 mg / vial;
1974-12-31;
Intramuscular , Intravenous;
Powder For Solution;
08:12.28.28 – POLYMYXINS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5524
COLISTIMETHATE FOR INJECTION U.S.P.;
02244849;
colistin (colistimethate sodium) 150 mg / vial;
2002-04-15;
Intramuscular , Intravenous;
Powder For Solution;
08:12.28.28 – POLYMYXINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68839
COLISTIMETHATE FOR INJECTION;
02403544;
colistin (colistimethate sodium) 150 mg / vial;
2014-06-05;
Intramuscular , Intravenous;
Powder For Solution;
08:12.28.28 – POLYMYXINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88833
SANTYL;
02063670;
collagenase 250 unit / g;
1994-12-31;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
SMITH & NEPHEW INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16678
PREMARIN;
02414678;
conjugated estrogens 0.3 mg;
2014-10-03;
Oral;
Tablet (Extended-Release);
68:16.04 – ESTROGENS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89930
PREMARIN;
02414686;
conjugated estrogens 0.625 mg;
2014-10-03;
Oral;
Tablet (Extended-Release);
68:16.04 – ESTROGENS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89931
PREMARIN VAGINAL CREAM;
02043440;
conjugated estrogens 0.625 mg / g;
1994-12-31;
Vaginal;
Cream;
68:16.04 – ESTROGENS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15704
PREMARIN;
02414694;
conjugated estrogens 1.25 mg;
2014-10-03;
Oral;
Tablet (Extended-Release);
68:16.04 – ESTROGENS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89932
PREMARIN INTRAVENOUS;
02043386;
conjugated estrogens 25 mg / vial;
1994-12-31;
Intramuscular , Intravenous;
Powder For Solution;
68:16.04 – ESTROGENS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16736
MICRO CU;
00786969;
copper (cupric sulfate) 0.4 mg / ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13563
CORTISONE ACETATE;
00280437;
cortisone acetate 25 mg;
1973-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1802
EUCRISA;
02476991;
crisaborole 2 % / w/w;
2018-08-29;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96774
XALKORI;
02384256;
crizotinib 200 mg;
2012-05-10;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86999
XALKORI;
02384264;
crizotinib 250 mg;
2012-05-10;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87000
PMS-SODIUM CROMOGLYCATE;
02046113;
cromolyn sodium 1 %;
1993-12-31;
Inhalation;
Solution;
48:10.32 – MAST-CELL STABILIZERS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14758
NALCROM;
00500895;
cromolyn sodium 100 mg;
1981-12-31;
Oral;
Capsule;
48:10.32 – MAST-CELL STABILIZERS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4114
CROMOLYN EYE DROPS;
02009277;
cromolyn sodium 2 %;
1993-12-31;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13857
EURAX CREAM 10%;
00623377;
crotamiton 10 %;
1953-12-31;
Topical;
Cream;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
COLUMBIA LABORATORIES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7152
TEVA-CYCLOBENZAPRINE;
02080052;
cyclobenzaprine hydrochloride 10 mg;
1994-12-31;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15912
APO-CYCLOBENZAPRINE;
02177145;
cyclobenzaprine hydrochloride 10 mg;
1995-12-31;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18806
PMS-CYCLOBENZAPRINE – TAB 10MG;
02212048;
cyclobenzaprine hydrochloride 10 mg;
1996-12-31;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19827
CYCLOBENZAPRINE – 10;
02220644;
cyclobenzaprine hydrochloride 10 mg;
1997-01-15;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43292
RIVA-CYCLOBENZAPRINE;
02242079;
cyclobenzaprine hydrochloride 10 mg;
2000-05-23;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65753
CYCLOBENZAPRINE;
02287064;
cyclobenzaprine hydrochloride 10 mg;
2010-02-25;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77249
AURO-CYCLOBENZAPRINE;
02348853;
cyclobenzaprine hydrochloride 10 mg;
2011-06-15;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83419
JAMP-CYCLOBENZAPRINE;
02357127;
cyclobenzaprine hydrochloride 10 mg;
2011-10-18;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84222
CYCLOBENZAPRINE;
02424584;
cyclobenzaprine hydrochloride 10 mg;
2014-10-01;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90926
AG-CYCLOBENZAPRINE;
02485419;
cyclobenzaprine hydrochloride 10 mg;
2020-02-28;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97566
FLEXERIL;
02495422;
cyclobenzaprine hydrochloride 10 mg;
2020-03-20;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
ORIMED PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98534
ODAN-CYCLOPENTOLATE;
00626627;
cyclopentolate hydrochloride 1 %;
1984-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5997
CYCLOGYL;
00252506;
cyclopentolate hydrochloride 1 % / w/v;
1972-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1530
MINIMS CYCLOPENTOLATE HYDROCHLORIDE;
02148382;
cyclopentolate hydrochloride 1 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18742
PROCYTOX;
02241799;
cyclophosphamide 1000 mg / vial;
2003-11-18;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65464
PROCYTOX;
02241797;
cyclophosphamide 200 mg / vial;
2000-11-26;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65462
PROCYTOX;
02241800;
cyclophosphamide 2000 mg / vial;
2003-11-03;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65465
PROCYTOX TAB 25MG;
02241795;
cyclophosphamide 25 mg;
2000-09-01;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65460
PROCYTOX TAB 50MG;
02241796;
cyclophosphamide 50 mg;
2000-08-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65461
PROCYTOX;
02241798;
cyclophosphamide 500 mg / vial;
2000-10-26;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65463
RESTASIS;
02355655;
cyclosporine 0.05 % / w/v;
2010-09-29;
Ophthalmic;
Emulsion;
52:08.92 – ANTI-INFLAMMATORY AGENTS, MISCELLANEOUS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84087
TEVA-CYCLOSPORINE;
02462486;
cyclosporine 0.05 % / w/v;
2017-12-04;
Ophthalmic;
Emulsion;
52:08.92 – ANTI-INFLAMMATORY AGENTS, MISCELLANEOUS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95023
RESTASIS MULTIDOSE;
02476835;
cyclosporine 0.05 % / w/v;
2018-08-09;
Ophthalmic;
Emulsion;
52:08.92 – ANTI-INFLAMMATORY AGENTS, MISCELLANEOUS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96764
VERKAZIA;
02484137;
cyclosporine 0.1 % / w/v;
2019-04-26;
Ophthalmic;
Emulsion;
52:08.92 – ANTI-INFLAMMATORY AGENTS, MISCELLANEOUS;
Prescription;
SANTEN INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97446
NEORAL 10MG;
02237671;
cyclosporine 10 mg;
1998-10-02;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61016
NEORAL 100MG;
02150670;
cyclosporine 100 mg;
1995-12-31;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17799
SANDOZ CYCLOSPORINE;
02242821;
cyclosporine 100 mg;
2001-12-27;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66649
NEORAL ORAL SOLUTION 100MG/ML;
02150697;
cyclosporine 100 mg / ml;
1995-12-31;
Oral;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17801
NEORAL 25MG;
02150689;
cyclosporine 25 mg;
1995-12-31;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17813
SANDOZ CYCLOSPORINE;
02247073;
cyclosporine 25 mg;
2005-05-16;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71308
NEORAL 50MG;
02150662;
cyclosporine 50 mg;
1995-12-31;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17814
SANDOZ CYCLOSPORINE;
02247074;
cyclosporine 50 mg;
2006-10-18;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71309
SANDIMMUNE IV 50MG/ML;
00593257;
cyclosporine 50 mg / ml;
1984-12-31;
Intravenous;
Liquid;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5790
JAMP-CYPROHEPTADINE;
02332248;
cyproheptadine hydrochloride 4 mg;
2010-05-03;
Oral;
Tablet;
04:04.92 – MISCELLANEOUS DERIVATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81790
ANDROCUR DEPOT;
00704423;
cyproterone acetate 100 mg / ml;
1990-12-31;
Intramuscular;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11880
ANDROCUR;
00704431;
cyproterone acetate 50 mg;
1987-12-31;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7394
CYPROTERONE;
02245898;
cyproterone acetate 50 mg;
2004-04-20;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70015
MED-CYPROTERONE;
02390760;
cyproterone acetate 50 mg;
2012-10-02;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87616
RIVA-CYPROTERONE;
02395797;
cyproterone acetate 50 mg;
2012-11-28;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88085
PROCYSBI;
02464705;
cysteamine (cysteamine bitartrate) 25 mg;
2017-10-17;
Oral;
Capsule (Delayed Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
HORIZON THERAPEUTICS IRELAND DAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95283
PROCYSBI;
02464713;
cysteamine (cysteamine bitartrate) 75 mg;
2017-10-17;
Oral;
Capsule (Delayed Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
HORIZON THERAPEUTICS IRELAND DAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95284
CYSTADROPS;
02485605;
cysteamine (cysteamine hydrochloride) 0.37 % / w/w;
2019-05-15;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97584
CYTARABINE INJECTION;
02126656;
cytarabine 100 mg / ml;
1996-09-23;
Intrathecal , Intravenous , Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43843
PMS-CYTARABINE;
02406772;
cytarabine 100 mg / ml;
2014-01-16;
Intrathecal , Intravenous , Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89145
PMS-CYTARABINE;
02406764;
cytarabine 20 mg / ml;
2014-01-16;
Intrathecal , Intravenous , Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89144
CYTOGAM;
02231962;
cytomegalovirus immunoglobulin (human) 50 mg / ml;
2000-04-25;
Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51418

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut